BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Rodríguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL; COVID-STORM Clinicians., COVID Clinicians., Imagine COVID Group., French COVID Cohort Study Group., CoV-Contact Cohort., Amsterdam UMC Covid-19 Biobank., COVID Human Genetic Effort., NIAID-USUHS/TAGC COVID Immunity Group. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020;370:eabd4570. [PMID: 32972995 DOI: 10.1126/science.abd4570] [Cited by in Crossref: 904] [Cited by in F6Publishing: 918] [Article Influence: 452.0] [Reference Citation Analysis]
Number Citing Articles
1 Beer J, Crotta S, Breithaupt A, Ohnemus A, Becker J, Sachs B, Kern L, Llorian M, Ebert N, Labroussaa F, Nhu Thao TT, Trueeb BS, Jores J, Thiel V, Beer M, Fuchs J, Kochs G, Wack A, Schwemmle M, Schnepf D. Impaired immune response drives age-dependent severity of COVID-19. J Exp Med 2022;219:e20220621. [PMID: 36129445 DOI: 10.1084/jem.20220621] [Reference Citation Analysis]
2 Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Le Voyer T, Bizien L, Manry J, Rosain J, Philippot Q, Goavec K, Padey B, Cupic A, Laurent E, Saker K, Vanker M, Särekannu K, Abel L, Aiuti A, Al-muhsen S, Al-mulla F, Anderson MS, Andreakos E, Arias AA, Baris Feldman H, Belot A, Biggs CM, Bogunovic D, Bolze A, Bondarenko A, Bousfiha AA, Brodin P, Bryceson Y, Bustamante CD, Butte MJ, Casari G, Christodoulou J, Condino-neto A, Constantinescu SN, Cooper MA, Dalgard CL, Desai M, Drolet BA, El Baghdadi J, Espinosa-padilla S, Fellay J, Flores C, Fragkou PC, Franco JL, Froidure A, Galani IE, Gregersen PK, Grimbacher B, Haerynck F, Hagin D, Halwani R, Hammarström L, Heath JR, Henrickson SE, Hsieh EW, Husebye E, Imai K, Itan Y, Jarvis ED, Karamitros T, Kisand K, Koltsida O, Ku C, Lau Y, Ling Y, Lucas CL, Maniatis T, Mansouri D, Maródi L, Meyts I, Milner JD, Mironska K, Mogensen TH, Morio T, Ng LF, Notarangelo LD, Novelli A, Novelli G, O'farrelly C, Okada S, Okamoto K, Ozcelik T, Pan-hammarström Q, Pape JW, Perez de Diego R, Perlin DS, Pesole G, Planas AM, Prando C, Pujol A, Quintana-murci L, Ramaswamy S, Rapti V, Renia L, Resnick I, Rodríguez-gallego C, Rovina N, Sancho-shimizu V, Sediva A, Seppänen MR, Shahrooei M, Shcherbina A, Slaby O, Snow AL, Soler-palacín P, Spaan AN, Tancevski I, Tangye SG, Abou Tayoun A, Temel ŞG, Tsiodras S, Turvey SE, Uddin KF, Uddin MJ, van de Beek D, Vinh DC, von Bernuth H, Wauters J, Zatz M, Zawadzki P, Su HC, Casanova J, Morel P, Richard P, Bonneaudeau B, Cannet D, Gallian P, Jeanne M, Perroquin M, Hamzeh-cognasse H, Cognasse F, Tiberghien P, Nadif R, Goldberg M, Ozguler A, Henny J, Lemonnier S, Coeuret-pellicer M, Le Got S, Zins M, Tzourio C, Debette S, Dufouil C, Soumaré A, Lachaize M, Fievet N, Flaig A, Martin F, Mehlal-sedkaoui S, Sallette J, Hernu R, Lina B, Schwebel C, Wroblewski I, Morand P, Souweine B, Boeuf B, Peigue-lafeuille H, Darmon M, Patural H, Pozzetto B, Quenot JP, Colomb B, Pothier P, Belot A, Abad Arranz M, Aguilar Guisado M, Escoresca Ortega A, Gallardo Ríos R, Merino Díaz L, Del Mar Muñoz Garcia M, Ramírez Duque N, Romero Vázquez GM, Sánchez Cordero MJ, Salamanca Rivera C, Niubó J, Rombauts A, Navarrete N, Romero Oraa L, Palomo V, García-salum T, Ferres M, Le Corre N, Sánchez-céspedes J, Balsera-manzanero M, Carratala J, Retamar-gentil P, Abelenda-alonso G, Valiente A, Tiberghien P, Zins M, Debette S, Meyts I, Haerynck F, Castagnoli R, Notarangelo LD, Gonzalez-granado LI, Dominguez-pinilla N, Andreakos E, Triantafyllia V, Rodríguez-gallego C, Solé-violán J, Ruiz-hernandez JJ, Rodríguez de Castro F, Ferreres J, Briones M, Wauters J, Vanderbeke L, Feys S, Kuo C, Lei W, Ku C, Tal G, Etzioni A, Hanna S, Fournet T, Casalegno J, Queromes G, Argaud L, Javouhey E, Rosa-calatrava M, Cordero E, Aydillo T, Medina RA, Kisand K, Puel A, Jouanguy E, Abel L, Cobat A, Trouillet-assant S, García-sastre A, Casanova J; COVID Human Genetic Effort, Etablissement Français du Sang Study Group, Constances Cohort, 3C-Dijon Study, Cerba HealthCare Group, Lyon Antigrippe Working Group, REIPI INF Working Group. Autoantibodies against type I IFNs in patients with critical influenza pneumonia. Journal of Experimental Medicine 2022;219:e20220514. [DOI: 10.1084/jem.20220514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Costa Silva RCM, Bandeira-Melo C, Paula Neto HA, Vale AM, Travassos LH. COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies. Med Hypotheses 2022;167:110943. [PMID: 36105250 DOI: 10.1016/j.mehy.2022.110943] [Reference Citation Analysis]
4 Majumder N, Deepak V, Hadique S, Aesoph D, Velayutham M, Ye Q, Mazumder MHH, Lewis SE, Kodali V, Roohollahi A, Guo NL, Hu G, Khramtsov VV, Johnson RJ, Wen S, Kelley EE, Hussain S. Redox imbalance in COVID-19 pathophysiology. Redox Biol 2022;56:102465. [PMID: 36116160 DOI: 10.1016/j.redox.2022.102465] [Reference Citation Analysis]
5 Cremoni M, Allouche J, Graça D, Zorzi K, Fernandez C, Teisseyre M, Benzaken S, Ruetsch-chelli C, Esnault VLM, Dellamonica J, Carles M, Barrière J, Ticchioni M, Brglez V, Seitz-polski B. Low baseline IFN-γ response could predict hospitalization in COVID-19 patients. Front Immunol 2022;13:953502. [DOI: 10.3389/fimmu.2022.953502] [Reference Citation Analysis]
6 Clerbaux L, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. JCM 2022;11:5691. [DOI: 10.3390/jcm11195691] [Reference Citation Analysis]
7 Steiger S, Ehreiser L, Anders J, Anders H. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials. Front Immunol 2022;13:999704. [DOI: 10.3389/fimmu.2022.999704] [Reference Citation Analysis]
8 Ji X, Chen B, Ze B, Zhou W. Human genetic basis of severe or critical illness in COVID-19. Front Cell Infect Microbiol 2022;12:963239. [DOI: 10.3389/fcimb.2022.963239] [Reference Citation Analysis]
9 Leung D, Mu X, Duque JSR, Cheng SMS, Wang M, Zhang W, Zhang Y, Tam IYS, Lee TSS, Lam JHY, Chan SM, Cheang CH, Chung Y, Wong HHW, Lee AMT, Li WY, Chaothai S, Tsang LCH, Chua GT, Cheong K, Au EYL, Kwok JSY, Chan KW, Chong PCY, Lee PPW, Ho MHK, Lee TL, Tu W, Peiris M, Lau YL. Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity. Front Immunol 2022;13:982155. [DOI: 10.3389/fimmu.2022.982155] [Reference Citation Analysis]
10 Bencze D, Fekete T, Pázmándi K. Correlation between Type I Interferon Associated Factors and COVID-19 Severity. Int J Mol Sci 2022;23:10968. [PMID: 36142877 DOI: 10.3390/ijms231810968] [Reference Citation Analysis]
11 Zalewska M, Fus W, Konka A, Wystyrk K, Bochenek A, Botor H, Fronczek M, Zembala-John J, Adamek B. An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results. Vaccines (Basel) 2022;10:1546. [PMID: 36146624 DOI: 10.3390/vaccines10091546] [Reference Citation Analysis]
12 DeWolf S, Laracy JC, Perales MA, Kamboj M, van den Brink MRM, Vardhana S. SARS-CoV-2 in immunocompromised individuals. Immunity 2022:S1074-7613(22)00500-3. [PMID: 36182669 DOI: 10.1016/j.immuni.2022.09.006] [Reference Citation Analysis]
13 Sanches Santos Rizzo Zuttion M, Moore SKL, Chen P, Beppu AK, Hook JL. New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome. Biomolecules 2022;12:1273. [PMID: 36139112 DOI: 10.3390/biom12091273] [Reference Citation Analysis]
14 Laurent P, Yang C, Rendeiro AF, Nilsson-Payant BE, Carrau L, Chandar V, Bram Y, tenOever BR, Elemento O, Ivashkiv LB, Schwartz RE, Barrat FJ. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19. Sci Immunol 2022;7:eadd4906. [PMID: 36083891 DOI: 10.1126/sciimmunol.add4906] [Reference Citation Analysis]
15 Langelier MJ, Vinh DC. Host-directed immunotherapy to fight infectious diseases. Curr Opin Pediatr 2022. [PMID: 36081357 DOI: 10.1097/MOP.0000000000001176] [Reference Citation Analysis]
16 Daza-cajigal V, Albuquerque AS, Young DF, Ciancanelli MJ, Moulding D, Angulo I, Jeanne-julien V, Rosain J, Minskaia E, Casanova J, Boisson-dupuis S, Bustamante J, Randall RE, Mchugh TD, Thrasher AJ, Burns SO. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria. Front Immunol 2022;13:888427. [DOI: 10.3389/fimmu.2022.888427] [Reference Citation Analysis]
17 Latini A, Vancheri C, Amati F, Morini E, Grelli S, Claudia M, Vita P, Colona VL, Murdocca M, Andreoni M, Malagnino V, Raponi M, Cocciadiferro D, Novelli A, Borgiani P, Novelli G. Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors. J Cell Mol Med 2022. [PMID: 36073344 DOI: 10.1111/jcmm.17492] [Reference Citation Analysis]
18 Liu Z, Yang M, Yu K, Lian Z, Deng S. Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments. Front Pharmacol 2022;13:989664. [DOI: 10.3389/fphar.2022.989664] [Reference Citation Analysis]
19 Enichen E, Harvey C, Demmig-adams B. COVID-19 Spotlights Connections between Disease and Multiple Lifestyle Factors. American Journal of Lifestyle Medicine. [DOI: 10.1177/15598276221123005] [Reference Citation Analysis]
20 Zoellner N, Coesfeld N, De Vos FH, Denter J, Xu HC, Zimmer E, Knebel B, Al-hasani H, Mossner S, Lang PA, Floss DM, Scheller J. Synthetic mimetics assigned a major role to IFNAR2 in type I interferon signaling. Front Microbiol 2022;13:947169. [DOI: 10.3389/fmicb.2022.947169] [Reference Citation Analysis]
21 Tian X, Xu F, Zhu Q, Feng Z, Dai W, Zhou Y, You Q, Xu X. Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114791] [Reference Citation Analysis]
22 Liu G, Gack MU. Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus. Current Opinion in Immunology 2022. [DOI: 10.1016/j.coi.2022.102252] [Reference Citation Analysis]
23 Cornet M, Grose C, Vexler Z, Wu YW, Fullerton HJ. The Role of Infection and Inflammation in the Pathogenesis of Pediatric Arterial Ischemic Stroke. Seminars in Pediatric Neurology 2022. [DOI: 10.1016/j.spen.2022.100995] [Reference Citation Analysis]
24 Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Uchida S, Uno S, Nishimura T, Ishiguro T, Isono T, Shibata S, Matsui Y, Hosoda C, Takano K, Nishida T, Kobayashi Y, Takaku Y, Takayanagi N, Ueda S, Tada A, Miyawaki M, Yamamoto M, Yoshida E, Hayashi R, Nagasaka T, Arai S, Kaneko Y, Sasaki K, Tagaya E, Kawana M, Arimura K, Takahashi K, Anzai T, Ito S, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa CT, Nakajima J, Nakano Y, Nakajima Y, Anan R, Arai R, Kurihara Y, Harada Y, Nishio K, Ueda T, Azuma M, Saito R, Sado T, Miyazaki Y, Sato R, Haruta Y, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Kimura T, Sato T, Takei R, Hagimoto S, Noguchi Y, Yamano Y, Sasano H, Ota S, Nakamori Y, Yoshiya K, Saito F, Yoshihara T, Wada D, Iwamura H, Kanayama S, Maruyama S, Yoshiyama T, Ohta K, Kokuto H, Ogata H, Tanaka Y, Arakawa K, Shimoda M, Osawa T, Tateno H, Hase I, Yoshida S, Suzuki S, Kawada M, Horinouchi H, Saito F, Mitamura K, Hagihara M, Ochi J, Uchida T, Baba R, Arai D, Ogura T, Takahashi H, Hagiwara S, Nagao G, Konishi S, Nakachi I, Murakami K, Yamada M, Sugiura H, Sano H, Matsumoto S, Kimura N, Ono Y, Baba H, Suzuki Y, Nakayama S, Masuzawa K, Namba S, Suzuki K, Naito Y, Liu YC, Takuwa A, Sugihara F, Wing JB, Sakakibara S, Hizawa N, Shiroyama T, Miyawaki S, Kawamura Y, Nakayama A, Matsuo H, Maeda Y, Nii T, Noda Y, Niitsu T, Adachi Y, Enomoto T, Amiya S, Hara R, Yamaguchi Y, Murakami T, Kuge T, Matsumoto K, Yamamoto Y, Yamamoto M, Yoneda M, Kishikawa T, Yamada S, Kawabata S, Kijima N, Takagaki M, Sasa N, Ueno Y, Suzuki M, Takemoto N, Eguchi H, Fukusumi T, Imai T, Fukushima M, Kishima H, Inohara H, Tomono K, Kato K, Takahashi M, Matsuda F, Hirata H, Takeda Y, Koh H, Manabe T, Funatsu Y, Ito F, Fukui T, Shinozuka K, Kohashi S, Miyazaki M, Shoko T, Kojima M, Adachi T, Ishikawa M, Takahashi K, Inoue T, Hirano T, Kobayashi K, Takaoka H, Watanabe K, Miyazawa N, Kimura Y, Sado R, Sugimoto H, Kamiya A, Kuwahara N, Fujiwara A, Matsunaga T, Sato Y, Okada T, Hirai Y, Kawashima H, Narita A, Niwa K, Sekikawa Y, Nishi K, Nishitsuji M, Tani M, Suzuki J, Nakatsumi H, Ogura T, Kitamura H, Hagiwara E, Murohashi K, Okabayashi H, Mochimaru T, Nukaga S, Satomi R, Oyamada Y, Mori N, Baba T, Fukui Y, Odate M, Mashimo S, Makino Y, Yagi K, Hashiguchi M, Kagyo J, Shiomi T, Fuke S, Saito H, Tsuchida T, Fujitani S, Takita M, Morikawa D, Yoshida T, Izumo T, Inomata M, Kuse N, Awano N, Tone M, Ito A, Nakamura Y, Hoshino K, Maruyama J, Ishikura H, Takata T, Odani T, Amishima M, Hattori T, Shichinohe Y, Kagaya T, Kita T, Ohta K, Sakagami S, Koshida K, Hayashi K, Shimizu T, Kozu Y, Hiranuma H, Gon Y, Izumi N, Nagata K, Ueda K, Taki R, Hanada S, Kawamura K, Ichikado K, Nishiyama K, Muranaka H, Nakamura K, Hashimoto N, Wakahara K, Sakamoto K, Omote N, Ando A, Kodama N, Kaneyama Y, Maeda S, Kuraki T, Matsumoto T, Yokote K, Nakada TA, Abe R, Oshima T, Shimada T, Harada M, Takahashi T, Ono H, Sakurai T, Shibusawa T, Kimizuka Y, Kawana A, Sano T, Watanabe C, Suematsu R, Sageshima H, Yoshifuji A, Ito K, Takahashi S, Ishioka K, Nakamura M, Masuda M, Wakabayashi A, Watanabe H, Ueda S, Nishikawa M, Chihara Y, Takeuchi M, Onoi K, Shinozuka J, Sueyoshi A, Nagasaki Y, Okamoto M, Ishihara S, Shimo M, Tokunaga Y, Kusaka Y, Ohba T, Isogai S, Ogawa A, Inoue T, Fukuyama S, Eriguchi Y, Yonekawa A, Kan-O K, Matsumoto K, Kanaoka K, Ihara S, Komuta K, Inoue Y, Chiba S, Yamagata K, Hiramatsu Y, Kai H, Asano K, Oguma T, Ito Y, Hashimoto S, Yamasaki M, Kasamatsu Y, Komase Y, Hida N, Tsuburai T, Oyama B, Takada M, Kanda H, Kitagawa Y, Fukuta T, Miyake T, Yoshida S, Ogura S, Abe S, Kono Y, Togashi Y, Takoi H, Kikuchi R, Ogawa S, Ogata T, Ishihara S, Kanehiro A, Ozaki S, Fuchimoto Y, Wada S, Fujimoto N, Nishiyama K, Terashima M, Beppu S, Yoshida K, Narumoto O, Nagai H, Ooshima N, Motegi M, Umeda A, Miyagawa K, Shimada H, Endo M, Ohira Y, Watanabe M, Inoue S, Igarashi A, Sato M, Sagara H, Tanaka A, Ohta S, Kimura T, Shibata Y, Tanino Y, Nikaido T, Minemura H, Sato Y, Yamada Y, Hashino T, Shinoki M, Iwagoe H, Takahashi H, Fujii K, Kishi H, Kanai M, Imamura T, Yamashita T, Yatomi M, Maeno T, Hayashi S, Takahashi M, Kuramochi M, Kamimaki I, Tominaga Y, Ishii T, Utsugi M, Ono A, Tanaka T, Kashiwada T, Fujita K, Saito Y, Seike M, Watanabe H, Matsuse H, Kodaka N, Nakano C, Oshio T, Hirouchi T, Makino S, Egi M, Omae Y, Nannya Y, Ueno T, Katayama K, Ai M, Fukui Y, Kumanogoh A, Sato T, Hasegawa N, Tokunaga K, Ishii M, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K, Okada Y; Biobank Japan Project. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature 2022;609:754-60. [PMID: 35940203 DOI: 10.1038/s41586-022-05163-5] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cariou M, Picard L, Guéguen L, Jacquet S, Cimarelli A, Fregoso OI, Molaro A, Navratil V, Etienne L. Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19. Proc Natl Acad Sci U S A 2022;119:e2206610119. [PMID: 35947637 DOI: 10.1073/pnas.2206610119] [Reference Citation Analysis]
26 Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C. The role of B cells in COVID-19 infection and vaccination. Front Immunol 2022;13:988536. [DOI: 10.3389/fimmu.2022.988536] [Reference Citation Analysis]
27 Yi J, Miao J, Zuo Q, Owusu F, Dong Q, Lin P, Wang Q, Gao R, Kong X, Yang L. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Front Immunol 2022;13:978619. [DOI: 10.3389/fimmu.2022.978619] [Reference Citation Analysis]
28 Upadhyai P, Shenoy PU, Banjan B, Albeshr MF, Mahboob S, Manzoor I, Das R. Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. Life 2022;12:1300. [DOI: 10.3390/life12091300] [Reference Citation Analysis]
29 Selickman J, Vrettou CS, Mentzelopoulos SD, Marini JJ. COVID-19-Related ARDS: Key Mechanistic Features and Treatments. J Clin Med 2022;11:4896. [PMID: 36013135 DOI: 10.3390/jcm11164896] [Reference Citation Analysis]
30 van der Made CI, Netea MG, van der Veerdonk FL, Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Med 2022;14. [DOI: 10.1186/s13073-022-01100-3] [Reference Citation Analysis]
31 Xue B, Li H, Liu S, Feng Q, Xu Y, Deng R, Chen S, Wang J, Li X, Wan M, Tang S, Zhu H. The redox cycling of STAT2 maintains innate immune homeostasis. Cell Rep 2022;40:111215. [PMID: 35977519 DOI: 10.1016/j.celrep.2022.111215] [Reference Citation Analysis]
32 Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, Kuriyama S, Ohki S, Yamamoto E, Inaba Y, Shiko Y, Aoki A, Kokubo K, Hirasawa R, Hishiya T, Tsuji K, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Tsukamoto T, Nakamura S, Urushibara T, Kaneda S, Sakao S, Tobiume M, Suzuki Y, Tsujiwaki M, Kubo T, Hasegawa T, Nakase H, Nishida O, Takahashi K, Baba K, Iizumi Y, Okazaki T, Kimura MY, Yoshino I, Igari H, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Ikehara Y, Yokote K, Nakayama T. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proc Natl Acad Sci U S A 2022;119:e2203437119. [PMID: 35895716 DOI: 10.1073/pnas.2203437119] [Reference Citation Analysis]
33 Mathian A, Breillat P, Dorgham K, Bastard P, Charre C, Lhote R, Quentric P, Moyon Q, Mariaggi AA, Mouries-Martin S, Mellot C, Anna F, Haroche J, Cohen-Aubart F, Sterlin D, Zahr N, Gervais A, Le Voyer T, Bizien L, Amiot Q, Pha M, Hié M, Chasset F, Yssel H, Miyara M, Charneau P, Ghillani-Dalbin P, Casanova JL, Rozenberg F, Amoura Z, Gorochov G. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α. Ann Rheum Dis 2022:annrheumdis-2022-222549. [PMID: 35973806 DOI: 10.1136/ard-2022-222549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Xu Z, Choi JH, Dai DL, Luo J, Ladak RJ, Li Q, Wang Y, Zhang C, Wiebe S, Liu ACH, Ran X, Yang J, Naeli P, Garzia A, Zhou L, Mahmood N, Deng Q, Elaish M, Lin R, Mahal LK, Hobman TC, Pelletier J, Alain T, Vidal SM, Duchaine T, Mazhab-Jafari MT, Mao X, Jafarnejad SM, Sonenberg N. SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation. Proc Natl Acad Sci U S A 2022;119:e2204539119. [PMID: 35878012 DOI: 10.1073/pnas.2204539119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Guo K, Barrett BS, Morrison JH, Mickens KL, Vladar EK, Hasenkrug KJ, Poeschla EM, Santiago ML. Interferon resistance of emerging SARS-CoV-2 variants. Proc Natl Acad Sci U S A 2022;119:e2203760119. [PMID: 35867811 DOI: 10.1073/pnas.2203760119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Delshad M, Sanaei MJ, Pourbagheri-Sigaroodi A, Bashash D. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination. Int Immunopharmacol 2022;111:109128. [PMID: 35963158 DOI: 10.1016/j.intimp.2022.109128] [Reference Citation Analysis]
37 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Averyanova M, Vishnyakova P, Yureneva S, Yakushevskaya O, Fatkhudinov T, Elchaninov A, Sukhikh G. Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic. Front Immunol 2022;13:928171. [DOI: 10.3389/fimmu.2022.928171] [Reference Citation Analysis]
39 Conti F, Pacillo L, Amodio D, Rivalta B, Moratti M, Campoli C, Zama D, Corsini I, Giancotta C, Bernardi S, Naviglio S, Cicalese MP, Rabusin M, Aiuti A, Cancrini C, Lanari M, Viale P, Palma P, Pession A, Finocchi A. SARS‐CoV ‐2 infection and treatment in a cohort of patients with inborn errors of immunity. Pediatric Allergy Immunology 2022;33. [DOI: 10.1111/pai.13833] [Reference Citation Analysis]
40 Laracy JC, Kamboj M, Vardhana SA. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside. Curr Opin Infect Dis 2022;35:271-9. [PMID: 35849516 DOI: 10.1097/QCO.0000000000000841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 M M, F C, M G, S F, A B. How to: diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial and fungal infections. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.07.021] [Reference Citation Analysis]
42 Seraceni S, Zocca E, Cervone TE, Tomassetti F, Polidori I, Valisi M, Broccolo F, Calugi G, Bernardini S, Pieri M. T-Cell Assay after COVID-19 Vaccination Could Be a Useful Tool? A Pilot Study on Interferon-Gamma Release Assay in Healthcare Workers. Diseases 2022;10:49. [DOI: 10.3390/diseases10030049] [Reference Citation Analysis]
43 Patel H, McArdle A, Seaby E, Levin M, Whittaker E. The immunopathogenesis of SARS-CoV-2 infection in children: diagnostics, treatment and prevention. Clin Transl Immunology 2022;11:e1405. [PMID: 35903804 DOI: 10.1002/cti2.1405] [Reference Citation Analysis]
44 Aiello A, Grossi A, Meschi S, Meledandri M, Vanini V, Petrone L, Casetti R, Cuzzi G, Salmi A, Altera AM, Pierelli L, Gualano G, Ascoli Bartoli T, Castilletti C, Agrati C, Girardi E, Palmieri F, Nicastri E, Di Rosa E, Goletti D. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave. Front Immunol 2022;13:920227. [DOI: 10.3389/fimmu.2022.920227] [Reference Citation Analysis]
45 Al-sayyar A, Hulme KD, Thibaut R, Bayry J, Sheedy FJ, Short KR, Alzaid F. Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity. Front Endocrinol 2022;13:919223. [DOI: 10.3389/fendo.2022.919223] [Reference Citation Analysis]
46 Van der Sluis RM, Holm CK, Jakobsen MR. Plasmacytoid dendritic cells during COVID-19: Ally or adversary? Cell Rep 2022;40:111148. [PMID: 35858624 DOI: 10.1016/j.celrep.2022.111148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Mitchell S, Jaccard E, Schmitz FM, von Känel E, Collombet P, Cornuz J, Waeber G, Guessous I, Guttormsen S. Investigating acceptability of a training programme in precision medicine for frontline healthcare professionals: a mixed methods study. BMC Med Educ 2022;22:556. [PMID: 35850770 DOI: 10.1186/s12909-022-03613-2] [Reference Citation Analysis]
48 Aouissi HA, Kechebar MSA, Ababsa M, Roufayel R, Neji B, Petrisor AI, Hamimes A, Epelboin L, Ohmagari N. The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study. Healthcare (Basel) 2022;10:1341. [PMID: 35885867 DOI: 10.3390/healthcare10071341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Migliorini F, Vaishya R, Eschweiler J, Oliva F, Hildebrand F, Maffulli N. Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review. Medicina (Kaunas) 2022;58:941. [PMID: 35888660 DOI: 10.3390/medicina58070941] [Reference Citation Analysis]
50 Clavarino G, Leroy C, Epaulard O, Raskovalova T, Vilotitch A, Pernollet M, Dumestre-pérard C, Defendi F, Le Maréchal M, Le Gouellec A, Audoin P, Bosson J, Poignard P, Roustit M, Jacob M, Cesbron J. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome. Front Immunol 2022;13:889813. [DOI: 10.3389/fimmu.2022.889813] [Reference Citation Analysis]
51 Dhanya CR, Shailaja A, Mary AS, Kandiyil SP, Savithri A, Lathakumari VS, Veettil JT, Vandanamthadathil JJ, Madhavan M. RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease. Pathogens 2022;11:800. [PMID: 35890044 DOI: 10.3390/pathogens11070800] [Reference Citation Analysis]
52 Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells 2022;11:2198. [DOI: 10.3390/cells11142198] [Reference Citation Analysis]
53 Zecevic M, Kotur N, Ristivojevic B, Gasic V, Skodric-trifunovic V, Stjepanovic M, Stevanovic G, Lavadinovic L, Zukic B, Pavlovic S, Stankovic B. Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population. Front Genet 2022;13:911010. [DOI: 10.3389/fgene.2022.911010] [Reference Citation Analysis]
54 Bartolo L, Afroz S, Pan Y, Xu R, Williams L, Lin C, Tanes C, Bittinger K, Friedman ES, Gimotty PA, Wu GD, Su LF. SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens. Sci Immunol . [DOI: 10.1126/sciimmunol.abn3127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
55 Dahlgren MW, Plumb AW, Niss K, Lahl K, Brunak S, Johansson-lindbom B. Type I Interferons Promote Germinal Centers Through B Cell Intrinsic Signaling and Dendritic Cell Dependent Th1 and Tfh Cell Lineages. Front Immunol 2022;13:932388. [DOI: 10.3389/fimmu.2022.932388] [Reference Citation Analysis]
56 Beucher G, Blondot ML, Celle A, Pied N, Recordon-Pinson P, Esteves P, Faure M, Métifiot M, Lacomme S, Dacheux D, Robinson DR, Längst G, Beaufils F, Lafon ME, Berger P, Landry M, Malvy D, Trian T, Andreola ML, Wodrich H. Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction. Proc Natl Acad Sci U S A 2022;119:e2202370119. [PMID: 35749382 DOI: 10.1073/pnas.2202370119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Schäfer A, Leist SR, Gralinski LE, Martinez DR, Winkler ES, Okuda K, Hawkins PE, Gully KL, Graham RL, Scobey DT, Bell TA, Hock P, Shaw GD, Loome JF, Madden EA, Anderson E, Baxter VK, Taft-benz SA, Zweigart MR, May SR, Dong S, Clark M, Miller DR, Lynch RM, Heise MT, Tisch R, Boucher RC, Pardo Manuel de Villena F, Montgomery SA, Diamond MS, Ferris MT, Baric RS, Lednicky JA. A Multitrait Locus Regulates Sarbecovirus Pathogenesis. mBio. [DOI: 10.1128/mbio.01454-22] [Reference Citation Analysis]
58 Pierangeli A, Gentile M, Oliveto G, Frasca F, Sorrentino L, Matera L, Nenna R, Viscido A, Fracella M, Petrarca L, D’ettorre G, Ceccarelli G, Midulla F, Antonelli G, Scagnolari C. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω. Front Immunol 2022;13:873232. [DOI: 10.3389/fimmu.2022.873232] [Reference Citation Analysis]
59 Romana M, Leduc M, Hermand P, Bruce J, Gautier EF, Martino F, Garnier Y, Baccini V, Le Van Kim C. Proteomic analysis of neutrophils from patients with COVID-19. Br J Haematol 2022. [PMID: 35818311 DOI: 10.1111/bjh.18347] [Reference Citation Analysis]
60 Bestion E, Halfon P, Mezouar S, Mège JL. Cell and Animal Models for SARS-CoV-2 Research. Viruses 2022;14:1507. [PMID: 35891487 DOI: 10.3390/v14071507] [Reference Citation Analysis]
61 Lamacchia G, Mazzoni A, Spinicci M, Vanni A, Salvati L, Peruzzi B, Bencini S, Capone M, Carnasciali A, Farahvachi P, Rocca A, Kiros ST, Graziani L, Zammarchi L, Mencarini J, Colao MG, Caporale R, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization. J Clin Immunol 2022. [PMID: 35809212 DOI: 10.1007/s10875-022-01325-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Sadighi Akha AA, Kumánovics A. Anti-cytokine autoantibodies and inborn errors of immunity. J Immunol Methods 2022;508:113313. [PMID: 35817172 DOI: 10.1016/j.jim.2022.113313] [Reference Citation Analysis]
63 Song H, Park S, Huh J, Lee Y, Jung D, Yang C, Kim SH, Kim HM, Kim Y. N-glycosylation of UNC93B1 at a Specific Asparagine Residue Is Required for TLR9 Signaling. Front Immunol 2022;13:875083. [DOI: 10.3389/fimmu.2022.875083] [Reference Citation Analysis]
64 Campbell TM, Liu Z, Zhang Q, Moncada-Velez M, Covill LE, Zhang P, Alavi Darazam I, Bastard P, Bizien L, Bucciol G, Lind Enoksson S, Jouanguy E, Karabela ŞN, Khan T, Kendir-Demirkol Y, Arias AA, Mansouri D, Marits P, Marr N, Migeotte I, Moens L, Ozcelik T, Pellier I, Sendel A, Shahrooei M, Smith CIE, Vandernoot I, Willekens K, Bergman P, Abel L, Cobat A, Casanova JL, Meyts I, Bryceson YT; COVID Human Genetic Effort. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency. J Exp Med 2022;219:e20220202. [PMID: 35670811 DOI: 10.1084/jem.20220202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Diamond MS, Lambris JD, Ting JP, Tsang JS. Considering innate immune responses in SARS-CoV-2 infection and COVID-19. Nat Rev Immunol 2022. [PMID: 35788185 DOI: 10.1038/s41577-022-00744-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Zhuang C, Chen R, Zheng Z, Lu J, Hong C. Toll-Like Receptor 3 in Cardiovascular Diseases. Heart Lung Circ 2022;31:e93-e109. [PMID: 35367134 DOI: 10.1016/j.hlc.2022.02.012] [Reference Citation Analysis]
67 Chiale C, Greene TT, Zuniga EI. Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection. Immunol Rev 2022. [PMID: 35775361 DOI: 10.1111/imr.13113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
68 Natale NR, Lukens JR, Petri WA Jr. The nervous system during COVID-19: Caught in the crossfire. Immunol Rev 2022. [PMID: 35770683 DOI: 10.1111/imr.13114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Rovito R, Augello M, Ben-Haim A, Bono V, d'Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol 2022;13:912336. [PMID: 35757770 DOI: 10.3389/fimmu.2022.912336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Sánchez-montalvá A, Álvarez-sierra D, Martínez-gallo M, Perurena-prieto J, Arrese-muñoz I, Ruiz-rodríguez JC, Espinosa-pereiro J, Bosch-nicolau P, Martínez-gómez X, Antón A, Martínez-valle F, Riveiro-barciela M, Blanco-grau A, Rodríguez-frias F, Castellano-escuder P, Poyatos-canton E, Bas-minguet J, Martínez-cáceres E, Sánchez-pla A, Zurera-egea C, Teniente-serra A, Hernández-gonzález M, Pujol-borrell R; the “Hospital Vall d’Hebron Group for the study of COVID-19 immune profile”. Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study. Front Immunol 2022;13:902837. [DOI: 10.3389/fimmu.2022.902837] [Reference Citation Analysis]
71 Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022;76:102608. [PMID: 35863101 DOI: 10.1016/j.conb.2022.102608] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Ventura-Santana E, Ninan JR, Snyder CM, Okeke EB. Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand. Front Immunol 2022;13:902206. [PMID: 35757734 DOI: 10.3389/fimmu.2022.902206] [Reference Citation Analysis]
73 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Tonutti A, Motta F, Ceribelli A, Isailovic N, Selmi C, De Santis M. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review. Front Immunol 2022;13:937667. [DOI: 10.3389/fimmu.2022.937667] [Reference Citation Analysis]
75 Lu Y, Tseng L, Huang Y, Yang C, Chen Y, Chen H. The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis. Pharmaceuticals 2022;15:794. [DOI: 10.3390/ph15070794] [Reference Citation Analysis]
76 Rivalta B, Amodio D, Giancotta C, Santilli V, Pacillo L, Zangari P, Cotugno N, Manno EC, Finocchi A, Bernardi S, Colagrossi L, Gentile L, Russo C, Perno CF, Rossi P, Cancrini C, Palma P. Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment. Front Immunol 2022;13:891274. [DOI: 10.3389/fimmu.2022.891274] [Reference Citation Analysis]
77 Herbert A, Poptsova M. Z-RNA and the Flipside of the SARS Nsp13 Helicase: Is There a Role for Flipons in Coronavirus-Induced Pathology? Front Immunol 2022;13:912717. [DOI: 10.3389/fimmu.2022.912717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bruiners N, Guerrini V, Ukey R, Dikdan RJ, Yang JH, Mishra PK, Onyuka A, Handler D, Vieth J, Carayannopoulos M, Guo S, Pollen M, Pinter A, Tyagi S, Feingold D, Philipp C, Libutti SK, Gennaro ML. Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report. Front Med 2022;9:915367. [DOI: 10.3389/fmed.2022.915367] [Reference Citation Analysis]
79 Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-hammarström Q, Abolhassani H, Bompoil T, Dorgham K, Gorochov G, Laouenan C, Rodríguez-gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-picado J, Ozcelik T, Keles S, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang S, Puel A, Wilson MR, Trouillet-assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova J, Derisi JL, Abel L, Achille C, Aiuti A, Al-muhsen S, Al-mulla F, Anderson MS, Andreakos E, Angelini M, Arias AA, Aytekin G, Baldanti F, Feldman HB, Belot A, Bergami F, Biggs CM, Bogunovic D, Bolze A, Bondarenko A, Bousfiha AA, Brodin P, Bryceson Y, Bustamante CD, Butte MJ, Casari G, Christodoulou J, Condino-neto A, Constantinescu SN, Conti F, Cooper MA, Dalgard CL, Desai M, Drolet BA, El Baghdadi J, Ergun R, Ergun D, Espinosa-padilla S, Fellay J, Flores C, Franco JL, Froidure A, Ghirardello S, Gregersen PK, Grimbacher B, Haerynck F, Hagin D, Halwani R, Hammarström L, Heath JR, Henrickson SE, Hsieh EW, Husebye E, Imai K, Itan Y, Jarvis ED, Kanat F, Karamitros T, Kisand K, Kopcha V, Korda M, Ku C, Lau Y, Ling Y, Lucas CL, Maniatis T, Mansouri D, Maródi L, Meyts I, Milner JD, Mironska K, Mogensen TH, Mojoli F, Morandeira F, Morio T, Ng LF, Notarangelo LD, Novelli A, Novelli G, O'farrelly C, Okada S, Okamoto K, Ozcelik T, Pagani M, Pan-hammarström Q, Pape JW, de Diego RP, Perlin DS, Pesole G, Pession A, Piralla A, Planas AM, Prando C, Pujol A, Quintana-murci L, Ramaswamy S, Renia L, Resnick I, Rigo-bonnin R, Rodríguez-gallego C, Sancho-shimizu V, Sediva A, Seppänen MR, Shahrooei M, Shcherbina A, Slaby O, Snow AL, Soler-palacín P, Spaan AN, Tancevski I, Tangye SG, Abou Tayoun A, Tulek B, Turvey SE, Uddin KMF, Uddin M, Clément B, Abe-jones Y, Asthana S, Bhide S, Calfee CS, Carrillo SA, Chak S, Collins Z, Erle DJ, Fragiadakis GK, Ghale R, Hendrickson CM, Jauregui A, Kangelaris KN, Krummel MF, Langelier CR, Lea T, Lee D, Leligdowicz A, Leroux C, Lota R, Matthay M, Nguyen V, Patel R, Pierce L, Prasad P, Rao AA, Rashid A, Rodriguez N, Samad B, Shaw C, Sigman A, Tang K, Altamirano LT, Ward A, Willmore A, Wilson M, Woodruff PG, Abel L, Allavena C, Andrejak C, Angoulvant F, Azoulay C, Bachelet D, Bartoli M, Basmaci R, Behilill S, Beluze M, Benech N, Benkerrou D, Bhavsar K, Bitker L, Bouadma L, Bouscambert M, Paz PC, Cervantes-gonzalez M, Chair A, Chirouze C, Coelho A, Cordel H, Couffignal C, Couffin-cadiergues S, d’Ortenzio E, De Montmollin E, Debard A, Debray M, Deplanque D, Descamps D, Desvallée M, Diallo A, Diehl J, Diouf A, Dorival C, Dubos F, Duval X, Eloy P, Enouf V, Epaulard O, Esperou H, Esposito-farese M, Etienne M, Garot D, Gault N, Gaymard A, Ghosn J, Gigante T, Gilg M, Goehringer F, Guedj J, Hoctin A, Hoffmann I, Houas I, Hulot J, Jaafoura S, Kafif O, Kaguelidou F, Kali S, Kerroumi Y, Khalil A, Khan C, Kimmoun A, Laine F, Laouénan C, Laribi S, Le M, Le Bris C, Le Gac S, Le Hingrat Q, Le Mestre S, Le Nagard H, Lemaignen A, Lemee V, Lescure F, Letrou S, Levy Y, Lina B, Lingas G, Lucet JC, Machado M, Malvy D, Mambert M, Manuel A, Mentré F, Meziane A, Mouquet H, Mullaert J, Neant N, Nguyen D, Noret M, Papadopoulos A, Paul C, Peiffer-smadja N, Peigne V, Petrov-sanchez V, Peytavin G, Pham H, Picone O, Piquard V, Poissy J, Puéchal O, Rosa-calatrava M, Rossignol B, Rossignol P, Roy C, Schneider M, Su R, Tardivon C, Tellier M, Téoulé F, Terrier O, Timsit J, Tual C, Tubiana S, Van Der Werf S, Vanel N, Veislinger A, Visseaux B, Wiedemann A, Yazdanpanah Y; COVID HGE consortium, French COVID study group, COMET consortium. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol . [DOI: 10.1126/sciimmunol.abp8966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
80 Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut 2022:gutjnl-2021-326792. [PMID: 35701093 DOI: 10.1136/gutjnl-2021-326792] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
81 Puhl AC, Gomes GF, Damasceno S, Godoy AS, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha FQ, Alves-Filho JC, Cunha TM, Ekins S. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse. ACS Infect Dis 2022;8:1147-60. [PMID: 35609344 DOI: 10.1021/acsinfecdis.2c00091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM. Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products. Mol Ther Methods Clin Dev 2022;25:439-47. [PMID: 35506060 DOI: 10.1016/j.omtm.2022.04.013] [Reference Citation Analysis]
83 Hoteit R, Yassine HM. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines (Basel) 2022;10:919. [PMID: 35746526 DOI: 10.3390/vaccines10060919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
84 Znaidia M, Demeret C, van der Werf S, Komarova AV. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. Viruses 2022;14:1247. [PMID: 35746718 DOI: 10.3390/v14061247] [Reference Citation Analysis]
85 Wallis RS, O’garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat Rev Immunol. [DOI: 10.1038/s41577-022-00734-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Chang L, Zhou G, Ou H, Xia J. mGWAS-Explorer: Linking SNPs, Genes, Metabolites, and Diseases for Functional Insights. Metabolites 2022;12:526. [PMID: 35736459 DOI: 10.3390/metabo12060526] [Reference Citation Analysis]
87 Bastard P, Hsiao KC, Zhang Q, Choin J, Best E, Chen J, Gervais A, Bizien L, Materna M, Harmant C, Roux M, Hawley NL, Weeks DE, McGarvey ST, Sandoval K, Barberena-Jonas C, Quinto-Cortés CD, Hagelberg E, Mentzer AJ, Robson K, Coulibaly B, Seeleuthner Y, Bigio B, Li Z, Uzé G, Pellegrini S, Lorenzo L, Sbihi Z, Latour S, Besnard M, Adam de Beaumais T, Jacqz Aigrain E, Béziat V, Deka R, Esera Tulifau L, Viali S, Reupena MS, Naseri T, McNaughton P, Sarkozy V, Peake J, Blincoe A, Primhak S, Stables S, Gibson K, Woon ST, Drake KM, Hill AVS, Chan CY, King R, Ameratunga R, Teiti I, Aubry M, Cao-Lormeau VM, Tangye SG, Zhang SY, Jouanguy E, Gray P, Abel L, Moreno-Estrada A, Minster RL, Quintana-Murci L, Wood AC, Casanova JL. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes. J Exp Med 2022;219:e20220028. [PMID: 35442418 DOI: 10.1084/jem.20220028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
88 Meyts I. Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic. J Exp Med 2022;219:e20220491. [PMID: 35486090 DOI: 10.1084/jem.20220491] [Reference Citation Analysis]
89 Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Børresen ML, Thompson BJ, Stremenova Spegarova J, Hatton CF, Stæger FF, Andersen MK, Whittaker J, Paludan SR, Jørgensen SE, Thomsen MK, Mikkelsen JG, Heilmann C, Buhas D, Øbro NF, Bay JT, Marquart HV, de la Morena MT, Klejka JA, Hirschfeld M, Borgwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Albrechtsen A, Alizadehfar R, Allenspach EJ, Hambleton S, Mogensen TH. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J Exp Med 2022;219:e20212427. [PMID: 35442417 DOI: 10.1084/jem.20212427] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
90 Fava VM, Bourgey M, Nawarathna PM, Orlova M, Cassart P, Vinh DC, Cheng MP, Bourque G, Schurr E, Langlais D. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19. Sci Adv 2022;8:eabm2510. [PMID: 35648852 DOI: 10.1126/sciadv.abm2510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Szyda J, Dobosz P, Stojak J, Sypniewski M, Suchocki T, Kotlarz K, Mroczek M, Stępień M, Słomian D, Butkiewicz S, Sztromwasser P, Liu J, Król ZJ. Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19? Int J Mol Sci 2022;23:6272. [PMID: 35682950 DOI: 10.3390/ijms23116272] [Reference Citation Analysis]
92 Bai H, Ma J, Mao W, Zhang X, Nie Y, Hao J, Wang X, Qin H, Zeng Q, Hu F, Qi X, Chen X, Li D, Zhang B, Shi B, Zhang C. Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing. Blood Cells Mol Dis 2022;97:102678. [PMID: 35716403 DOI: 10.1016/j.bcmd.2022.102678] [Reference Citation Analysis]
93 Biancolella M, Colona VL, Mehrian-Shai R, Watt JL, Luzzatto L, Novelli G, Reichardt JKV. COVID-19 2022 update: transition of the pandemic to the endemic phase. Hum Genomics 2022;16:19. [PMID: 35650595 DOI: 10.1186/s40246-022-00392-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
94 Wang Y, Abolhassani H, Hammarström L, Pan-hammarström Q. SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects. ABBS. [DOI: 10.3724/abbs.2022071] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Petersen DC, Steyl C, Scholtz D, Baker B, Abdullah I, Uren C, Möller M; and for The COVID-19 Host Genetics Project. African Genetic Representation in the Context of SARS-CoV-2 Infection and COVID-19 Severity. Front Genet 2022;13:909117. [PMID: 35620464 DOI: 10.3389/fgene.2022.909117] [Reference Citation Analysis]
96 Liu P, Fang M, Luo Y, Zheng F, Jin Y, Cheng F, Zhu H, Jin X. Rare Variants in Inborn Errors of Immunity Genes Associated With Covid-19 Severity. Front Cell Infect Microbiol 2022;12:888582. [DOI: 10.3389/fcimb.2022.888582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Zguro K, Fallerini C, Fava F, Furini S, Renieri A. Host genetic basis of COVID-19: from methodologies to genes. Eur J Hum Genet 2022. [PMID: 35618891 DOI: 10.1038/s41431-022-01121-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Shahrokh S, Baradaran Ghavami S, Asadzadeh Aghdaei H, Parigi TL, Farmani M, Danese S, Ebrahimi Daryani N, Vossoughinia H, Balaii H, Alborzi F, Khoramjoo SM, Khanabadi B, Seyed Salehi A, Bastani A, Sharifi M, Safari MT, Malekpour H, Sherkat G, Saberafsharian M, Miri MB, Moosavi SH, Anaraki F, Nazemalhosseini-Mojarad E, Mohebi SR, Shojaie S, Pourhoseingholi MA, Zali MR. High prevalence of SARS-Coronavirus-2 in patients with inflammatory bowel disease and the role of soluble angiotensin converting Enzyme2. Arch Physiol Biochem 2022;:1-8. [PMID: 35617972 DOI: 10.1080/13813455.2022.2080228] [Reference Citation Analysis]
99 Tegethoff SA, Danziger G, Kühn D, Kimmer C, Adams T, Heintz L, Metz C, Reifenrath K, Angresius R, Mang S, Rixecker T, Becker A, Geisel J, Jentgen C, Seiler F, Reichert MC, Fröhlich F, Meyer S, Rissland J, Ewen S, Wagenpfeil G, Last K, Smola S, Bals R, Lammert F, Becker SL, Krawczyk M, Lepper PM, Papan C. TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study. Int J Infect Dis 2022;122:178-87. [PMID: 35643306 DOI: 10.1016/j.ijid.2022.05.051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Lupașcu (Moisi) RE, Ilie MI, Velescu BȘ, Udeanu DI, Sultana C, Ruță S, Arsene AL. COVID-19-Current Therapeutical Approaches and Future Perspectives. Processes 2022;10:1053. [DOI: 10.3390/pr10061053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A; HGID Lab., COVID Clinicians., COVID-STORM Clinicians., NIAID Immune Response to COVID Group., NH-COVAIR Study Group., Danish CHGE., Danish Blood Donor Study., St. James's Hospital, SARS CoV2 Interest Group., French COVID Cohort Study Group., Imagine COVID-Group., Milieu Intérieur Consortium., CoV-Contact Cohort., Amsterdam UMC Covid-19 Biobank Investigators., COVID Human Genetic Effort., CP-COVID-19 Group., CONSTANCES cohort., 3C-Dijon Study., Cerba Health-Care., Etablissement Français du Sang Study group. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci U S A 2022;119:e2200413119. [PMID: 35576468 DOI: 10.1073/pnas.2200413119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
102 Li D, Wang X, Liao Y, Wang S, Shan J, Ji J. Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components. Front Immunol 2022;13:842453. [PMID: 35592339 DOI: 10.3389/fimmu.2022.842453] [Reference Citation Analysis]
103 Pararajasingam A, Bradley RE, Evans J, Lowe A, Goodwin R, Jolles S. Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib. Front Pediatr 2022;10:837568. [PMID: 35547545 DOI: 10.3389/fped.2022.837568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Reference Citation Analysis]
105 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
106 Izquierdo-pujol J, Moron-lopez S, Dalmau J, Gonzalez-aumatell A, Carreras-abad C, Mendez M, Rodrigo C, Martinez-picado J. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front Pediatr 2022;10:894204. [DOI: 10.3389/fped.2022.894204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
107 Zhang Z. The Existence of at Least Three Genomic Signature Patterns and at Least Seven Subtypes of COVID-19 and the End of the Disease. Vaccines 2022;10:761. [DOI: 10.3390/vaccines10050761] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Garreta E, Prado P, Stanifer ML, Monteil V, Marco A, Ullate-Agote A, Moya-Rull D, Vilas-Zornoza A, Tarantino C, Romero JP, Jonsson G, Oria R, Leopoldi A, Hagelkruys A, Gallo M, González F, Domingo-Pedrol P, Gavaldà A, Del Pozo CH, Hasan Ali O, Ventura-Aguiar P, Campistol JM, Prosper F, Mirazimi A, Boulant S, Penninger JM, Montserrat N. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metab 2022:S1550-4131(22)00136-X. [PMID: 35561674 DOI: 10.1016/j.cmet.2022.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
109 Aberumand B, Ayoub Goulstone W, Betschel S. Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency. Allergy Asthma Clin Immunol 2022;18:38. [PMID: 35534860 DOI: 10.1186/s13223-022-00679-x] [Reference Citation Analysis]
110 Akbil B, Meyer T, Stubbemann P, Thibeault C, Staudacher O, Niemeyer D, Jansen J, Mühlemann B, Doehn J, Tabeling C, Nusshag C, Hirzel C, Sanchez DS, Nieters A, Lother A, Duerschmied D, Schallner N, Lieberum JN, August D, Rieg S, Falcone V, Hengel H, Kölsch U, Unterwalder N, Hübner RH, Jones TC, Suttorp N, Drosten C, Warnatz K, Spinetti T, Schefold JC, Dörner T, Sander LE, Corman VM, Merle U, Kurth F, von Bernuth H, Meisel C, Goffinet C; Pa-COVID study Group. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies. J Clin Immunol 2022. [PMID: 35511314 DOI: 10.1007/s10875-022-01252-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
111 Dhaliwal M, Tyagi R, Malhotra P, Barman P, Loganathan SK, Sharma J, Sharma K, Mondal S, Rawat A, Singh S. Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C. Front Pediatr 2022;10:790273. [DOI: 10.3389/fped.2022.790273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen. Nat Commun 2022;13:2442. [PMID: 35508460 DOI: 10.1038/s41467-022-30134-9] [Reference Citation Analysis]
113 Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology 2022. [PMID: 35505267 DOI: 10.1007/s10787-022-00992-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 Rivera EG, Patnaik A, Salvemini J, Jain S, Lee K, Lozeau D, Yao Q. SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination. Clin Immunol 2022;238:109027. [PMID: 35513305 DOI: 10.1016/j.clim.2022.109027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Abuhammour W, Yavuz L, Jain R, Abu Hammour K, Al-Hammouri GF, El Naofal M, Halabi N, Yaslam S, Ramaswamy S, Taylor A, Wafadari D, Alsarhan A, Khansaheb H, Deesi ZO, Varghese RM, Uddin M, Al Suwaidi H, Al-Hammadi S, Alkhaja A, AlDabal LM, Loney T, Nowotny N, Al Khayat A, Alsheikh-Ali A, Abou Tayoun A. Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children. JAMA Netw Open 2022;5:e2214985. [PMID: 35639375 DOI: 10.1001/jamanetworkopen.2022.14985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
116 Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet 2022. [PMID: 35501396 DOI: 10.1038/s41576-022-00478-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
117 Haschka D, Petzer V, Burkert FR, Fritsche G, Wildner S, Bellmann-Weiler R, Tymoszuk P, Weiss G. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients. Eur J Immunol 2022. [PMID: 35491910 DOI: 10.1002/eji.202149680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Brennan CM, Nadella S, Zhao X, Dima RJ, Jordan-Martin N, Demestichas BR, Kleeman SO, Ferrer M, von Gablenz EC, Mourikis N, Rubin ME, Adnani H, Lee H, Ha T, Prum S, Schleicher CB, Fox SS, Ryan MG, Pili C, Goldberg G, Crawford JM, Goodwin S, Zhang X, Preall JB, Costa ASH, Conigliaro J, Masci JR, Yang J, Tuveson DA, Tracey KJ, Janowitz T. Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial. Gut 2022;71:879-88. [PMID: 35144974 DOI: 10.1136/gutjnl-2022-326952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
119 Ramasamy R. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2. Viruses 2022;14:933. [PMID: 35632675 DOI: 10.3390/v14050933] [Reference Citation Analysis]
120 Ulndreaj A, Wang M, Misaghian S, Paone L, Sigal GB, Stengelin M, Campbell C, Van Nynatten LR, Soosaipillai A, Ghorbani A, Mathew A, Fraser DD, Diamandis EP, Prassas I. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens. Clin Chem Lab Med 2022. [PMID: 35475723 DOI: 10.1515/cclm-2022-0239] [Reference Citation Analysis]
121 Vanderwall ER, Barrow KA, Rich LM, Read DF, Trapnell C, Okoloko O, Ziegler SF, Hallstrand TS, White MP, Debley JS. Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. Sci Rep 2022;12:6972. [PMID: 35484173 DOI: 10.1038/s41598-022-10763-2] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
122 Hromić-jahjefendić A, Barh D, Ramalho Pinto CH, Gabriel Rodrigues Gomes L, Picanço Machado JL, Afolabi OO, Tiwari S, Aljabali AAA, Tambuwala MM, Serrano-aroca Á, Redwan EM, Uversky VN, Lundstrom K. Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review. Viruses 2022;14:910. [DOI: 10.3390/v14050910] [Reference Citation Analysis]
123 Zaffina S, Piano Mortari E, Di Prinzio RR, Cappa M, Novelli A, Agolini E, Raponi M, Dallapiccola B, Locatelli F, Perno CF, Carsetti R. Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4. Front Immunol 2022;13:869042. [PMID: 35464479 DOI: 10.3389/fimmu.2022.869042] [Reference Citation Analysis]
124 Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Vila J, Garcia F, Garcia-Vidal C, Soriano A; Hospital Clinic of Barcelona COVID-19 research group. Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study. Infect Dis Ther 2022. [PMID: 35476212 DOI: 10.1007/s40121-022-00623-x] [Reference Citation Analysis]
125 Levy G, Guglielmelli P, Langmuir P, Constantinescu S. JAK inhibitors and COVID-19. J Immunother Cancer 2022;10:e002838. [PMID: 35459733 DOI: 10.1136/jitc-2021-002838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
126 Gray PE, Bartlett AW, Tangye SG. Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals. Clin Transl Immunology 2022;11:e1365. [PMID: 35444807 DOI: 10.1002/cti2.1365] [Reference Citation Analysis]
127 Nelson RW, Chen Y, Venezia OL, Majerus RM, Shin DS, Carrington MN, Yu XG, Wesemann DR, Moon JJ, Luster AD, Abayneh BA, Allen P, Alter G, Antille D, Armstrong K, Balazs A, Bals J, Barbash M, Bartsch Y, Boucau J, Boyce S, Braley J, Branch K, Broderick K, Carney J, Chan A, Chevalier J, Chowdhury F, Daley G, Davidson S, Dougan M, Drew D, Einkauf K, Elliman A, Fallon J, Fedirko L, Finn K, Flaherty K, Flannery J, Forde P, Garcia-broncano P, Gettings E, Golan D, Griffin A, Grimmel S, Grinke K, Hall K, Hartana C, Healy M, Heller H, Henault D, Holland G, Jiang C, Jilg N, Kaplonek P, Karpell M, Kayitesi C, Lam EC, Lavalle V, Lefteri K, Lian X, Lichterfeld M, Lingwood D, Liu H, Liu J, Lu Y, Luthern S, Ly N, Marchewka J, Martino B, Mcnamara R, Michell A, Millstrom I, Miranda N, Nambu C, Nelson S, Noone M, O'callaghan C, Ommerborn C, Osborn M, Pacheco LC, Phan N, Pillai S, Porto FA, Rassadkina Y, Reissis A, Rosenthal A, Ruzicka F, Ryan E, Seiger K, Selleck K, Sessa L, Sharpe A, Sharr C, Shin S, Singh N, Slaughenhaupt S, Sheppard KS, Sun W, Sun X, Suschana E, Ticheli H, Trocha-piechocka A, Wilson V, Wong C, Worrall D, Zhu A, Manickas-hill Z, Demers E, Judge K, Ghebremichael MS, Lai P, Li J, Yu XG, Walker B, Carrington M, Martin M, Yuki Y; MGH COVID-19 Collection & Processing Team†. SARS-CoV-2 epitope-specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability. Sci Immunol . [DOI: 10.1126/sciimmunol.abl9464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 López-Cortés A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, León Cáceres Á, Simbaña-Rivera K, Gómez-Jaramillo AM, Echeverría-Garcés G, García-Cárdenas JM, Guevara-Ramírez P, Cabrera-Andrade A, Puig San Andrés L, Cevallos-Robalino D, Bautista J, Armendáriz-Castillo I, Pérez-Villa A, Abad-Sojos A, Ramos-Medina MJ, León-Sosa A, Abarca E, Pérez-Meza ÁA, Nieto-Jaramillo K, Jácome AV, Morillo A, Arias-Erazo F, Fuenmayor-González L, Quiñones LA, Kyriakidis NC. Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials. Front Pharmacol 2022;13:833174. [PMID: 35422702 DOI: 10.3389/fphar.2022.833174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Reyes LF, Bastidas A, Narváez PO, Parra-Tanoux D, Fuentes YV, Serrano-Mayorga CC, Ortíz V, Caceres EL, Ospina-Tascon G, Díaz AM, Jibaja M, Vera M, Silva E, Gorordo-Delsol LA, Maraschin F, Varón-Vega F, Buitrago R, Poveda M, Saucedo LM, Estenssoro E, Ortíz G, Nin N, Calderón LE, Montaño GS, Chaar AJ, García F, Ramírez V, Picoita F, Peláez C, Unigarro L, Friedman G, Cucunubo L, Bruhn A, Hernández G, Martin-Loeches I; LIVEN-Covid-19 Investigators. Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study. PLoS One 2022;17:e0265529. [PMID: 35358238 DOI: 10.1371/journal.pone.0265529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Chung MH, Chua GT, Leung D, Chan KW, Nicholls J, Lau YL. Fatal SARS in X-Linked Lymphoproliferative Disease Type 1: A Case Report. Front Pediatr 2022;10:794110. [DOI: 10.3389/fped.2022.794110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Liu X, Wei L, Xu F, Zhao F, Huang Y, Fan Z, Mei S, Hu Y, Zhai L, Guo J, Zheng A, Cen S, Liang C, Guo F. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response. Sci Signal 2022;15:eabg8744. [PMID: 35412852 DOI: 10.1126/scisignal.abg8744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
132 Novelli G, Biancolella M. COVID-19 and Molecular Genetics. Genes 2022;13:676. [DOI: 10.3390/genes13040676] [Reference Citation Analysis]
133 Robinson PC, Liew DFL, Tanner HL, Grainger JR, Dwek RA, Reisler RB, Steinman L, Feldmann M, Ho LP, Hussell T, Moss P, Richards D, Zitzmann N. COVID-19 therapeutics: Challenges and directions for the future. Proc Natl Acad Sci U S A 2022;119:e2119893119. [PMID: 35385354 DOI: 10.1073/pnas.2119893119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
134 Nathan C. Nonresolving inflammation redux. Immunity 2022;55:592-605. [PMID: 35417674 DOI: 10.1016/j.immuni.2022.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
135 Sharma NK, Sarode SC. Do compromised mitochondria aggravate severity and fatality by SARS-CoV-2? Curr Med Res Opin 2022;:1-10. [PMID: 35403526 DOI: 10.1080/03007995.2022.2065140] [Reference Citation Analysis]
136 Gibellini L, De Biasi S, Meschiari M, Gozzi L, Paolini A, Borella R, Mattioli M, Lo Tartaro D, Fidanza L, Neroni A, Busani S, Girardis M, Guaraldi G, Mussini C, Cozzi-Lepri A, Cossarizza A. Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival. Front Immunol 2022;13:842150. [PMID: 35386702 DOI: 10.3389/fimmu.2022.842150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Tolomeo M, Cavalli A, Cascio A. STAT1 and Its Crucial Role in the Control of Viral Infections. Int J Mol Sci 2022;23:4095. [PMID: 35456913 DOI: 10.3390/ijms23084095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
138 Brück N, Schütz C, Kallinich T. Das Pädiatrische Inflammatorische Multisystem Syndrom (PIMS) in der COVID-19 Pandemie. Aktuelle Rheumatologie 2022;47:117-27. [DOI: 10.1055/a-1715-5027] [Reference Citation Analysis]
139 Puel A, Bastard P, Bustamante J, Casanova JL. Human autoantibodies underlying infectious diseases. J Exp Med 2022;219:e20211387. [PMID: 35319722 DOI: 10.1084/jem.20211387] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
140 Burbelo PD, Castagnoli R, Shimizu C, Delmonte OM, Dobbs K, Discepolo V, Lo Vecchio A, Guarino A, Licciardi F, Ramenghi U, Rey-Jurado E, Vial C, Marseglia GL, Licari A, Montagna D, Rossi C, Montealegre Sanchez GA, Barron K, Warner BM, Chiorini JA, Espinosa Y, Noguera L, Dropulic L, Truong M, Gerstbacher D, Mató S, Kanegaye J, Tremoulet AH, Eisenstein EM, Su HC, Imberti L, Poli MC, Burns JC, Notarangelo LD, Cohen JI; Pediatric Emergency Medicine Kawasaki Group. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C. Front Immunol 2022;13:841126. [PMID: 35360001 DOI: 10.3389/fimmu.2022.841126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Steiner S, Schwarz T, Corman VM, Gebert L, Kleinschmidt MC, Wald A, Gläser S, Kruse JM, Zickler D, Peric A, Meisel C, Meyer T, Staudacher OL, Wittke K, Kedor C, Bauer S, Besher NA, Kalus U, Pruß A, Drosten C, Volk HD, Scheibenbogen C, Hanitsch LG. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity. Front Immunol 2022;13:840126. [PMID: 35359967 DOI: 10.3389/fimmu.2022.840126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
142 Zaratin P, Banwell B, Coetzee T, Comi G, Feinstein A, Hyde R, Salvetti M, Smith K. Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance. Mult Scler J Exp Transl Clin 2022;8:20552173221099181. [PMID: 35530174 DOI: 10.1177/20552173221099181] [Reference Citation Analysis]
143 Maurer DJ, Liu C, Xepapadaki P, Stanic B, Bachert C, Finotto S, Gao YD, Graser A, Jartti T, Kistler W, Kowalski M, Lukkarinen H, Pasioti M, Tan G, Villiger M, Zhang L, Zhang N, Akdis M, Papadopoulos NG, Akdis CA. Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers. Allergy 2022;77:1216-30. [PMID: 34547110 DOI: 10.1111/all.15105] [Reference Citation Analysis]
144 Choi MY, Clarke AE, Buhler K, Jung M, Mathew H, Zhang M, Cardwell FS, Waldhauser H, Fritzler MJ. Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort. Lupus Sci Med 2022;9:e000667. [PMID: 35393285 DOI: 10.1136/lupus-2022-000667] [Reference Citation Analysis]
145 Lazova S, Dimitrova Y, Hristova D, Tzotcheva I, Velikova T. Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C—Can We Match the Puzzle? Antibodies 2022;11:25. [DOI: 10.3390/antib11020025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 33.0] [Reference Citation Analysis]
147 Barmania F, Mellet J, Ryder MA, Ford G, Herd CL, Tamuhla T, Hendricks C, Giles R, Kalua T, Joubert F, Tiffin N, Pepper MS. Coronavirus Host Genetics South Africa (COHG-SA) database-a variant database for gene regions associated with SARS-CoV-2 outcomes. Eur J Hum Genet 2022. [PMID: 35351987 DOI: 10.1038/s41431-022-01089-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
148 Celebi AT, Uzel G, Oylumlu E, Baykasoglu C, Mugan A, Joly S, Ciraci C. Computational Modeling of T Cell Hypersensitivity during Coronavirus Infections Leading to Autoimmunity and Lethality. Comput Math Methods Med 2022;2022:9444502. [PMID: 35341005 DOI: 10.1155/2022/9444502] [Reference Citation Analysis]
149 Youssry I, Abd Elaziz D, Ayad N, Eyada I. The Cause–Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic. Hematology Reports 2022;14:95-102. [DOI: 10.3390/hematolrep14020014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Delanghe JR, Speeckaert MM. Host polymorphisms and COVID-19 infection. Adv Clin Chem 2022;107:41-77. [PMID: 35337605 DOI: 10.1016/bs.acc.2021.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Veraldi N, Vivès RR, Blanchard-rohner G, L’huillier AG, Wagner N, Rohr M, Beghetti M, De Agostini A, Grazioli S. Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19. J Mol Med. [DOI: 10.1007/s00109-022-02190-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
153 Wang X, Bai H, Ma J, Qin H, Zeng Q, Hu F, Jiang T, Mao W, Zhao Y, Chen X, Qi X, Li M, Xu J, Hao J, Wang Y, Ding X, Liu Y, Huang T, Fang C, Ge C, Li D, Hu K, Ren X, Zhang B, Zhang B, Shi B, Zhang C. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients. Front Immunol 2022;13:812514. [PMID: 35281000 DOI: 10.3389/fimmu.2022.812514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Gu W, Gan H, Ma Y, Xu L, Cheng ZJ, Li B, Zhang X, Jiang W, Sun J, Sun B, Hao C. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity. Virol J 2022;19. [DOI: 10.1186/s12985-022-01783-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
155 Chang T, Yang J, Deng H, Chen D, Yang X, Tang ZH. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection. Front Immunol 2022;13:843342. [PMID: 35265087 DOI: 10.3389/fimmu.2022.843342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
156 Bader SM, Cooney JP, Pellegrini M, Doerflinger M. Programmed cell death: the pathways to severe COVID-19? Biochem J 2022;479:609-28. [PMID: 35244141 DOI: 10.1042/BCJ20210602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
157 Georgakopoulou VE, Lembessis P, Skarlis C, Gkoufa A, Sipsas NV, Mavragani CP. Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes. Front Med 2022;9:850472. [DOI: 10.3389/fmed.2022.850472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Jain SK, Bivalacqua TJ, Yegnasubramanian S, Bishai WR. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation. bioRxiv 2022:2022. [PMID: 35313583 DOI: 10.1101/2022.03.15.484018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Galbraith MD, Kinning KT, Sullivan KD, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter R, Jordan KR, Russell S, Dzieciatkowska M, Reisz JA, Gamboni F, Cendali F, Ghosh T, Guo K, Wilson CC, Santiago ML, Monte AA, Bennett TD, Hansen KC, Hsieh EWY, D'Alessandro A, Espinosa JM. Specialized interferon action in COVID-19. Proc Natl Acad Sci U S A 2022;119:e2116730119. [PMID: 35217532 DOI: 10.1073/pnas.2116730119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
160 Chandran A, Rosenheim J, Nageswaran G, Swadling L, Pollara G, Gupta RK, Burton AR, Guerra-Assunção JA, Woolston A, Ronel T, Pade C, Gibbons JM, Sanz-Magallon Duque De Estrada B, Robert de Massy M, Whelan M, Semper A, Brooks T, Altmann DM, Boyton RJ, McKnight Á, Captur G, Manisty C, Treibel TA, Moon JC, Tomlinson GS, Maini MK, Chain BM, Noursadeghi M; COVIDsortium Investigators. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections. Cell Rep Med 2022;3:100557. [PMID: 35474751 DOI: 10.1016/j.xcrm.2022.100557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Smatti MK, Alkhatib HA, Al Thani AA, Yassine HM. Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents. Front Med 2022;9:802312. [DOI: 10.3389/fmed.2022.802312] [Reference Citation Analysis]
162 Nelson CE, Namasivayam S, Foreman TW, Kauffman KD, Sakai S, Dorosky DE, Lora NE, Brooks K, Potter EL, Garza NL, Lafont BAP, Johnson RF, Roederer M, Sher A, Weiskopf D, Sette A, de Wit E, Hickman HD, Brenchley JM, Via LE, Barber DL, Abdi A, Dayao EK, Fleegle JD, Gomez F, Piazza MK, Repoli KM, Sloan BY, Butler AL, Walker AM, Weiner DM, Woodcock MJ, Vatthauer A; NIAID/DIR Tuberculosis Imaging Program 3 †. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Sci Immunol 2022;:eabo0535. [PMID: 35271298 DOI: 10.1126/sciimmunol.abo0535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
163 Liechti T, Iftikhar Y, Mangino M, Beddall M, Goss C, O'Halloran J, Mudd P, Roederer M. Immune phenotypes that predict COVID-19 severity. Res Sq 2022:rs. [PMID: 35291290 DOI: 10.21203/rs.3.rs-1378671/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Ahmed Z, Renart EG, Zeeshan S. Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19. Per Med 2022. [PMID: 35261286 DOI: 10.2217/pme-2021-0132] [Reference Citation Analysis]
165 Marx S, Kümmerer BM, Grützner C, Kato H, Schlee M, Renn M, Bartok E, Hartmann G. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection. Mol Ther Nucleic Acids 2022;27:1225-34. [PMID: 35186439 DOI: 10.1016/j.omtn.2022.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
166 Bruce J, Johnson SB. Exploring the ethics of genetic prioritisation for COVID-19 vaccines. Eur J Hum Genet 2022. [PMID: 35250030 DOI: 10.1038/s41431-022-01058-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Mattoo S, Kim S, Ahn D, Myoung J. Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin. Viruses 2022;14:530. [DOI: 10.3390/v14030530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
168 Wang C, Walter JE. Autoantibodies in immunodeficiency syndromes: The Janus faces of immune dysregulation. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100948] [Reference Citation Analysis]
169 Kim NE, Song YJ. Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins. J Microbiol 2022;60:300-7. [PMID: 35089584 DOI: 10.1007/s12275-022-1502-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Ebongue MSN, Lemogoum D, Endale-mangamba LM, Barche B, Eyoum C, Simo Yomi SH, Mekolo D, Ngambi V, Doumbe J, Sike CM, Boombhi J, Ngondi G, Biholong C, Kamdem J, Mbenoun L, Tegeu CK, Djomou A, Dzudie A, Kamdem F, Ntock FN, Mfeukeu LK, Sobngwi E, Penda I, Njock R, Essomba N, Yombi JC, Ngatchou W. Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon. Travel Medicine and Infectious Disease 2022. [DOI: 10.1016/j.tmaid.2022.102292] [Reference Citation Analysis]
171 Xu H, Akinyemi IA, Chitre SA, Loeb JC, Lednicky JA, Mcintosh MT, Bhaduri-mcintosh S. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology 2022;568:13-22. [DOI: 10.1016/j.virol.2022.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 20.0] [Reference Citation Analysis]
172 Milota T, Sobotkova M, Smetanova J, Bloomfield M, Vydlakova J, Chovancova Z, Litzman J, Hakl R, Novak J, Malkusova I, Hanzlikova J, Jilek D, Hutyrova B, Novak V, Krcmova I, Sediva A, Kralickova P. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study. Front Immunol 2022;13:835770. [DOI: 10.3389/fimmu.2022.835770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
173 Bastard P. Why do people die from COVID-19? Science 2022;375:829-30. [PMID: 35201875 DOI: 10.1126/science.abn9649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
174 Ortega-peña S, Rodríguez-martínez S, Cancino-diaz ME, Cancino-diaz JC. Staphylococcus epidermidis Controls Opportunistic Pathogens in the Nose, Could It Help to Regulate SARS-CoV-2 (COVID-19) Infection? Life 2022;12:341. [DOI: 10.3390/life12030341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Schmiedel BJ, Gonzalez-Colin C, Fajardo V, Rocha J, Madrigal A, Ramírez-Suástegui C, Bhattacharyya S, Simon H, Greenbaum JA, Peters B, Seumois G, Ay F, Chandra V, Vijayanand P. Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type-dependent effects of disease-risk variants. Sci Immunol 2022;7:eabm2508. [PMID: 35213211 DOI: 10.1126/sciimmunol.abm2508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
176 Oliveira JADPD, Athaide MMD, Rahman AU, de Mattos Barbosa MG, Jardim MM, Moraes MO, Pinheiro RO. Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19. Front Cell Infect Microbiol 2022;12:815738. [DOI: 10.3389/fcimb.2022.815738] [Reference Citation Analysis]
177 Mogensen TH. Genetic susceptibility to viral disease in humans. Clin Microbiol Infect 2022:S1198-743X(22)00098-2. [PMID: 35218976 DOI: 10.1016/j.cmi.2022.02.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Pekayvaz K, Leunig A, Kaiser R, Joppich M, Brambs S, Janjic A, Popp O, Nixdorf D, Fumagalli V, Schmidt N, Polewka V, Anjum A, Knottenberg V, Eivers L, Wange LE, Gold C, Kirchner M, Muenchhoff M, Hellmuth JC, Scherer C, Rubio-Acero R, Eser T, Deák F, Puchinger K, Kuhl N, Linder A, Saar K, Tomas L, Schulz C, Wieser A, Enard W, Kroidl I, Geldmacher C, von Bergwelt-Baildon M, Keppler OT, Munschauer M, Iannacone M, Zimmer R, Mertins P, Hubner N, Hoelscher M, Massberg S, Stark K, Nicolai L. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. Nat Commun 2022;13:1018. [PMID: 35197461 DOI: 10.1038/s41467-022-28508-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
179 Shirato K, Sato S. Macrophage Meets the Circadian Clock: Implication of the Circadian Clock in the Role of Macrophages in Acute Lower Respiratory Tract Infection. Front Cell Infect Microbiol 2022;12:826738. [DOI: 10.3389/fcimb.2022.826738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Ishiyama K, Arakawa-Hoyt J, Aguilar OA, Damm I, Towfighi P, Sigdel T, Tamaki S, Babdor J, Spitzer MH, Reed EF, Sarwal MM, Lanier LL; CMV Systems Immunobiology Group. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients. Proc Natl Acad Sci U S A 2022;119:e2116588119. [PMID: 35181606 DOI: 10.1073/pnas.2116588119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
181 Schuhenn J, Meister TL, Todt D, Bracht T, Schork K, Billaud JN, Elsner C, Heinen N, Karakoese Z, Haid S, Kumar S, Brunotte L, Eisenacher M, Di Y, Lew J, Falzarano D, Chen J, Yuan Z, Pietschmann T, Wiegmann B, Uebner H, Taube C, Le-Trilling VTK, Trilling M, Krawczyk A, Ludwig S, Sitek B, Steinmann E, Dittmer U, Lavender KJ, Sutter K, Pfaender S. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2022;119:e2111600119. [PMID: 35131898 DOI: 10.1073/pnas.2111600119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
182 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
183 Sahajpal NS, Jill Lai CY, Hastie A, Mondal AK, Dehkordi SR, van der Made CI, Fedrigo O, Al-Ajli F, Jalnapurkar S, Byrska-Bishop M, Kanagal-Shamanna R, Levy B, Schieck M, Illig T, Bacanu SA, Chou JS, Randolph AG, Rojiani AM, Zody MC, Brownstein CA, Beggs AH, Bafna V, Jarvis ED, Hoischen A, Chaubey A, Kolhe R; COVID19hostgenomesv Consortium. Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. iScience 2022;25:103760. [PMID: 35036860 DOI: 10.1016/j.isci.2022.103760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
184 Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, Lasinio GJ, Álvarez-Sierra D, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Zhao M, Li L, de Wit H, Ouzounis CA, Wilmsen MEP, Alofs TM, Laport DA, van Wees T, Kraker G, Jaimes MC, Van Bockstael S, Hernández-González M, Rokx C, Rijnders BJA, Pujol-Borrell R, Katsikis PD. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nat Commun 2022;13:915. [PMID: 35177626 DOI: 10.1038/s41467-022-28621-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
185 Howell R, Clarke MA, Reuschl A, Chen T, Abbott-imboden S, Singer M, Lowe DM, Bennett CL, Chain B, Jolly C, Fisher J. Executable network of SARS-CoV-2-host interaction predicts drug combination treatments. npj Digit Med 2022;5. [DOI: 10.1038/s41746-022-00561-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Sauerwein KMT, Geier CB, Stemberger RF, Akyaman H, Illes P, Fischer MB, Eibl MM, Walter JE, Wolf HM. Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination. Front Immunol 2022;13:827048. [DOI: 10.3389/fimmu.2022.827048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
187 Alidjinou EK, Hirabidian M, Rabat A, Ouafi M, Nekoua MP, Sane F, Poissy J, Hober D; The Lille COVID Research Network (LICORNE). Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age. JCM 2022;11:961. [DOI: 10.3390/jcm11040961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O’brien DP, Pinto-fernández A. Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. Biomolecules 2022;12:300. [DOI: 10.3390/biom12020300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
189 Willemsen L, Chen H, van Roomen CPAA, Griffith GR, Siebeler R, Neele AE, Kroon J, Hoeksema MA, de Winther MPJ. Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses. Front Cardiovasc Med 2022;9:829877. [DOI: 10.3389/fcvm.2022.829877] [Reference Citation Analysis]
190 da Silva Torres MK, Bichara CDA, de Almeida MDNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, dos Santos EJM, de Carvalho CAM, Vallinoto ACR. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Front Microbiol 2022;13:789882. [DOI: 10.3389/fmicb.2022.789882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
191 Chen J, Du L, Wang F, Shao X, Wang X, Yu W, Bi S, Chen D, Pan X, Zeng S, Huang L, Liang Y, Li Y, Chen R, Xue F, Li X, Wang S, Zhuang M, Liu M, Lin L, Yan H, He F, Yu L, Jiang Q, Xiong Z, Zhang L, Cao B, Wang YL, Chen D. Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health. Cell Prolif 2022;:e13204. [PMID: 35141964 DOI: 10.1111/cpr.13204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Hilligan KL, Namasivayam S, Clancy CS, O'Mard D, Oland SD, Robertson SJ, Baker PJ, Castro E, Garza NL, Lafont BAP, Johnson R, Ronchese F, Mayer-Barber KD, Best SM, Sher A. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. J Exp Med 2022;219:e20211862. [PMID: 34889942 DOI: 10.1084/jem.20211862] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
193 Hoste L, Roels L, Naesens L, Bosteels V, Vanhee S, Dupont S, Bosteels C, Browaeys R, Vandamme N, Verstaen K, Roels J, Van Damme KFA, Maes B, De Leeuw E, Declercq J, Aegerter H, Seys L, Smole U, De Prijck S, Vanheerswynghels M, Claes K, Debacker V, Van Isterdael G, Backers L, Claes KBM, Bastard P, Jouanguy E, Zhang SY, Mets G, Dehoorne J, Vandekerckhove K, Schelstraete P, Willems J, Stordeur P, Janssens S, Beyaert R, Saeys Y, Casanova JL, Lambrecht BN, Haerynck F, Tavernier SJ; MIS-C Clinicians. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C. J Exp Med 2022;219:e20211381. [PMID: 34914824 DOI: 10.1084/jem.20211381] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
194 Leonardi L, Rivalta B, Leone F, Cancrini C, Caffarelli C, Marseglia GL, Cardinale F. Host Defenses to Viruses: Lessons from Inborn Errors of Immunity. Medicina 2022;58:248. [DOI: 10.3390/medicina58020248] [Reference Citation Analysis]
195 Hakovirta H, Jalkanen J, Saimanen E, Kukkonen T, Romsi P, Suominen V, Vikatmaa L, Valtonen M, Karvonen MK, Venermo M; INFORAAA Study Group. Induction of CD73 prevents death after emergency open aortic surgery for a ruptured abdominal aortic aneurysm: a randomized, double-blind, placebo-controlled study. Sci Rep 2022;12:1839. [PMID: 35115574 DOI: 10.1038/s41598-022-05771-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol 2022;23:186-93. [PMID: 35105982 DOI: 10.1038/s41590-021-01122-w] [Cited by in Crossref: 159] [Cited by in F6Publishing: 106] [Article Influence: 159.0] [Reference Citation Analysis]
197 Nakamura T, Isoda N, Sakoda Y, Harashima H. Strategies for fighting pandemic virus infections: Integration of virology and drug delivery. J Control Release 2022:S0168-3659(22)00068-2. [PMID: 35122872 DOI: 10.1016/j.jconrel.2022.01.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
198 Chen KY, Lee KY, Qin A, Luo CS, Yeh YK, Zheng JQ, Chen CM, Tsai CY, Lin S, Liao J, Huang YW, Feng PH. Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan. Adv Ther 2022;39:910-22. [PMID: 34910280 DOI: 10.1007/s12325-021-01998-y] [Reference Citation Analysis]
199 Varese A, Nakawesi J, Farias A, Kirsebom FCM, Paulsen M, Nuriev R, Johansson C. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection. PLoS Pathog 2022;18:e1010272. [PMID: 35108347 DOI: 10.1371/journal.ppat.1010272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
200 Sui C, Xiao T, Zhang S, Zeng H, Zheng Y, Liu B, Xu G, Gao C, Zhang Z. SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy. J Immunol 2022;208:753-61. [PMID: 34996837 DOI: 10.4049/jimmunol.2100684] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
201 Mcgonagle D, Kearney MF, O'regan A, O'donnell JS, Quartuccio L, Watad A, Bridgewood C. Therapeutic implications of ongoing alveolar viral replication in COVID-19. The Lancet Rheumatology 2022;4:e135-44. [DOI: 10.1016/s2665-9913(21)00322-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
202 Hou Y, Zhou Y, Jehi L, Luo Y, Gack MU, Chan TA, Yu H, Eng C, Pieper AA, Cheng F. Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients. Aging Cell 2022;21:e13544. [PMID: 35023286 DOI: 10.1111/acel.13544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Escobedo RA, Kaushal D, Singh DK. Insights Into the Changing Landscape of Coronavirus Disease 2019. Front Cell Infect Microbiol 2021;11:761521. [PMID: 35083164 DOI: 10.3389/fcimb.2021.761521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
204 Castagnoli R, Delmonte OM, Notarangelo LD. Congenital and acquired defects of immunity: An ever-evolving story. Pediatr Allergy Immunol 2022;33 Suppl 27:61-4. [PMID: 35080321 DOI: 10.1111/pai.13632] [Reference Citation Analysis]
205 Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem 2022. [PMID: 35084674 DOI: 10.1007/s11010-022-04356-w] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
206 Gil-etayo FJ, Garcinuño S, Utrero-rico A, Cabrera-marante O, Arroyo-sanchez D, Mancebo E, Pleguezuelo DE, Rodríguez-frías E, Allende LM, Morales-pérez P, Castro-panete MJ, Lalueza A, Lumbreras C, Paz-artal E, Serrano A. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution. Biomedicines 2022;10:296. [DOI: 10.3390/biomedicines10020296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
207 D'Onofrio V, Keulen L, Vandendriessche A, Dubois J, Cartuyvels R, Vanden Abeele ME, Fraussen J, Vandormael P, Somers V, Achten R, Dendooven A, Driessen A, Augsburg L, Hellings N, Lammens M, Vanrusselt J, Cox J. Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy. Sci Rep 2022;12:1360. [PMID: 35079048 DOI: 10.1038/s41598-022-05186-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Bastolla U, Chambers P, Abia D, Garcia-bermejo M, Fresno M. Is Covid-19 Severity Associated With ACE2 Degradation? Front Drug Discov 2022;1:789710. [DOI: 10.3389/fddsv.2021.789710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Konigsberg IR, Barnes B, Campbell M, Davidson E, Zhen Y, Pallisard O, Boorgula MP, Cox C, Nandy D, Seal S, Crooks K, Sticca E, Harrison GF, Hopkinson A, Vest A, Arnold CG, Kahn MG, Kao DP, Peterson BR, Wicks SJ, Ghosh D, Horvath S, Zhou W, Mathias RA, Norman PJ, Porecha R, Yang IV, Gignoux CR, Monte AA, Taye A, Barnes KC. Host methylation predicts SARS-CoV-2 infection and clinical outcome. Commun Med (Lond) 2021;1:42. [PMID: 35072167 DOI: 10.1038/s43856-021-00042-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
210 Nguyen HO, Schioppa T, Tiberio L, Facchinetti F, Villetti G, Civelli M, Del Prete A, Sozio F, Gaudenzi C, Passari M, Barbazza I, Sozzani S, Salvi V, Bosisio D. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs. Front Immunol 2022;12:797390. [DOI: 10.3389/fimmu.2021.797390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
211 Alberici F, Affatato S, Moratto D, Mescia F, Delbarba E, Guerini A, Tedesco M, Burbelo PD, Zani R, Castagna I, Gallico A, Tonoli M, Venturini M, Roccaro AM, Giacomelli M, Cohen JI, Giustini V, Dobbs K, Su HC, Fiorini C, Quaresima V, Viola FB, Vizzardi V, Gaggiotti M, Bossini N, Gaggia P, Badolato R, Notarangelo LD, Chiarini M, Scolari F. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response. J Nephrol. [DOI: 10.1007/s40620-021-01214-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
212 Coggins SA, Laing ED, Olsen CH, Goguet E, Moser M, Jackson-Thompson BM, Samuels EC, Pollett SD, Tribble DR, Davies J, Illinik L, Hollis-Perry M, Maiolatesi SE, Duplessis CA, Ramsey KF, Reyes AE, Alcorta Y, Wong MA, Wang G, Ortega O, Parmelee E, Lindrose AR, Snow AL, Malloy AMW, Letizia AG, Ewing D, Powers JH, Schully KL, Burgess TH, Broder CC, Mitre E. Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers. Open Forum Infect Dis 2022;9:ofab575. [PMID: 35047649 DOI: 10.1093/ofid/ofab575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
213 Girona-Alarcon M, Argüello G, Esteve-Sole A, Bobillo-Perez S, Burgos-Artizzu XP, Bonet-Carne E, Mensa-Vilaró A, Codina A, Hernández-Garcia M, Jou C, Alsina L, Jordan I. Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults. iScience 2022;25:103595. [PMID: 34904133 DOI: 10.1016/j.isci.2021.103595] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Amado-rodríguez L, Salgado del Riego E, Gomez de Ona J, López Alonso I, Gil-pena H, López-martínez C, Martín-vicente P, Lopez-vazquez A, Gonzalez Lopez A, Cuesta-llavona E, Rodriguez-garcia R, Boga JA, Elena alvarez-Arguelles M, Mayordomo-colunga J, Vidal-castineira JR, Crespo I, Fernandez M, Criado L, Salvadores V, Jimeno-demuth FJ, Blanch L, Prieto B, Fernandez-fernandez A, Lopez-larrea C, Coto E, Albaiceta GM. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study. eLife 2022;11:e73012. [DOI: 10.7554/elife.73012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
215 Rusu I, Turlacu M, Micheu MM. Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications. World J Clin Cases 2022; 10(3): 762-776 [DOI: 10.12998/wjcc.v10.i3.762] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
216 Chen LF, Yang CD, Cheng XB. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection. Front Immunol 2021;12:788368. [PMID: 35003106 DOI: 10.3389/fimmu.2021.788368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Lindahl H, Bryceson YT. Neuroinflammation Associated With Inborn Errors of Immunity. Front Immunol 2022;12:827815. [DOI: 10.3389/fimmu.2021.827815] [Reference Citation Analysis]
218 Mégarbane B. The Time Has Come to Understand the Mechanisms by Which Comorbidities Contribute to COVID-19 Severity. JPM 2022;12:123. [DOI: 10.3390/jpm12020123] [Reference Citation Analysis]
219 Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene 2022;808:145963. [PMID: 34530086 DOI: 10.1016/j.gene.2021.145963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
220 Law JC, Girard M, Chao GYC, Ward LA, Isho B, Rathod B, Colwill K, Li Z, Rini JM, Yue FY, Mubareka S, McGeer AJ, Ostrowski MA, Gommerman JL, Gingras AC, Watts TH. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset. J Immunol 2022;208:429-43. [PMID: 34903642 DOI: 10.4049/jimmunol.2100727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
221 Samelson AJ, Tran QD, Robinot R, Carrau L, Rezelj VV, Kain AM, Chen M, Ramadoss GN, Guo X, Lim SA, Lui I, Nuñez JK, Rockwood SJ, Wang J, Liu N, Carlson-Stevermer J, Oki J, Maures T, Holden K, Weissman JS, Wells JA, Conklin BR, TenOever BR, Chakrabarti LA, Vignuzzi M, Tian R, Kampmann M. BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. Nat Cell Biol 2022;24:24-34. [PMID: 35027731 DOI: 10.1038/s41556-021-00821-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
222 Zeng Y, Ali MK, Du J, Li X, Yang X, Yang J, Pu X, Yang L, Hong J, Mou B, Li L, Zhou Y. Resistant Starch in Rice: Its Biosynthesis and Mechanism of Action Against Diabetes-Related Diseases. Food Reviews International. [DOI: 10.1080/87559129.2021.2024221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
223 Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen L, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath J, Franco J, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte O, Zhang Y, Snow A, Holland S, Biggs C, Moncada-Vélez M, Arias A, Lorenzo L, Boucherit S, Anglicheau D, Planas A, Haerynck F, Duvlis S, Nussbaum R, Ozcelik T, Keles S, Bousfiha A, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarstrom Q, Hammarstrom L, Dupont A, Kurolap A, Metz C, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros L, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye S, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann N, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes L, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig M, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer A, Kennelly S, Bourke N, Halwani R, Sharif-Askari F, Dorgham K, Sallette J, Mehlal-Sedkaoui S, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh D, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan A, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton R, Mane S, Anderson M, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, deLamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen P, Rodríguez-Gallego C, Piemonti L, Notarangelo L, Su H, Kisand K, Okada S, Puel A, Jouanguy E, Rice C, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies. Res Sq 2022:rs. [PMID: 35043109 DOI: 10.21203/rs.3.rs-1225906/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Huffman JE, Butler-Laporte G, Khan A, Pairo-Castineira E, Drivas TG, Peloso GM, Nakanishi T, Ganna A, Verma A, Baillie JK, Kiryluk K, Richards JB, Zeberg H; COVID-19 Host Genetics Initiative. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nat Genet 2022. [PMID: 35027740 DOI: 10.1038/s41588-021-00996-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 25.0] [Reference Citation Analysis]
225 Lanari M, Venturini E, Pierantoni L, Stera G, Castelli Gattinara G, Esposito SMR, Favilli S, Franzoni E, Fusco E, Lionetti P, Maffeis C, Marseglia G, Massella L, Midulla F, Zanobini A, Zecca M, Villani A, Staiano A, Galli L; Other Collaborators. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement. Ital J Pediatr 2022;48:7. [PMID: 35022088 DOI: 10.1186/s13052-021-01187-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
226 Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, Yazdanpanah Y, Tran-Dinh A, Montravers P, Monteiro RC, Chollet-Martin S, Hurtado-Nedelec M, de Chaisemartin L. Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19. Sci Rep 2022;12:638. [PMID: 35022495 DOI: 10.1038/s41598-021-04705-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
227 Gu L, Casserly D, Brady G, Carpenter S, Bracken AP, Fitzgerald KA, Unterholzner L, Bowie AG. Myeloid cell nuclear differentiation antigen controls the pathogen-stimulated type I interferon cascade in human monocytes by transcriptional regulation of IRF7. Nat Commun 2022;13:14. [PMID: 35013241 DOI: 10.1038/s41467-021-27701-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
228 Roarty C, Waterfield T. Review and future directions for PIMS-TS (MIS-C). Arch Dis Child 2022:archdischild-2021-323143. [PMID: 35012934 DOI: 10.1136/archdischild-2021-323143] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
229 Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 2022;7:eabm5505. [PMID: 34995097 DOI: 10.1126/sciimmunol.abm5505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 34.0] [Reference Citation Analysis]
230 Zepeda-Cervantes J, Martínez-Flores D, Ramírez-Jarquín JO, Tecalco-Cruz ÁC, Alavez-Pérez NS, Vaca L, Sarmiento-Silva RE. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. Viruses 2022;14:94. [PMID: 35062298 DOI: 10.3390/v14010094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
231 Knight V. Immunodeficiency and Autoantibodies to Cytokines. J Appl Lab Med 2022;7:151-64. [PMID: 34996092 DOI: 10.1093/jalm/jfab139] [Reference Citation Analysis]
232 Leon J, Michelson DA, Olejnik J, Chowdhary K, Oh HS, Hume AJ, Galván-Peña S, Zhu Y, Chen F, Vijaykumar B, Yang L, Crestani E, Yonker LM, Knipe DM, Mühlberger E, Benoist C. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Proc Natl Acad Sci U S A 2022;119:e2116853118. [PMID: 34969849 DOI: 10.1073/pnas.2116853118] [Reference Citation Analysis]
233 Prosperini L, Tortorella C, Haggiag S, Ruggieri S, Galgani S, Gasperini C. Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies. J Neurol 2022. [PMID: 34984514 DOI: 10.1007/s00415-021-10951-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
234 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif LJ, Peeples ME, Liu SL. SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci U S A 2022;119:e2111400119. [PMID: 34937699 DOI: 10.1073/pnas.2111400119] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
235 Mao T, Israelow B, Lucas C, Vogels CBF, Gomez-Calvo ML, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M, Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A; Yale SARS-CoV-2 Genome Surveillance Initiative. A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice. J Exp Med 2022;219:e20211818. [PMID: 34757384 DOI: 10.1084/jem.20211818] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
236 Zhao X, Chen D, Li X, Griffith L, Chang J, An P, Guo JT. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. J Mol Biol 2022;:167438. [PMID: 34990653 DOI: 10.1016/j.jmb.2021.167438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2022;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
238 Karakoc Aydiner E, Bilgic Eltan S, Babayeva R, Aydiner O, Kepenekli E, Kolukisa B, Sefer AP, Yalcin Gungoren E, Karabiber E, Yucel EO, Ozdemir O, Kiykim A, Artac H, Yakici N, Yalcin K, Cokugras H, Celkan TT, Orhan F, Yesilipek MA, Baris S, Ozen A. Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses. Allergy 2022;77:282-95. [PMID: 34314546 DOI: 10.1111/all.15025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
239 Galati D, Zanotta S, Capitelli L, Bocchino M. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines. Allergy 2022;77:100-10. [PMID: 34245591 DOI: 10.1111/all.15004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
240 Wu B, Ramaiah A, Garcia G Jr, Hasiakos S, Arumugaswami V, Srikanth S. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling. J Immunol 2022;208:74-84. [PMID: 34819389 DOI: 10.4049/jimmunol.2100742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
241 Fang X. A commentary of “Type I Interferon Deficiency Can Lead to Severe COVID-19” in 10 remarkable discoveries from 2020 in Nature. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.01.005] [Reference Citation Analysis]
242 Larionova R, Byvaltsev K, Kravtsova О, Takha E, Petrov S, Kazarian G, Valeeva A, Shuralev E, Mukminov M, Renaudineau Y, Arleevskaya M. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. Journal of Translational Autoimmunity 2022;5:100154. [DOI: 10.1016/j.jtauto.2022.100154] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
243 Nln I, Fernandez-ruiz R, Muskardin TLW, Paredes JL, Blazer AD, Tuminello S, Attur M, Iturrate E, Petrilli CM, Abramson SB, Chakravarti A, Niewold TB. Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
244 Bastard P, Zhang Q, Zhang S, Jouanguy E, Casanova J. Type I interferons and SARS-CoV-2: from cells to organisms. Current Opinion in Immunology 2022. [DOI: 10.1016/j.coi.2022.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
245 David A, Parkinson N, Peacock TP, Pairo-castineira E, Khanna T, Cobat A, Tenesa A, Sancho-shimizu V, Casanova J, Abel L, Barclay WS, Baillie JK, Sternberg MJ. A common TMPRSS2 variant has a protective effect against severe COVID-19. Current Research in Translational Medicine 2022. [DOI: 10.1016/j.retram.2022.103333] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
246 Kernan KF, Ghaloul-Gonzalez L, Vockley J, Lamb J, Hollingshead D, Chandran U, Sethi R, Park HJ, Berg RA, Wessel D, Pollack MM, Meert KL, Hall MW, Newth CJL, Lin JC, Doctor A, Shanley T, Cornell T, Harrison RE, Zuppa AF, Banks R, Reeder RW, Holubkov R, Notterman DA, Dean JM, Carcillo JA. Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe Sepsis. J Clin Immunol 2022. [PMID: 34973142 DOI: 10.1007/s10875-021-01183-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
247 Ramana CV, Das B. Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection. Computational and Mathematical Biophysics 2021;9:273-88. [DOI: 10.1515/cmb-2020-0128] [Reference Citation Analysis]
248 Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. PLoS Pathog 2021;17:e1010106. [PMID: 34969061 DOI: 10.1371/journal.ppat.1010106] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
249 Croci S, Venneri MA, Mantovani S, Fallerini C, Benetti E, Picchiotti N, Campolo F, Imperatore F, Palmieri M, Daga S, Gabbi C, Montagnani F, Beligni G, Farias TDJ, Carriero ML, Di Sarno L, Alaverdian D, Aslaksen S, Cubellis MV, Spiga O, Baldassarri M, Fava F, Norman PJ, Frullanti E, Isidori AM, Amoroso A, Mari F, Furini S, Mondelli MU, Gen-Covid Multicenter Study, Chiariello M, Renieri A, Meloni I. The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. Autophagy 2021;:1-11. [PMID: 34964709 DOI: 10.1080/15548627.2021.1995152] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
250 Johansson AM, Malhotra U, Kim YG, Gomez R, Krist MP, Wald A, Koelle DM, Kwok WW, Sant AJ. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals. PLoS Pathog 2021;17:e1010203. [DOI: 10.1371/journal.ppat.1010203] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
251 Almendro-Vázquez P, Laguna-Goya R, Ruiz-Ruigomez M, Utrero-Rico A, Lalueza A, Maestro de la Calle G, Delgado P, Perez-Ordoño L, Muro E, Vila J, Zamarron I, Moreno-Batanero M, Chivite-Lacaba M, Gil-Etayo FJ, Martín-Higuera C, Meléndez-Carmona MÁ, Lumbreras C, Arellano I, Alarcon B, Allende LM, Aguado JM, Paz-Artal E. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination. PLoS Pathog 2021;17:e1010211. [PMID: 34962970 DOI: 10.1371/journal.ppat.1010211] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
252 Gaitán-Duarte HG, Álvarez-Moreno C, Rincón-Rodríguez CJ, Yomayusa-González N, Cortés JA, Villar JC, Bravo-Ojeda JS, García-Peña A, Adarme-Jaimes W, Rodríguez-Romero VA, Villate-Soto SL, Buitrago G, Chacón-Sarmiento J, Macias-Quintero M, Vaca CP, Gómez-Restrepo C, Rodríguez-Malagón N. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial. EClinicalMedicine 2022;43:101242. [PMID: 34957385 DOI: 10.1016/j.eclinm.2021.101242] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
253 Chapoval SP, Keegan AD. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection. Mol Med 2021;27:162. [PMID: 34961486 DOI: 10.1186/s10020-021-00423-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Alem F, Olanrewaju AA, Omole S, Hobbs HE, Ahsan N, Matulis G, Brantner CA, Zhou W, Petricoin EF, Liotta LA, Caputi M, Bavari S, Wu Y, Kashanchi F, Hakami RM. Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy. Cell Biosci 2021;11:220. [PMID: 34953502 DOI: 10.1186/s13578-021-00732-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
255 Mine K, Nagafuchi S, Mori H, Takahashi H, Anzai K. SARS-CoV-2 Infection and Pancreatic β Cell Failure. Biology (Basel) 2021;11:22. [PMID: 35053020 DOI: 10.3390/biology11010022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
256 Mantovani S, Daga S, Fallerini C, Baldassarri M, Benetti E, Picchiotti N, Fava F, Gallì A, Zibellini S, Bruttini M, Palmieri M, Croci S, Amitrano S, Alaverdian D, Capitani K, Furini S, Mari F, Meloni I, Frullanti E, Mondelli MU, Renieri A; GEN-COVID Multicenter Study. Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients. Genes Immun 2021. [PMID: 34952932 DOI: 10.1038/s41435-021-00157-1] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
257 Ramezankhani R, Solhi R, Chai YC, Vosough M, Verfaillie C. Organoid and microfluidics-based platforms for drug screening in COVID-19. Drug Discov Today 2021:S1359-6446(21)00565-1. [PMID: 34954328 DOI: 10.1016/j.drudis.2021.12.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
258 Wu J, Vodovotz Y, Abdelhamid S, Guyette FX, Yaffe MB, Gruen DS, Cyr A, Okonkwo DO, Kar UK, Krishnamoorthi N, Voinchet RG, Billiar IM, Yazer MH, Namas RA, Daley BJ, Miller RS, Harbrecht BG, Claridge JA, Phelan HA, Zuckerbraun BS, Johansson PI, Stensballe J, Morrissey JH, Tracy RP, Wisniewski SR, Neal MD, Sperry JL, Billiar TR; PAMPer study group. Multi-omic analysis in injured humans: Patterns align with outcomes and treatment responses. Cell Rep Med 2021;2:100478. [PMID: 35028617 DOI: 10.1016/j.xcrm.2021.100478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
259 Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha FQ, Alves-Filho JC, Cunha TM, Ekins S. Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice. bioRxiv 2021:2021. [PMID: 34981062 DOI: 10.1101/2021.12.16.472155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Dumitrescu L, Papathanasiou A, Coclitu C, Constantinescu CS, Popescu BO, Tanasescu R. Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic. QJM 2021;114:691-7. [PMID: 33486513 DOI: 10.1093/qjmed/hcaa348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Roberts I, Wright Muelas M, Taylor JM, Davison AS, Xu Y, Grixti JM, Gotts N, Sorokin A, Goodacre R, Kell DB. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 2021;18:6. [PMID: 34928464 DOI: 10.1007/s11306-021-01859-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
262 Sugrue JA, Bourke NM, O'Farrelly C. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature. Front Immunol 2021;12:757249. [PMID: 34917078 DOI: 10.3389/fimmu.2021.757249] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
263 Douillard V, Castelli EC, Mack SJ, Hollenbach JA, Gourraud PA, Vince N, Limou S; Covid-19|HLA & Immunogenetics Consortium and the SNP-HLA Reference Consortium. Current HLA Investigations on SARS-CoV-2 and Perspectives. Front Genet 2021;12:774922. [PMID: 34912378 DOI: 10.3389/fgene.2021.774922] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
264 Colarusso C, Maglio A, Terlizzi M, Vitale C, Molino A, Pinto A, Vatrella A, Sorrentino R. Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β. Biomedicines 2021;9:1931. [PMID: 34944747 DOI: 10.3390/biomedicines9121931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
265 Aricò E, Bracci L, Castiello L, Urbani F, Casanova JL, Belardelli F. Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19. Cytokine Growth Factor Rev 2021:S1359-6101(21)00092-7. [PMID: 34955389 DOI: 10.1016/j.cytogfr.2021.12.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Singh M, Chazal M, Quarato P, Bourdon L, Malabat C, Vallet T, Vignuzzi M, van der Werf S, Behillil S, Donati F, Sauvonnet N, Nigro G, Bourgine M, Jouvenet N, Cecere G. A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection. EMBO Rep 2021;:e54341. [PMID: 34914162 DOI: 10.15252/embr.202154341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Cunha MDP, Vilela APP, Molina CV, Acuña SM, Muxel SM, Barroso VM, Baroni S, Gomes de Oliveira L, Angelo YS, Peron JPS, Góes LGB, Campos ACA, Minóprio P. Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient. Front Med (Lausanne) 2021;8:760170. [PMID: 34901074 DOI: 10.3389/fmed.2021.760170] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
268 Haslbauer JD, Zinner C, Stalder AK, Schneeberger J, Menter T, Bassetti S, Mertz KD, Went P, Matter MS, Tzankov A. Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19. Front Immunol 2021;12:763098. [DOI: 10.3389/fimmu.2021.763098] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
269 Ianevski A, Yao R, Zusinaite E, Lello LS, Wang S, Jo E, Yang J, Ravlo E, Wang W, Lysvand H, Løseth K, Oksenych V, Tenson T, Windisch MP, Poranen MM, Nieminen AI, Nordbø SA, Fenstad MH, Grødeland G, Aukrust P, Trøseid M, Kantele A, Lastauskienė E, Vitkauskienė A, Legrand N, Merits A, Bjørås M, Kainov DE. Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections. Viruses 2021;13:2489. [PMID: 34960758 DOI: 10.3390/v13122489] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
270 Lang-Meli J, Fuchs J, Mathé P, Ho HE, Kern L, Jaki L, Rusignuolo G, Mertins S, Somogyi V, Neumann-Haefelin C, Trinkmann F, Müller M, Thimme R, Umhau M, Quinti I, Wagner D, Panning M, Cunningham-Rundles C, Laubner K, Warnatz K. Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency. J Clin Immunol 2021. [PMID: 34893946 DOI: 10.1007/s10875-021-01193-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
271 Mageau A, Papo T, Ruckly S, Strukov A, van Gysel D, Sacre K, Timsit JF. Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study. Ann Rheum Dis 2021:annrheumdis-2021-221599. [PMID: 34893471 DOI: 10.1136/annrheumdis-2021-221599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
272 Zhang C, Feng YG, Tam C, Wang N, Feng Y. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis. Front Immunol 2021;12:733171. [PMID: 34880855 DOI: 10.3389/fimmu.2021.733171] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
273 Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R, Mari F, Renieri A, Furini S; WES/WGS Working Group Within the HGI., GenOMICC Consortium., GEN-COVID Multicenter Study. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet 2021. [PMID: 34889978 DOI: 10.1007/s00439-021-02397-7] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
274 Regis E, Fontanella S, Lin L, Howard R, Haider S, Curtin JA, Edwards MR, Rattray M, Simpson A, Custovic A, Johnston SL. Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study. Sci Rep 2021;11:23741. [PMID: 34887467 DOI: 10.1038/s41598-021-03044-x] [Reference Citation Analysis]
275 Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, Aloufi A, AlSumait F, Berbari E, Halwani R. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS One 2021;16:e0260568. [PMID: 34874962 DOI: 10.1371/journal.pone.0260568] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
276 Mather MW, Jardine L, Talks B, Gardner L, Haniffa M. Complexity of immune responses in COVID-19. Semin Immunol 2021;55:101545. [PMID: 34865933 DOI: 10.1016/j.smim.2021.101545] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
277 Hooftman A, O'Neill LAJ. Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19? Curr Res Pharmacol Drug Discov 2021;2:100048. [PMID: 34870152 DOI: 10.1016/j.crphar.2021.100048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Bajad NG, Rayala S, Gutti G, Sharma A, Singh M, Kumar A, Singh SK. Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2. Curr Res Pharmacol Drug Discov 2021;2:100026. [PMID: 34870145 DOI: 10.1016/j.crphar.2021.100026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Hatton CF, Botting RA, Dueñas ME, Haq IJ, Verdon B, Thompson BJ, Spegarova JS, Gothe F, Stephenson E, Gardner AI, Murphy S, Scott J, Garnett JP, Carrie S, Powell J, Khan CMA, Huang L, Hussain R, Coxhead J, Davey T, Simpson AJ, Haniffa M, Hambleton S, Brodlie M, Ward C, Trost M, Reynolds G, Duncan CJA. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nat Commun 2021;12:7092. [PMID: 34876592 DOI: 10.1038/s41467-021-27318-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
280 Chen J, Jing H, Martin-Nalda A, Bastard P, Rivière JG, Liu Z, Colobran R, Lee D, Tung W, Manry J, Hasek M, Boucherit S, Lorenzo L, Rozenberg F, Aubart M, Abel L, Su HC, Soler Palacin P, Casanova JL, Zhang SY. Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis. J Exp Med 2021;218:e20211349. [PMID: 34726731 DOI: 10.1084/jem.20211349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
281 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
282 Kleymenov DA, Bykonia EN, Popova LI, Mazunina EP, Gushchin VA, Kolobukhina LV, Burgasova OA, Kruzhkova IS, Kuznetsova NA, Shidlovskaya EV, Divisenko EV, Pochtovyi AA, Bacalin VV, Smetanina SV, Tkachuk AP, Logunov DY, Gintsburg AL. A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels. Front Immunol 2021;12:771609. [PMID: 34858428 DOI: 10.3389/fimmu.2021.771609] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
283 Spiering AE, de Vries TJ. Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19. Front Immunol 2021;12:756262. [PMID: 34858409 DOI: 10.3389/fimmu.2021.756262] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
284 Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Front Microbiol 2021;12:761887. [PMID: 34858373 DOI: 10.3389/fmicb.2021.761887] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
285 Gilbert C, Lefeuvre C, Preisser L, Pivert A, Soleti R, Blanchard S, Delneste Y, Ducancelle A, Couez D, Jeannin P. Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals. Front Immunol 2021;12:750279. [PMID: 34858406 DOI: 10.3389/fimmu.2021.750279] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
286 . [An interview with Gilles Bloch, CEO of Inserm: Lessons and challenges of an unprecedented crisis]. Med Sci (Paris) 2021;37:959-62. [PMID: 34851265 DOI: 10.1051/medsci/2021179] [Reference Citation Analysis]
287 Cojocaru E, Cojocaru C, Antoniu SA, Stafie CS, Rajnoveanu A, Rajnoveanu RM. Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective. Expert Rev Respir Med 2021;:1-5. [PMID: 34793285 DOI: 10.1080/17476348.2022.2008910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
288 Goldstein ME, Scull MA. Modeling Innate Antiviral Immunity in Physiological Context. J Mol Biol 2021;:167374. [PMID: 34863779 DOI: 10.1016/j.jmb.2021.167374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
289 Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr 2021;33:648-56. [PMID: 34734915 DOI: 10.1097/MOP.0000000000001062] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
290 Demirdag Y, Fuleihan R, Orange JS, Yu JE. New primary immunodeficiencies 2021 context and future. Curr Opin Pediatr 2021;33:657-75. [PMID: 34670265 DOI: 10.1097/MOP.0000000000001075] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
291 Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr 2021;33:549-55. [PMID: 34534994 DOI: 10.1097/MOP.0000000000001061] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
292 Tangye SG, Bucciol G, Meyts I. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity. Curr Opin Allergy Clin Immunol 2021;21:515-24. [PMID: 34494617 DOI: 10.1097/ACI.0000000000000786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
293 Hammarström L, Marcotte H, Piralla A, Baldanti F, Pan-Hammarström Q. Antibody therapy for COVID-19. Curr Opin Allergy Clin Immunol 2021;21:553-8. [PMID: 34570010 DOI: 10.1097/ACI.0000000000000787] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
294 Ponsford MJ, Shillitoe BMJ, Humphreys IR, Gennery AR, Jolles S. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency. Curr Opin Allergy Clin Immunol 2021;21:525-34. [PMID: 34596095 DOI: 10.1097/ACI.0000000000000792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
295 Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines. Curr HIV/AIDS Rep 2021. [PMID: 34843064 DOI: 10.1007/s11904-021-00590-x] [Reference Citation Analysis]
296 Gu R, Mao T, Lu Q, Tianjiao Su T, Wang J. Myeloid dysregulation and therapeutic intervention in COVID-19. Semin Immunol 2021;55:101524. [PMID: 34823995 DOI: 10.1016/j.smim.2021.101524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
297 Lim PN, Cervantes MM, Pham LK, Rothchild AC. Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Rev Mol Med 2021;23:e18. [PMID: 34823627 DOI: 10.1017/erm.2021.21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
298 Miyashita Y, Kouwaki T, Tsukamoto H, Okamoto M, Nakamura K, Oshiumi H. TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor-mediated inflammatory responses. Life Sci Alliance 2022;5:e202101181. [PMID: 34819358 DOI: 10.26508/lsa.202101181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Randolph HE, Fiege JK, Thielen BK, Mickelson CK, Shiratori M, Barroso-Batista J, Langlois RA, Barreiro LB. Genetic ancestry effects on the response to viral infection are pervasive but cell type specific. Science 2021;374:1127-33. [PMID: 34822289 DOI: 10.1126/science.abg0928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
300 Casanova JL, Abel L. Mechanisms of viral inflammation and disease in humans. Science 2021;374:1080-6. [PMID: 34822298 DOI: 10.1126/science.abj7965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
301 Gorczynski RM, Lindley RA, Steele EJ, Wickramasinghe NC. Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2. JPM 2021;11:1253. [DOI: 10.3390/jpm11121253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
302 Ozcifci G, Aydin T, Atli Z, Balkan II, Tabak F, Oztas M, Ozguler Y, Ugurlu S, Hatemi G, Melikoglu M, Fresko I, Hamuryudan V, Seyahi E. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome. Rheumatol Int 2021. [PMID: 34825278 DOI: 10.1007/s00296-021-05056-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
303 Wang S, Hao M, Pan Z, Lei J, Zou X. Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients. PLoS Comput Biol 2021;17:e1009587. [PMID: 34818337 DOI: 10.1371/journal.pcbi.1009587] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
304 Galani IE, Andreakos E. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Semin Immunol 2021;55:101522. [PMID: 34815163 DOI: 10.1016/j.smim.2021.101522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
305 Sturmberg J, Paul E, Van Damme W, Ridde V, Brown GW, Kalk A. The danger of the single storyline obfuscating the complexities of managing SARS-CoV-2/COVID-19. J Eval Clin Pract 2021. [PMID: 34825442 DOI: 10.1111/jep.13640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Hossain MS, Pathan AQMSU, Islam MN, Tonmoy MIQ, Rakib MI, Munim MA, Saha O, Fariha A, Reza HA, Roy M, Bahadur NM, Rahaman MM. Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning. Inform Med Unlocked 2021;27:100798. [PMID: 34812411 DOI: 10.1016/j.imu.2021.100798] [Reference Citation Analysis]
307 Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Reference Citation Analysis]
308 Kulu H, Atasoy M, Özyurt K, Maurer M, Avcı A, Akkuş MR, Ertaş R. The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients. Front Immunol 2021;12:722406. [PMID: 34804011 DOI: 10.3389/fimmu.2021.722406] [Reference Citation Analysis]
309 Khan H, Winstone H, Jimenez-Guardeño JM, Graham C, Doores KJ, Goujon C, Matthews DA, Davidson AD, Rihn SJ, Palmarini M, Neil SJD, Malim MH. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathog 2021;17:e1009820. [PMID: 34807954 DOI: 10.1371/journal.ppat.1009820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
310 Asif AA, Hussain H, Senthil Kumaran S, Syed SB, Vanka V, Tharoor M, Rangwala US, Rathore U, Singhal M, Chatterjee T. Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review. J Community Hosp Intern Med Perspect 2021;11:760-8. [PMID: 34804386 DOI: 10.1080/20009666.2021.1984644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 López-Jiménez AT, Mostowy S. Emerging technologies and infection models in cellular microbiology. Nat Commun 2021;12:6764. [PMID: 34799563 DOI: 10.1038/s41467-021-26641-w] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
312 Schmiedel BJ, Rocha J, Gonzalez-Colin C, Bhattacharyya S, Madrigal A, Ottensmeier CH, Ay F, Chandra V, Vijayanand P. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types. Nat Commun 2021;12:6760. [PMID: 34799557 DOI: 10.1038/s41467-021-26888-3] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
313 Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021;12:693938. [PMID: 34790191 DOI: 10.3389/fimmu.2021.693938] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
314 Ferré EMN, Schmitt MM, Lionakis MS. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Front Pediatr 2021;9:723532. [PMID: 34790633 DOI: 10.3389/fped.2021.723532] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
315 Setaro AC, Gaglia MM. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. Curr Res Virol Sci 2021;2:100015. [PMID: 34786565 DOI: 10.1016/j.crviro.2021.100015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
316 D'Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, Gygli S, Rosas LA, Sadtler K, Kalish H, Blatti CA 3rd, Zhu R, Gatzke L, Bushell C, Memoli MJ, O'Day SJ, Fischer TD, Hammond TC, Lee RC, Cash JC, Powers ME, O'Keefe GE, Butnor KJ, Rapkiewicz AV, Travis WD, Layne SP, Kash JC, Taubenberger JK. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med 2021;13:eabj7790. [PMID: 34648357 DOI: 10.1126/scitranslmed.abj7790] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
317 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
318 Day JD, Park S, Ranard BL, Singh H, Chow CC, Vodovotz Y. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model. Front Immunol 2021;12:754127. [PMID: 34777366 DOI: 10.3389/fimmu.2021.754127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
319 Drosos AA, Pelechas E, Voulgari PV. Seronegative Erosive Arthritis Following SARS-CoV-2 Infection. Rheumatol Ther 2021. [PMID: 34786669 DOI: 10.1007/s40744-021-00395-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
320 Hulme KD, Noye EC, Short KR, Labzin LI. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections. Front Immunol 2021;12:770066. [PMID: 34777390 DOI: 10.3389/fimmu.2021.770066] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
321 Pshenichnaya NY, Kareva EN, Leneva IA, Bulgakova VA, Kravchenko IE, Nikolaeva IV, Grekova AI, Ivanova AP, Puzyreva LV, Khasanova GM, Orlova SN, Tikhonova EP, Petrov VA, Malinin OV, Kolaeva NV, Volchkova EV, Kanshina NN, Chulanov VP. Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020. Terapevticheskii arkhiv 2021;93:1306-15. [DOI: 10.26442/00403660.2021.11.201206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
322 Rahimi P, Tarharoudi R, Rahimpour A, Mosayebi Amroabadi J, Ahmadi I, Anvari E, Siadat SD, Aghasadeghi M, Fateh A. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients. Virol J 2021;18:221. [PMID: 34775984 DOI: 10.1186/s12985-021-01692-z] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
323 Oulas A, Richter J, Zanti M, Tomazou M, Michailidou K, Christodoulou K, Christodoulou C, Spyrou GM. In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches. BMC Genom Data 2021;22:48. [PMID: 34773976 DOI: 10.1186/s12863-021-01007-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
324 Garcia-Vidal C, Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Almuedo-Riera A, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Muñoz J, Vila J, Garcia F, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother 2021;76:3296-302. [PMID: 34473275 DOI: 10.1093/jac/dkab321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
325 Raadsen MP, Gharbharan A, Jordans CCE, Mykytyn AZ, Lamers MM, van den Doel PB, Endeman H, van den Akker JPC, GeurtsvanKessel CH, Koopmans MPG, Rokx C, Goeijenbier M, van Gorp ECM, Rijnders BJA, Haagmans BL. Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19. J Clin Immunol 2021. [PMID: 34767118 DOI: 10.1007/s10875-021-01168-3] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
326 Madden EA, Diamond MS. Host cell-intrinsic innate immune recognition of SARS-CoV-2. Curr Opin Virol 2021;52:30-8. [PMID: 34814102 DOI: 10.1016/j.coviro.2021.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
327 Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J. TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO). Hum Vaccin Immunother 2021;:1-29. [PMID: 34762551 DOI: 10.1080/21645515.2021.1953351] [Reference Citation Analysis]
328 Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the Ageing Immune System. Nat Aging 2021;1:769-82. [PMID: 34746804 DOI: 10.1038/s43587-021-00114-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
329 Zhou Y, Xu X, Wei H. Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment. Front Immunol 2021;12:716940. [PMID: 34745094 DOI: 10.3389/fimmu.2021.716940] [Reference Citation Analysis]
330 Agrawal S, Salazar J, Tran TM, Agrawal A. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2. Front Immunol 2021;12:739757. [PMID: 34745109 DOI: 10.3389/fimmu.2021.739757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 Nombel A, Fabien N, Coutant F. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Front Immunol 2021;12:773352. [PMID: 34745149 DOI: 10.3389/fimmu.2021.773352] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
332 Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J, Monin MB, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Händler K, Reynolds G, Blüthgen N, Hack G, Finnemann C, Nischalke HD, Strassburg CP, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt SV, Latz E, Hrusovsky K, Ball AJ, Johnson JM, Koenig PA, Schmidt FI, Haniffa M, Heath JR, Kümmerer BM, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander LE, Sawitzki B, Aschenbrenner AC, Schultze JL, Nattermann J; Deutsche COVID-19 OMICS Initiative (DeCOI). Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 2021;54:2650-2669.e14. [PMID: 34592166 DOI: 10.1016/j.immuni.2021.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 39] [Article Influence: 1.0] [Reference Citation Analysis]
333 Lévy R, Zhang P, Bastard P, Dorgham K, Melki I, Hadchouel A, Hartoularos GC, Neven B, Castelle M, Roy C, Toin T, Berteloot L, Bizien L, Abid H, Burgard M, Houhou-Fidouh N, Rozenberg F, Jouanguy E, Ye CJ, Gorochov G, Zhang Q, Casanova JL. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child. Proc Natl Acad Sci U S A 2021;118:e2114390118. [PMID: 34702736 DOI: 10.1073/pnas.2114390118] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
334 Cappadona C, Paraboschi EM, Ziliotto N, Bottaro S, Rimoldi V, Gerussi A, Azimonti A, Brenna D, Brunati A, Cameroni C, Campanaro G, Carloni F, Cavadini G, Ciravegna M, Composto A, Converso G, Corbella P, D'Eugenio D, Dal Rì G, Di Giorgio SM, Grondelli MC, Guerrera L, Laffoucriere G, Lando B, Lopedote L, Maizza B, Marconi E, Mariola C, Matronola GM, Menga LM, Montorsi G, Papatolo A, Patti R, Profeta L, Rebasti V, Smidili A, Tarchi SM, Tartaglia FC, Tettamanzi G, Tinelli E, Stuani R, Bolchini C, Pattini L, Invernizzi P, Degenhardt F, Franke A, Duga S, Asselta R. MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 Severity. J Pers Med 2021;11:1166. [PMID: 34834519 DOI: 10.3390/jpm11111166] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
335 Khwatenge CN, Pate M, Miller LC, Sang Y. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19. Front Immunol 2021;12:732913. [PMID: 34737743 DOI: 10.3389/fimmu.2021.732913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
336 Piontkivska H, Wales-McGrath B, Miyamoto M, Wayne ML. ADAR Editing in Viruses: An Evolutionary Force to Reckon with. Genome Biol Evol 2021;13:evab240. [PMID: 34694399 DOI: 10.1093/gbe/evab240] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
337 Nath P, Chauhan NR, Jena KK, Datey A, Kumar ND, Mehto S, De S, Nayak TK, Priyadarsini S, Rout K, Bal R, Murmu KC, Kalia M, Patnaik S, Prasad P, Reggiori F, Chattopadhyay S, Chauhan S. Inhibition of IRGM establishes a robust antiviral immune state to restrict pathogenic viruses. EMBO Rep 2021;22:e52948. [PMID: 34467632 DOI: 10.15252/embr.202152948] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
338 Bednash JS, Kagan VE, Englert JA, Farkas D, Tyurina YY, Tyurin VA, Samovich SN, Farkas L, Elhance A, Johns F, Lee H, Cheng L, Majumdar A, Jones D, Mejia OR, Ruane-Foster M, Londino JD, Mallampalli RK, Robinson RT. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling. Transl Res 2021:S1931-5244(21)00263-2. [PMID: 34740873 DOI: 10.1016/j.trsl.2021.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
339 Sohn SY, Hearing J, Mugavero J, Kirillov V, Gorbunova E, Helminiak L, Mishra S, Mackow E, Hearing P, Reich NC, Kim HK. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. mBio 2021;:e0275621. [PMID: 34724828 DOI: 10.1128/mBio.02756-21] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
340 Wu Y, Wang XH, Li XH, Song LY, Yu SL, Fang ZC, Liu YQ, Yuan LY, Peng CY, Zhang SY, Cheng W, Ma HC, Wang LF, Tang JM, Wang YF, Ji FY. Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China. Mil Med Res 2021;8:57. [PMID: 34724985 DOI: 10.1186/s40779-021-00351-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
341 Pillai S. Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation. Clinics in Laboratory Medicine 2021. [DOI: 10.1016/j.cll.2021.10.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Le NK, Kaman K, Martin HC, Mullur J, Stenehjem KK, Coomar L, Bahar B, Dutta M, Izurieta R, Brooks JP. The immunologic response to severe acute respiratory syndrome coronavirus 2. Allergy Asthma Proc 2021;42:495-505. [PMID: 34871157 DOI: 10.2500/aap.2021.42.210077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
343 Kitsou K, Kotanidou A, Paraskevis D, Karamitros T, Katzourakis A, Tedder R, Hurst T, Sapounas S, Kotsinas A, Gorgoulis V, Spoulou V, Tsiodras S, Lagiou P, Magiorkinis G. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients. Microbiol Spectr 2021;9:e0126021. [PMID: 34612698 DOI: 10.1128/Spectrum.01260-21] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
344 Sarzani R, Spannella F, Giulietti F, Di Pentima C, Giordano P, Giacometti A. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence. Intern Emerg Med 2021. [PMID: 34718937 DOI: 10.1007/s11739-021-02860-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
345 Bloomfield M, Parackova Z, Hanzlikova J, Lastovicka J, Sediva A. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients. J Clin Immunol 2021. [PMID: 34718945 DOI: 10.1007/s10875-021-01163-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Chaudhary JK, Yadav R, Chaudhary PK, Maurya A, Kant N, Rugaie OA, Haokip HR, Yadav D, Roshan R, Prasad R, Chatrath A, Singh D, Jain N, Dhamija P. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Cells 2021;10:2949. [PMID: 34831172 DOI: 10.3390/cells10112949] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
347 Furutani Y, Toguchi M, Higuchi S, Yanaka K, Gailhouste L, Qin XY, Masaki T, Ochi S, Matsuura T. Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α. Int J Mol Sci 2021;22:11641. [PMID: 34769072 DOI: 10.3390/ijms222111641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
348 Plaçais L, Richier Q, Noël N, Lacombe K, Mariette X, Hermine O. Immune interventions in COVID-19: a matter of time? Mucosal Immunol 2021. [PMID: 34711920 DOI: 10.1038/s41385-021-00464-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
349 Lee BT, Barber GP, Benet-Pagès A, Casper J, Clawson H, Diekhans M, Fischer C, Gonzalez JN, Hinrichs AS, Lee CM, Muthuraman P, Nassar LR, Nguy B, Pereira T, Perez G, Raney BJ, Rosenbloom KR, Schmelter D, Speir ML, Wick BD, Zweig AS, Haussler D, Kuhn RM, Haeussler M, Kent WJ. The UCSC Genome Browser database: 2022 update. Nucleic Acids Res 2021:gkab959. [PMID: 34718705 DOI: 10.1093/nar/gkab959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
350 Khanmohammadi S, Rezaei N, Khazaei M, Shirkani A. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19. J Clin Immunol 2021. [PMID: 34713375 DOI: 10.1007/s10875-021-01166-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
351 Coleman C, Doyle-Meyers LA, Russell-Lodrigue KE, Golden N, Threeton B, Song K, Pierre G, Baribault C, Bohm RP, Maness NJ, Kolls JK, Rappaport J, Mudd JC. Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys. Front Immunol 2021;12:754642. [PMID: 34691074 DOI: 10.3389/fimmu.2021.754642] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
352 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
353 Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, Guimaraes R, Malagon-Lopez J, Spinnhirny P, Lederle A, Mohseninia R, Hirschler A, Muller L, Bastard P, Gervais A, Zhang Q, Danion F, Ruch Y, Schenck M, Collange O, Chamaraux-Tran TN, Molitor A, Pichot A, Bernard A, Tahar O, Bibi-Triki S, Wu H, Paul N, Mayeur S, Larnicol A, Laumond G, Frappier J, Schmidt S, Hanauer A, Macquin C, Stemmelen T, Simons M, Mariette X, Hermine O, Fafi-Kremer S, Goichot B, Drenou B, Kuteifan K, Pottecher J, Mertes PM, Kailasan S, Aman MJ, Pin E, Nilsson P, Thomas A, Viari A, Sanlaville D, Schneider F, Sibilia J, Tharaux PL, Casanova JL, Hansmann Y, Lidar D, Radosavljevic M, Gulcher JR, Meziani F, Moog C, Chittenden TW, Bahram S. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med 2021;:eabj7521. [PMID: 34698500 DOI: 10.1126/scitranslmed.abj7521] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
354 Stamatakis G, Samiotaki M, Temponeras I, Panayotou G, Stratikos E. Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein. J Biol Chem 2021;297:101329. [PMID: 34688668 DOI: 10.1016/j.jbc.2021.101329] [Reference Citation Analysis]
355 Howard-Jones AR, Burgner DP, Crawford NW, Goeman E, Gray PE, Hsu P, Kuek S, McMullan BJ, Tosif S, Wurzel D, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, Britton PN. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J Paediatr Child Health 2021. [PMID: 34694037 DOI: 10.1111/jpc.15811] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
356 Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol 2021;101:108255. [PMID: 34688149 DOI: 10.1016/j.intimp.2021.108255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
357 Chung H, Green PHR, Wang TC, Kong XF. Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence. J Inflamm Res 2021;14:5187-200. [PMID: 34675597 DOI: 10.2147/JIR.S280953] [Reference Citation Analysis]
358 Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, Boisson B, Delavari S, Bastard P, Aranda-Guillén M, Wang Y, Zuo F, Sardh F, Marcotte H, Du L, Zhang SY, Zhang Q, Rezaei N, Kämpe O, Casanova JL, Hammarström L, Pan-Hammarström Q. X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia. J Clin Immunol 2021. [PMID: 34686943 DOI: 10.1007/s10875-021-01151-y] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
359 Rincon-Arevalo H, Aue A, Ritter J, Szelinski F, Khadzhynov D, Zickler D, Stefanski L, Lino AC, Körper S, Eckardt KU, Schrezenmeier H, Dörner T, Schrezenmeier EV. Altered increase in STAT1 expression and phosphorylation in severe COVID-19. Eur J Immunol 2021. [PMID: 34676541 DOI: 10.1002/eji.202149575] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
360 Regierer AC, Hasseli R, Schäfer M, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schmeiser T, Schulze-Koops H, Strangfeld A, Voll RE, Specker C, Mueller-Ladner U. TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD. RMD Open 2021;7:e001896. [PMID: 34670840 DOI: 10.1136/rmdopen-2021-001896] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
361 Zhuang X, Tsukuda S, Wrensch F, Wing PAC, Schilling M, Harris JM, Borrmann H, Morgan SB, Cane JL, Mailly L, Thakur N, Conceicao C, Sanghani H, Heydmann L, Bach C, Ashton A, Walsh S, Tan TK, Schimanski L, Huang KA, Schuster C, Watashi K, Hinks TSC, Jagannath A, Vausdevan SR, Bailey D, Baumert TF, McKeating JA. The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells. iScience 2021;24:103144. [PMID: 34545347 DOI: 10.1016/j.isci.2021.103144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
362 Niessl J, Sekine T, Buggert M. T cell immunity to SARS-CoV-2. Semin Immunol 2021;:101505. [PMID: 34711489 DOI: 10.1016/j.smim.2021.101505] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
363 Chen HH, Chen HM, Chen YM, Chen YH, Lin CH, Chao WC. Impact of systemic lupus erythematosus on the 5-year survival of critically ill septic patients. Arthritis Res Ther 2021;23:264. [PMID: 34674749 DOI: 10.1186/s13075-021-02649-x] [Reference Citation Analysis]
364 Seth N, Tuano KS, Chinen J. Inborn errors of immunity: Recent progress. J Allergy Clin Immunol 2021:S0091-6749(21)01621-3. [PMID: 34688776 DOI: 10.1016/j.jaci.2021.10.010] [Reference Citation Analysis]
365 Heilbronner U, Streit F, Vogl T, Senner F, Schaupp SK, Reich-Erkelenz D, Papiol S, Oraki Kohshour M, Klöhn-Saghatolislam F, Kalman JL, Heilbronner M, Gade K, Comes AL, Budde M, Andlauer TFM, Anderson-Schmidt H, Adorjan K, Stürmer T, Loerbroks A, Amelang M, Poisel E, Foo J, Heilmann-Heimbach S, Forstner AJ, Degenhardt F, Zimmermann J, Wiltfang J, von Hagen M, Spitzer C, Schmauss M, Reininghaus E, Reimer J, Konrad C, Juckel G, Lang FU, Jäger M, Figge C, Fallgatter AJ, Dietrich DE, Dannlowski U, Baune BT, Arolt V, Anghelescu IG, Nöthen MM, Witt SH, Andreassen OA, Chen CH, Falkai P, Rietschel M, Schulze TG, Schulte EC. Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection. BJPsych Open 2021;7:e188. [PMID: 34659794 DOI: 10.1192/bjo.2021.1030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Wilkinson T. Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial. Lancet Respir Med 2021;9:1344-5. [PMID: 34672951 DOI: 10.1016/S2213-2600(21)00412-4] [Reference Citation Analysis]
367 Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 2021;72:103629. [PMID: 34655949 DOI: 10.1016/j.ebiom.2021.103629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
368 Castelli EC, de Castro MV, Naslavsky MS, Scliar MO, Silva NSB, Andrade HS, Souza AS, Pereira RN, Castro CFB, Mendes-Junior CT, Meyer D, Nunes K, Matos LRB, Silva MVR, Wang JYT, Esposito J, Coria VR, Bortolin RH, Hirata MH, Magawa JY, Cunha-Neto E, Coelho V, Santos KS, Marin MLC, Kalil J, Mitne-Neto M, Maciel RMB, Passos-Bueno MR, Zatz M. MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals. Front Immunol 2021;12:742881. [PMID: 34650566 DOI: 10.3389/fimmu.2021.742881] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
369 Bellucci G, Rinaldi V, Buscarinu MC, Reniè R, Bigi R, Pellicciari G, Morena E, Romano C, Marrone A, Mechelli R, Salvetti M, Ristori G. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Front Immunol 2021;12:755333. [PMID: 34646278 DOI: 10.3389/fimmu.2021.755333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
370 Zhang Y, Chen S, Jin Y, Ji W, Zhang W, Duan G. An Update on Innate Immune Responses during SARS-CoV-2 Infection. Viruses 2021;13:2060. [PMID: 34696490 DOI: 10.3390/v13102060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
371 Walker FC, Sridhar PR, Baldridge MT. Differential roles of interferons in innate responses to mucosal viral infections. Trends Immunol 2021;42:1009-23. [PMID: 34629295 DOI: 10.1016/j.it.2021.09.003] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
372 Toscano S, Chisari CG, Patti F. Multiple Sclerosis, COVID-19 and Vaccines: Making the Point. Neurol Ther 2021;10:627-49. [PMID: 34625925 DOI: 10.1007/s40120-021-00288-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
373 Katzenstein TL, Jørgensen SE, Mortensen J, Helleberg M, Kalhauge A, Mogensen TH. Fulminant H1N1 and severe acute respiratory syndrome coronavirus-2 infections with a 4-year interval without an identifiable underlying cause: a case report. J Med Case Rep 2021;15:505. [PMID: 34625101 DOI: 10.1186/s13256-021-03113-9] [Reference Citation Analysis]
374 Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain 2021:awab337. [PMID: 34619763 DOI: 10.1093/brain/awab337] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
375 Gozman L, Perry K, Nikogosov D, Klabukov I, Shevlyakov A, Baranova A. A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients. Front Genet 2021;12:709388. [PMID: 34603376 DOI: 10.3389/fgene.2021.709388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Vono M, Huttner A, Lemeille S, Martinez-Murillo P, Meyer B, Baggio S, Sharma S, Thiriard A, Marchant A, Godeke GJ, Reusken C, Alvarez C, Perez-Rodriguez F, Eckerle I, Kaiser L, Loevy N, Eberhardt CS, Blanchard-Rohner G, Siegrist CA, Didierlaurent AM. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Rep 2021;37:109773. [PMID: 34587479 DOI: 10.1016/j.celrep.2021.109773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
377 Upadhyay AA, Hoang TN, Pino M, Boddapati AK, Viox EG, Lee MYH, Corry J, Strongin Z, Cowan DA, Beagle EN, Horton TR, Hamilton S, Aoued H, Harper JL, Nguyen K, Pellegrini KL, Tharp GK, Piantadosi A, Levit RD, Amara RR, Barratt-Boyes SM, Ribeiro SP, Sekaly RP, Vanderford TH, Schinazi RF, Paiardini M, Bosinger SE. TREM2+ and interstitial macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques. bioRxiv 2021:2021. [PMID: 34642693 DOI: 10.1101/2021.10.05.463212] [Reference Citation Analysis]
378 Khan AA, Alahmari AA, Almuzaini Y, Alamri F, Alsofayan YM, Aburas A, Al-Muhsen S, Van Kerkhove M, Yezli S, Ciottone GR, Assiri AM, Jokhdar HA. Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia. Front Immunol 2021;12:727989. [PMID: 34603300 DOI: 10.3389/fimmu.2021.727989] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
379 Decker T. The early interferon catches the SARS-CoV-2. J Exp Med 2021;218:e20211667. [PMID: 34424267 DOI: 10.1084/jem.20211667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
380 Cable J, Elowitz MB, Domingos AI, Habib N, Itzkovitz S, Hamidzada H, Balzer MS, Yanai I, Liberali P, Whited J, Streets A, Cai L, Stergachis AB, Hong CKY, Keren L, Guilliams M, Alon U, Shalek AK, Hamel R, Pfau SJ, Raj A, Quake SR, Zhang NR, Fan J, Trapnell C, Wang B, Greenwald NF, Vento-Tormo R, Santos SDM, Spencer SL, Garcia HG, Arekatla G, Gaiti F, Arbel-Goren R, Rulands S, Junker JP, Klein AM, Morris SA, Murray JI, Galloway KE, Ratz M, Romeike M. Single cell biology-a Keystone Symposia report. Ann N Y Acad Sci 2021. [PMID: 34605044 DOI: 10.1111/nyas.14692] [Reference Citation Analysis]
381 Chauvineau-Grenier A, Bastard P, Servajean A, Gervais A, Rosain J, Jouanguy E, Cobat A, Casanova JL, Rossi B. Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital. Res Sq 2021:rs. [PMID: 34611657 DOI: 10.21203/rs.3.rs-915062/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
382 Hargadon KM. A call for discovery: Re-envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0-The COVID-19 Genome Atlas. Clin Transl Discov 2021;1:e7. [PMID: 34901953 DOI: 10.1002/ctd2.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Lindley RA, Steele EJ. Analysis of SARS‐CoV‐2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti‐viral responses. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Cecon E, Izabelle C, Poder SL, Real F, Zhu A, Tu L, Ghigna MR, Klonjkowski B, Bomsel M, Jockers R, Dam J. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2. J Pineal Res 2022;72:e12772. [PMID: 34586649 DOI: 10.1111/jpi.12772] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
385 Mangge H, Kneihsl M, Schnedl W, Sendlhofer G, Curcio F, Domenis R. Immune Responses against SARS-CoV-2-Questions and Experiences. Biomedicines 2021;9:1342. [PMID: 34680460 DOI: 10.3390/biomedicines9101342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
386 Solanich X, Rigo-Bonnin R, Gumucio VD, Bastard P, Rosain J, Philippot Q, Perez-Fernandez XL, Fuset-Cabanes MP, Gordillo-Benitez MÁ, Suarez-Cuartin G, Boza-Hernandez E, Riera-Mestre A, Parra-Martínez A, Colobran R, Antolí A, Navarro S, Rocamora-Blanch G, Framil M, Calatayud L, Corbella X, Casanova JL, Morandeira F, Sabater-Riera J. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona. J Clin Immunol 2021;41:1733-44. [PMID: 34570326 DOI: 10.1007/s10875-021-01136-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
387 Sefik E, Qu R, Kaffe E, Zhao J, Junqueira C, Mirza H, Brewer R, Han A, Steach H, Israelow B, Chen YG, Halene S, Iwasaki A, Meffre E, Nussenzweig M, Lieberman J, Wilen CB, Kluger Y, Flavell RA. Viral replication in human macrophages enhances an inflammatory cascade and interferon driven chronic COVID-19 in humanized mice. bioRxiv 2021:2021. [PMID: 34611663 DOI: 10.1101/2021.09.27.461948] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
388 Arkin LM, Moon JJ, Tran JM, Asgari S, O'Farrelly C, Casanova JL, Cowen EW, Mays JW, Singh AM, Drolet BA; COVID Human Genetic Effort. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. J Invest Dermatol 2021;141:2791-6. [PMID: 34561087 DOI: 10.1016/j.jid.2021.05.024] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
389 Castiglione F, Deb D, Srivastava AP, Liò P, Liso A. From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling. Front Immunol 2021;12:646972. [PMID: 34557181 DOI: 10.3389/fimmu.2021.646972] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
390 Gallman AE, Fassett MS. Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatol Clin 2021;39:533-43. [PMID: 34556243 DOI: 10.1016/j.det.2021.05.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb HH, Zehra B, Begum G, Hameid RA, Ahmed A, Deesi Z, Alkhajeh A, Uddin KMF, Akter H, Safizadeh Shabestari SA, Almidani O, Islam A, Gaudet M, Kandasamy RK, Loney T, Tayoun AA, Nowotny N, Woodbury-Smith M, Rahman P, Kuebler WM, Yaseen Hachim M, Casanova JL, Berdiev BK, Alsheikh-Ali A, Uddin M. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience 2021;24:103030. [PMID: 34458692 DOI: 10.1016/j.isci.2021.103030] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
392 Beyer DK, Forero A. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2. J Mol Biol 2021;:167265. [PMID: 34562466 DOI: 10.1016/j.jmb.2021.167265] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
393 Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, Escaig R, Anjum A, Hoffknecht ML, Gold C, Brambs S, Engel A, Stockhausen S, Knottenberg V, Titova A, Haji M, Scherer C, Muenchhoff M, Hellmuth JC, Saar K, Schubert B, Hilgendorff A, Schulz C, Kääb S, Zimmer R, Hübner N, Massberg S, Mertins P, Nicolai L, Stark K. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 2021;6:e150862. [PMID: 34403366 DOI: 10.1172/jci.insight.150862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
394 van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ; UCSF COMET consortium. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med 2021;13:eabh2624. [PMID: 34429372 DOI: 10.1126/scitranslmed.abh2624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
395 Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher KA. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A 2021;118:e2101071118. [PMID: 34479991 DOI: 10.1073/pnas.2101071118] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
396 Krysko O, Kondakova E, Vershinina O, Galova E, Blagonravova A, Gorshkova E, Bachert C, Ivanchenko M, Krysko DV, Vedunova M. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study. Front Immunol 2021;12:715072. [PMID: 34539644 DOI: 10.3389/fimmu.2021.715072] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
397 Connelly JA, Chong H, Esbenshade AJ, Frame D, Failing C, Secord E, Walkovich K. Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatr Clin North Am 2021;68:1029-54. [PMID: 34538297 DOI: 10.1016/j.pcl.2021.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
398 Ronit A, Jørgensen SE, Roed C, Eriksson R, Iepsen UW, Plovsing RR, Storgaard M, Gustafsson F, Hansen AE, Mogensen TH. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome. Front Immunol 2021;12:718744. [PMID: 34531865 DOI: 10.3389/fimmu.2021.718744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
399 Zaman MS, Sizemore RC. Diverse Manifestations of COVID-19: Some Suggested Mechanisms. Int J Environ Res Public Health 2021;18:9785. [PMID: 34574709 DOI: 10.3390/ijerph18189785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
400 Youngs J, Provine NM, Lim N, Sharpe HR, Amini A, Chen YL, Luo J, Edmans MD, Zacharopoulou P, Chen W, Sampson O, Paton R, Hurt WJ, Duncan DA, McNaughton AL, Miao VN, Leaver S, Wyncoll DLA, Ball J, Hopkins P, Skelly DT, Barnes E, Dunachie S, Ogg G, Lambe T, Pavord I, Shalek AK, Thompson CP, Xue L, Macallan DC, Goulder P, Klenerman P, Bicanic T; Oxford Immunology Network Covid-19 response T cell Consortium., Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. PLoS Pathog 2021;17:e1009804. [PMID: 34529726 DOI: 10.1371/journal.ppat.1009804] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
401 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
402 Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, Sisti S, Criscuolo E, Spreafico R, Long JM, Ambrosi A, Liu E, Frangipane V, Saracino L, Bozzini S, Marongiu L, Facchini FA, Bottazzi A, Fossali T, Colombo R, Clementi M, Tagliabue E, Chou J, Pontiroli AE, Meloni F, Wack A, Mancini N, Zanoni I. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell 2021;184:4953-4968.e16. [PMID: 34492226 DOI: 10.1016/j.cell.2021.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
403 Greene TT, Zuniga EI. Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings. Viruses 2021;13:1839. [PMID: 34578420 DOI: 10.3390/v13091839] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
404 Islam MA, Albarracin L, Tomokiyo M, Valdez JC, Sacur J, Vizoso-Pinto MG, Andrade BGN, Cuadrat RRC, Kitazawa H, Villena J. Immunobiotic Lactobacilli Improve Resistance of Respiratory Epithelial Cells to SARS-CoV-2 Infection. Pathogens 2021;10:1197. [PMID: 34578229 DOI: 10.3390/pathogens10091197] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
405 Yildiz H, Castanares-Zapatero D, Pierman G, Pothen L, De Greef J, Aboubakar Nana F, Rodriguez-Villalobos H, Belkhir L, Yombi JC. Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. Int J Gen Med 2021;14:5111-7. [PMID: 34511993 DOI: 10.2147/IJGM.S326666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
406 Alaiya A, Alshukairi A, Shinwari Z, Al-Fares M, Alotaibi J, AlOmaim W, Alsharif I, Bakheet R, Alharbi L, Allam R, Asiri A, Memish Z, Alromaih K, Al-Mozaini M. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients. J Inflamm Res 2021;14:4313-28. [PMID: 34511970 DOI: 10.2147/JIR.S322430] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
407 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
408 Bourgin M, Derosa L, Silva CAC, Goubet AG, Dubuisson A, Danlos FX, Grajeda-Iglesias C, Cerbone L, Geraud A, Laparra A, Aprahamian F, Nirmalathasan N, Madeo F, Zitvogel L, Kroemer G, Durand S. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients. Aging (Albany NY) 2021;13:20860-85. [PMID: 34517343 DOI: 10.18632/aging.203525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
409 Hetemäki I, Laakso S, Välimaa H, Kleino I, Kekäläinen E, Mäkitie O, Arstila TP. Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections. Clin Immunol 2021;231:108851. [PMID: 34508889 DOI: 10.1016/j.clim.2021.108851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
410 Russo G, Solimini A, Zuccalà P, Zingaropoli MA, Carraro A, Pasculli P, Perri V, Marocco R, Kertusha B, Del Borgo C, Del Giudice E, Fondaco L, Tieghi T, D'Agostino C, Oliva A, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M. Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study. PLoS One 2021;16:e0257376. [PMID: 34506608 DOI: 10.1371/journal.pone.0257376] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
411 Ferré EMN, Schmitt MM, Ochoa S, Rosen LB, Shaw ER, Burbelo PD, Stoddard JL, Rampertaap S, DiMaggio T, Bergerson JRE, Rosenzweig SD, Notarangelo LD, Holland SM, Lionakis MS. SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients. Front Immunol 2021;12:720205. [PMID: 34504497 DOI: 10.3389/fimmu.2021.720205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
412 de Cevins C, Luka M, Smith N, Meynier S, Magérus A, Carbone F, García-Paredes V, Barnabei L, Batignes M, Boullé A, Stolzenberg MC, Pérot BP, Charbit B, Fali T, Pirabakaran V, Sorin B, Riller Q, Abdessalem G, Beretta M, Grzelak L, Goncalves P, Di Santo JP, Mouquet H, Schwartz O, Zarhrate M, Parisot M, Bole-Feysot C, Masson C, Cagnard N, Corneau A, Brunaud C, Zhang SY, Casanova JL, Bader-Meunier B, Haroche J, Melki I, Lorrot M, Oualha M, Moulin F, Bonnet D, Belhadjer Z, Leruez M, Allali S, Gras-Leguen C, de Pontual L, Fischer A, Duffy D, Rieux-Laucat F, Toubiana J, Ménager MM; Pediatric-Biocovid Study Group. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med (N Y) 2021;2:1072-1092.e7. [PMID: 34414385 DOI: 10.1016/j.medj.2021.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
413 Deakin CT, Cornish GH, Ng KW, Faulkner N, Bolland W, Hope J, Rosa A, Harvey R, Hussain S, Earl C, Jebson BR, Wilkinson MGLL, Marshall LR, O'Brien K, Rosser EC, Radziszewska A, Peckham H, Patel H, Heaney J, Rickman H, Paraskevopoulou S, Houlihan CF, Spyer MJ, Gamblin SJ, McCauley J, Nastouli E, Levin M, Cherepanov P, Ciurtin C, Wedderburn LR, Kassiotis G. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med (N Y) 2021;2:1093-1109.e6. [PMID: 34414384 DOI: 10.1016/j.medj.2021.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
414 Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice. Arterioscler Thromb Vasc Biol 2021;41:2773-85. [PMID: 34496633 DOI: 10.1161/ATVBAHA.121.316925] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
415 Gao D, Ciancanelli MJ, Zhang P, Harschnitz O, Bondet V, Hasek M, Chen J, Mu X, Itan Y, Cobat A, Sancho-Shimizu V, Bigio B, Lorenzo L, Ciceri G, McAlpine J, Anguiano E, Jouanguy E, Chaussabel D, Meyts I, Diamond MS, Abel L, Hur S, Smith GA, Notarangelo L, Duffy D, Studer L, Casanova JL, Zhang SY. TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons. J Clin Invest 2021;131:134529. [PMID: 33393505 DOI: 10.1172/JCI134529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
416 Blanchard-Rohner G, Didierlaurent A, Tilmanne A, Smeesters P, Marchant A. Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention. Vaccines (Basel) 2021;9:1002. [PMID: 34579240 DOI: 10.3390/vaccines9091002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
417 Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, Keller MD, McDermott DH, Rao VK, Dimitrova D, Quiros-Roldan E, Imberti L, Ferrè EMN, Schmitt M, Lafeer C, Pfister J, Shaw D, Draper D, Truong M, Ulrick J, DiMaggio T, Urban A, Holland SM, Lionakis MS, Cohen JI, Ricotta EE, Notarangelo LD, Freeman AF. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol 2021;148:1192-7. [PMID: 34492260 DOI: 10.1016/j.jaci.2021.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
418 Wang X, Xu G, Liu X, Liu Y, Zhang S, Zhang Z. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection. Cell Mol Immunol 2021;18:2313-24. [PMID: 34471261 DOI: 10.1038/s41423-021-00754-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
419 Kwon D. Rogue antibodies involved in almost one-fifth of COVID deaths. Nature 2021;597:162. [PMID: 34471247 DOI: 10.1038/d41586-021-02337-5] [Reference Citation Analysis]
420 Severa M, Diotti RA, Etna MP, Rizzo F, Fiore S, Ricci D, Iannetta M, Sinigaglia A, Lodi A, Mancini N, Criscuolo E, Clementi M, Andreoni M, Balducci S, Barzon L, Stefanelli P, Clementi N, Coccia EM. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog 2021;17:e1009878. [PMID: 34473805 DOI: 10.1371/journal.ppat.1009878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
421 Sulaiman I, Chung M, Angel L, Tsay JJ, Wu BG, Yeung ST, Krolikowski K, Li Y, Duerr R, Schluger R, Thannickal SA, Koide A, Rafeq S, Barnett C, Postelnicu R, Wang C, Banakis S, Pérez-Pérez L, Shen G, Jour G, Meyn P, Carpenito J, Liu X, Ji K, Collazo D, Labarbiera A, Amoroso N, Brosnahan S, Mukherjee V, Kaufman D, Bakker J, Lubinsky A, Pradhan D, Sterman DH, Weiden M, Heguy A, Evans L, Uyeki TM, Clemente JC, de Wit E, Schmidt AM, Shopsin B, Desvignes L, Wang C, Li H, Zhang B, Forst CV, Koide S, Stapleford KA, Khanna KM, Ghedin E, Segal LN. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat Microbiol 2021;6:1245-58. [PMID: 34465900 DOI: 10.1038/s41564-021-00961-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
422 Movaqar A, Yaghoubi A, Rezaee SR, Jamehdar SA, Soleimanpour S. Coronaviruses construct an interconnection way with ERAD and autophagy. Future Microbiol 2021;16:1135-51. [PMID: 34468179 DOI: 10.2217/fmb-2021-0044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The role of type I interferon in the treatment of COVID-19. J Med Virol 2021. [PMID: 34468995 DOI: 10.1002/jmv.27317] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
424 Li Y, Ke Y, Xia X, Wang Y, Cheng F, Liu X, Jin X, Li B, Xie C, Liu S, Chen W, Yang C, Niu Y, Jia R, Chen Y, Liu X, Wang Z, Zheng F, Jin Y, Li Z, Yang N, Cao P, Chen H, Ping J, He F, Wang C, Zhou G. Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov 2021;7:76. [PMID: 34465742 DOI: 10.1038/s41421-021-00318-6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
425 Wu P, Ding L, Li X, Liu S, Cheng F, He Q, Xiao M, Wu P, Hou H, Jiang M, Long P, Wang H, Liu L, Qu M, Shi X, Jiang Q, Mo T, Ding W, Fu Y, Han S, Huo X, Zeng Y, Zhou Y, Zhang Q, Ke J, Xu X, Ni W, Shao Z, Wang J, Liu P, Li Z, Jin Y, Zheng F, Wang F, Liu L, Li W, Liu K, Peng R, Xu X, Lin Y, Gao H, Shi L, Geng Z, Mu X, Yan Y, Wang K, Wu D, Hao X, Cheng S, Qiu G, Guo H, Li K, Chen G, Sun Z, Lin X, Jin X, Wang F, Sun C, Wang C. Trans-ethnic genome-wide association study of severe COVID-19. Commun Biol 2021;4:1034. [PMID: 34465887 DOI: 10.1038/s42003-021-02549-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
426 Hilligan KL, Namasivayam S, Clancy CS, O'Mard D, Oland SD, Robertson SJ, Baker PJ, Castro E, Garza NL, Lafont BAP, Johnson R, Ronchese F, Mayer-Barber KD, Best SM, Sher A. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. bioRxiv 2021:2021. [PMID: 34494021 DOI: 10.1101/2021.08.30.458273] [Reference Citation Analysis]
427 Philippot Q, Casanova JL, Puel A. Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both? Curr Opin Immunol 2021;72:318-23. [PMID: 34455138 DOI: 10.1016/j.coi.2021.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
428 Zanoni I. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? Curr Opin Virol 2021;50:119-27. [PMID: 34454352 DOI: 10.1016/j.coviro.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
429 Aguiar VRC, Augusto DG, Castelli EC, Hollenbach JA, Meyer D, Nunes K, Petzl-Erler ML. An immunogenetic view of COVID-19. Genet Mol Biol 2021;44:e20210036. [PMID: 34436508 DOI: 10.1590/1678-4685-GMB-2021-0036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
430 Sarohan AR, Kızıl M, İnkaya AÇ, Mahmud S, Akram M, Cen O. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal 2021;87:110121. [PMID: 34438017 DOI: 10.1016/j.cellsig.2021.110121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
431 Palermo E, Di Carlo D, Sgarbanti M, Hiscott J. Type I Interferons in COVID-19 Pathogenesis. Biology (Basel) 2021;10:829. [PMID: 34571706 DOI: 10.3390/biology10090829] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
432 Maródi L; the J Project Study group. The 10 th anniversary of the world primary immunodeficiency week: A J Project celebration. Eur J Immunol 2021;51:2364-6. [DOI: 10.1002/eji.202170105] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
433 Giovannoni F, Li Z, Remes-Lenicov F, Dávola ME, Elizalde M, Paletta A, Ashkar AA, Mossman KL, Dugour AV, Figueroa JM, Barquero AA, Ceballos A, Garcia CC, Quintana FJ. AHR signaling is induced by infection with coronaviruses. Nat Commun 2021;12:5148. [PMID: 34446714 DOI: 10.1038/s41467-021-25412-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
434 Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A 2021;118:e2024358118. [PMID: 34400495 DOI: 10.1073/pnas.2024358118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
435 Sun G, Cui Q, Garcia G Jr, Wang C, Zhang M, Arumugaswami V, Riggs AD, Shi Y. Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses. Sci Rep 2021;11:17146. [PMID: 34433867 DOI: 10.1038/s41598-021-96462-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
436 Bhushan B L S, Wanve S, Koradia P, Bhomia V, Soni P, Chakraborty S, Khobragade A, Joshi S, Mendiratta SK, Kansagra KK, Parihar A, Sharma S, Patel J; Study Investigators Group. Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study. Int J Infect Dis 2021;111:281-7. [PMID: 34428542 DOI: 10.1016/j.ijid.2021.08.044] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
437 Dejani NN, Elshabrawy HA, Bezerra Filho CDSM, de Sousa DP. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives. Biomolecules 2021;11:1254. [PMID: 34439920 DOI: 10.3390/biom11081254] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
438 Gabryszewski SJ, England RN, Sun D, Gentile TL, Hochgertel W, Jyonouchi S, Silverman M, Zaoutis T, Sullivan KE, Henrickson SE. Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID. J Clin Immunol 2021;41:1745-7. [PMID: 34420125 DOI: 10.1007/s10875-021-01093-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
439 Khattak FA, Akbar NU, Riaz M, Hussain M, Rehman K, Khan SN, Khan TA. Novel IL-β12R1 deficiency-mediates recurrent cutaneous leishmaniasis. Int J Infect Dis 2021;112:338-45. [PMID: 34438084 DOI: 10.1016/j.ijid.2021.08.049] [Reference Citation Analysis]
440 Oikonomou V, Break TJ, Gaffen SL, Moutsopoulos NM, Lionakis MS. Infections in the monogenic autoimmune syndrome APECED. Curr Opin Immunol 2021;72:286-97. [PMID: 34418591 DOI: 10.1016/j.coi.2021.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
441 Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, Gobbini A, Galeota E, Manara C, Bombaci M, Pesce E, Zagato E, Favalli A, Sarnicola ML, Curti S, Crosti M, Martinovic M, Fabbris T, Marini F, Donnici L, Lorenzo M, Mancino M, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, De Feo T, Prati D, Manganaro L, Granucci F, Lanzavecchia A, De Francesco R, Gori A, Grifantini R, Abrignani S. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol 2021;6:eabg5021. [PMID: 34376481 DOI: 10.1126/sciimmunol.abg5021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
442 Yatim N, Boussier J, Tetu P, Smith N, Bruel T, Charbit B, Barnabei L, Corneau A, Da Meda L, Allayous C, Baroudjian B, Jebali M, Herms F, Grzelak L, Staropoli I, Calmettes V, Hadjadj J, Peyrony O, Cassius C, LeGoff J, Kramkimel N, Aractingi S, Fontes M, Blanc C, Rieux-Laucat F, Schwartz O, Terrier B, Duffy D, Lebbé C. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Sci Adv 2021;7:eabg4081. [PMID: 34407944 DOI: 10.1126/sciadv.abg4081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
443 Kim SB, Ryoo S, Huh K, Joo EJ, Kim YJ, Choi WS, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Park DA, Yu SY, Lee HJ, Kim J, Jin Y, Park J, Peck KR, Choi M, Yeom JS; Korean Society of Infectious Diseases (KSID). Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19. Infect Chemother 2021;53:166-219. [PMID: 34409790 DOI: 10.3947/ic.2021.0303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
444 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Federico L, de Biase D, Zippi M, Zancanaro M. COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Cytokine 2021;148:155628. [PMID: 34411989 DOI: 10.1016/j.cyto.2021.155628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
445 Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL; HGID Lab., COVID Clinicians., COVID-STORM Clinicians., NIAID Immune Response to COVID Group., NH-COVAIR Study Group., Danish CHGE., Danish Blood Donor Study., St. James's Hospital., SARS CoV2 Interest group., French COVID Cohort Study Group., Imagine COVID-Group., Milieu Intérieur Consortium., CoV-Contact Cohort., Amsterdam UMC Covid-19., Biobank Investigators., COVID Human Genetic Effort., CONSTANCES cohort., 3C-Dijon Study., Cerba Health-Care., Etablissement du Sang study group. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol 2021;6:eabl4340. [PMID: 34413139 DOI: 10.1126/sciimmunol.abl4340] [Cited by in Crossref: 77] [Cited by in F6Publishing: 105] [Article Influence: 77.0] [Reference Citation Analysis]
446 Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cells 2021;10:2134. [PMID: 34440903 DOI: 10.3390/cells10082134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
447 Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL; COVID Human Genetic Effort., COVID-STORM Clinicians., COVID Clinicians., Imagine COVID Group., French COVID Cohort Study Group., CoV-Contact Cohort., Amsterdam UMC Covid-., Biobank., NIAID-USUHS COVID Study Group. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol 2021;6:eabl4348. [PMID: 34413140 DOI: 10.1126/sciimmunol.abl4348] [Cited by in Crossref: 59] [Cited by in F6Publishing: 75] [Article Influence: 59.0] [Reference Citation Analysis]
448 Goncalves D, Mezidi M, Bastard P, Perret M, Saker K, Fabien N, Pescarmona R, Lombard C, Walzer T, Casanova JL, Belot A, Richard JC, Trouillet-Assant S. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients. Clin Transl Immunology 2021;10:e1327. [PMID: 34429968 DOI: 10.1002/cti2.1327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
449 Yokoi S, Iwata Y, Tanaka Y, Sugiura K. COVID-19-associated livedo and purpura: clinical and histopathological findings. Eur J Dermatol 2021. [PMID: 34405810 DOI: 10.1684/ejd.2021.4084] [Reference Citation Analysis]
450 Maurya R, Kanakan A, Vasudevan JS, Chattopadhyay P, Pandey R. Infection outcome needs two to tango: human host and the pathogen. Brief Funct Genomics 2021:elab037. [PMID: 34402498 DOI: 10.1093/bfgp/elab037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
451 Filippatos F, Tatsi EB, Michos A. Immune response to SARS-CoV-2 in children: A review of the current knowledge. Pediatr Investig 2021;:e12283. [PMID: 34540321 DOI: 10.1002/ped4.12283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
452 Börold J, Eletto D, Busnadiego I, Mair NK, Moritz E, Schiefer S, Schmidt N, Petric PP, Wong WW, Schwemmle M, Hale BG. BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity. EMBO Rep 2021;:e52823. [PMID: 34397140 DOI: 10.15252/embr.202152823] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
453 Chen Y, Lin J, Zhao Y, Ma X, Yi H. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. J Zhejiang Univ Sci B 2021;22:609-32. [PMID: 34414698 DOI: 10.1631/jzus.B2000808] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
454 Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Novak N, Merk HF, Rabe U, Schlenter WW, Ring J, Wehrmann W, Mülleneisen NK, Wrede H, Fuchs T, Jensen-Jarolim E. Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe : Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA). Allergo J 2021;30:34-47. [PMID: 34393384 DOI: 10.1007/s15007-021-4848-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
455 Deyà-Martínez A, García-García A, Gonzalez-Navarro EA, Yiyi L, Vlagea A, Jordan I, Fumadó V, Fortuny C, Español M, Launes C, Esteve-Solé A, Juan M, Pascal M, Alsina L. COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era. Clin Immunol 2021;230:108821. [PMID: 34391937 DOI: 10.1016/j.clim.2021.108821] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
456 Quaresima V, Scarpazza C, Sottini A, Fiorini C, Signorini S, Delmonte OM, Signorini L, Quiros-Roldan E, Imberti L. Sex differences in a cohort of COVID-19 Italian patients hospitalized during the first and second pandemic waves. Biol Sex Differ 2021;12:45. [PMID: 34380555 DOI: 10.1186/s13293-021-00386-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
457 Albrecht L, Bishop E, Jay B, Lafoux B, Minoves M, Passaes C. COVID-19 Research: Lessons from Non-Human Primate Models. Vaccines (Basel) 2021;9:886. [PMID: 34452011 DOI: 10.3390/vaccines9080886] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
458 Dorff T, Hirasawa Y, Acoba J, Pagano I, Tamura D, Pal S, Zhang M, Waitz R, Dhal A, Haynes W, Shon J, Scholz M, Furuya H, Chan OTM, Huang J, Rosser C. Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. J Immunother Cancer 2021;9:e002931. [PMID: 34376554 DOI: 10.1136/jitc-2021-002931] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
459 Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat Commun 2021;12:4888. [PMID: 34373466 DOI: 10.1038/s41467-021-25191-5] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
460 Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 2021. [PMID: 34373622 DOI: 10.1038/s41577-021-00588-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 63] [Article Influence: 1.0] [Reference Citation Analysis]
461 Bessière P, Wasniewski M, Picard-Meyer E, Servat A, Figueroa T, Foret-Lucas C, Coggon A, Lesellier S, Boué F, Cebron N, Gausserès B, Trumel C, Foucras G, Salguero FJ, Monchatre-Leroy E, Volmer R. Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model. PLoS Pathog 2021;17:e1009427. [PMID: 34370799 DOI: 10.1371/journal.ppat.1009427] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
462 Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med 2021;218:e20211211. [PMID: 34357402 DOI: 10.1084/jem.20211211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
463 Akter S, Roy AS, Tonmoy MIQ, Islam MS. Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach. J Biomol Struct Dyn 2021;:1-17. [PMID: 34355676 DOI: 10.1080/07391102.2021.1957714] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
464 Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-Roussel D, Verrier B, Israel-Biet D, Freymond N, Cottin V, Calender A. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses. Cells 2021;10:1995. [PMID: 34440765 DOI: 10.3390/cells10081995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
465 Hoch NC. Host ADP-ribosylation and the SARS-CoV-2 macrodomain. Biochem Soc Trans 2021:BST20201212. [PMID: 34351418 DOI: 10.1042/BST20201212] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
466 Povysil G, Butler-Laporte G, Gharavi AG, Richards JB, Goldstein DB, Kiryluk K. Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply. J Clin Invest 2021;131:152475. [PMID: 34156980 DOI: 10.1172/JCI152475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
467 Van Eyndhoven LC, Singh A, Tel J. Decoding the dynamics of multilayered stochastic antiviral IFN-I responses. Trends Immunol 2021;42:824-39. [PMID: 34364820 DOI: 10.1016/j.it.2021.07.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
468 Zhang Q, Cobat A, Bastard P, Notarangelo LD, Su HC, Abel L, Casanova JL; COVID Human Genetic Effort (CHGE). Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. J Clin Invest 2021;131:152474. [PMID: 34166232 DOI: 10.1172/JCI152474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
469 Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch AP, Kasten M, Zapatero-Belinchón FJ, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand JL, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan GF, Höfer A, Kühnel MP, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer TJ, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One 2021;16:e0255335. [PMID: 34347801 DOI: 10.1371/journal.pone.0255335] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
470 Rouchka EC, Chariker JH, Alejandro B, Adcock RS, Singhal R, Ramirez J, Palmer KE, Lasnik AB, Carrico R, Arnold FW, Furmanek S, Zhang M, Wolf LA, Waigel S, Zacharias W, Bordon J, Chung D. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. Sci Rep 2021;11:15715. [PMID: 34344959 DOI: 10.1038/s41598-021-95197-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
471 Batista CM, Foti L. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Int Immunopharmacol 2021;99:108036. [PMID: 34371330 DOI: 10.1016/j.intimp.2021.108036] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
472 Ferreira de Araújo JL, Menezes D, Saraiva-Duarte JM, de Lima Ferreira L, Santana de Aguiar R, Pedra de Souza R. Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020? Rev Med Virol 2021;:e2283. [PMID: 34338380 DOI: 10.1002/rmv.2283] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
473 Sianes-Gallén M, Pujol-García AM, Rus García M, Partera Luque C, López Postigo M, Call Mañosa S, Camposo Montesino MC, Ibáñez Touriño B, Ribas Obon E, Segura Rodríguez T, Cores Fuentes P, Tamame Sanantonio M, Jornet-Gibert M. Pressure injuries during the SARS-CoV-2 pandemic: A retrospective, case-control study. J Tissue Viability 2021:S0965-206X(21)00096-6. [PMID: 34389188 DOI: 10.1016/j.jtv.2021.07.011] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
474 Bogunovic D, Merad M. Children and SARS-CoV-2. Cell Host Microbe 2021;29:1040-2. [PMID: 34265242 DOI: 10.1016/j.chom.2021.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
475 Merad M, Subramanian A, Wang TT. An aberrant inflammatory response in severe COVID-19. Cell Host Microbe 2021;29:1043-7. [PMID: 34265243 DOI: 10.1016/j.chom.2021.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
476 Awadasseid A, Yin Q, Wu Y, Zhang W. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection. Biomed Pharmacother 2021;142:111957. [PMID: 34339917 DOI: 10.1016/j.biopha.2021.111957] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
477 Pathak GA, Singh K, Miller-Fleming TW, Wendt FR, Ehsan N, Hou K, Johnson R, Lu Z, Gopalan S, Yengo L, Mohammadi P, Pasaniuc B, Polimanti R, Davis LK, Mancuso N. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization. Nat Commun 2021;12:4569. [PMID: 34315903 DOI: 10.1038/s41467-021-24824-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
478 Gaur P, Riehn M, Zha L, Köster M, Hauser H, Wirth D. Defective interferon amplification and impaired host responses against influenza virus in obese mice. Obesity (Silver Spring) 2021;29:1272-8. [PMID: 34314110 DOI: 10.1002/oby.23196] [Reference Citation Analysis]
479 Marx V. Scientists set out to connect the dots on long COVID. Nat Methods 2021;18:449-53. [PMID: 33911230 DOI: 10.1038/s41592-021-01145-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
480 Menezes MCS, Veiga ADM, Martins de Lima T, Kunimi Kubo Ariga S, Vieira Barbeiro H, de Lucena Moreira C, Pinto AAS, Brandao RA, Marchini JF, Alencar JC, Marino LO, Gomez LM, Olsen Saraiva Camara N, Souza HP. Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients. Sci Rep 2021;11:15223. [PMID: 34315957 DOI: 10.1038/s41598-021-94624-4] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
481 Abers MS, Rosen LB, Delmonte OM, Shaw E, Bastard P, Imberti L, Quaresima V, Biondi A, Bonfanti P, Castagnoli R, Casanova JL, Su HC, Notarangelo LD, Holland SM, Lionakis MS. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Immunol Cell Biol 2021. [PMID: 34309902 DOI: 10.1111/imcb.12495] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
482 Min YQ, Huang M, Sun X, Deng F, Wang H, Ning YJ. Immune evasion of SARS-CoV-2 from interferon antiviral system. Comput Struct Biotechnol J 2021;19:4217-25. [PMID: 34336145 DOI: 10.1016/j.csbj.2021.07.023] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
483 Valdés-Fernández BN, Duconge J, Espino AM, Ruaño G. Personalized health and the coronavirus vaccines-Do individual genetics matter? Bioessays 2021;:e2100087. [PMID: 34309055 DOI: 10.1002/bies.202100087] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
484 Kotsev SV, Miteva D, Krayselska S, Shopova M, Pishmisheva-Peleva M, Stanilova SA, Velikova T. Hypotheses and facts for genetic factors related to severe COVID-19. World J Virol 2021; 10(4): 137-155 [PMID: 34367930 DOI: 10.5501/wjv.v10.i4.137] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
485 Ramasamy R. Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air. Int J Mol Sci 2021;22:7919. [PMID: 34360686 DOI: 10.3390/ijms22157919] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
486 Abbadessa G, Lavorgna L, Trojsi F, Coppola C, Bonavita S. Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis. Expert Rev Neurother 2021;21:731-43. [PMID: 34278928 DOI: 10.1080/14737175.2021.1957673] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
487 Solanich X, Vargas-Parra G, van der Made CI, Simons A, Schuurs-Hoeijmakers J, Antolí A, Del Valle J, Rocamora-Blanch G, Setién F, Esteller M, van Reijmersdal SV, Riera-Mestre A, Sabater-Riera J, Capellá G, van de Veerdonk FL, van der Hoven B, Corbella X, Hoischen A, Lázaro C. Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19. Front Immunol 2021;12:719115. [PMID: 34367187 DOI: 10.3389/fimmu.2021.719115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
488 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
489 Boisson-Dupuis S, Bustamante J. Mycobacterial diseases in patients with inborn errors of immunity. Curr Opin Immunol 2021;72:262-71. [PMID: 34315005 DOI: 10.1016/j.coi.2021.07.001] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
490 Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, Karaliota S, Apostolakou F, Bagratuni T, Patseas D, Gumeni S, Trougakos IP, Dimopoulos MA, Felber BK, Pavlakis GN. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep 2021;36:109504. [PMID: 34352226 DOI: 10.1016/j.celrep.2021.109504] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
491 Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 2021:S0092-8674(21)00882-5. [PMID: 34352228 DOI: 10.1016/j.cell.2021.07.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 57] [Article Influence: 2.0] [Reference Citation Analysis]
492 Madany E, Okwan-Duodu D, Balbuena-Merle R, Hendrickson JE, Gibb DR. Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease. Front Med (Lausanne) 2021;8:679030. [PMID: 34368185 DOI: 10.3389/fmed.2021.679030] [Reference Citation Analysis]
493 Povysil G, Butler-Laporte G, Shang N, Wang C, Khan A, Alaamery M, Nakanishi T, Zhou S, Forgetta V, Eveleigh RJ, Bourgey M, Aziz N, Jones SJ, Knoppers B, Scherer SW, Strug LJ, Lepage P, Ragoussis J, Bourque G, Alghamdi J, Aljawini N, Albes N, Al-Afghani HM, Alghamdi B, Almutairi MS, Mahmoud ES, Abu-Safieh L, El Bardisy H, Harthi FSA, Alshareef A, Suliman BA, Alqahtani SA, Almalik A, Alrashed MM, Massadeh S, Mooser V, Lathrop M, Fawzy M, Arabi YM, Mbarek H, Saad C, Al-Muftah W, Jung J, Mangul S, Badji R, Thani AA, Ismail SI, Gharavi AG, Abedalthagafi MS, Richards JB, Goldstein DB, Kiryluk K. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J Clin Invest 2021;131:147834. [PMID: 34043590 DOI: 10.1172/JCI147834] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
494 Budinger GRS, Misharin AV, Ridge KM, Singer BD, Wunderink RG. Distinctive features of severe SARS-CoV-2 pneumonia. J Clin Invest 2021;131:149412. [PMID: 34263736 DOI: 10.1172/JCI149412] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
495 Sahanic S, Löffler-Ragg J, Tymoszuk P, Hilbe R, Demetz E, Masanetz RK, Theurl M, Holfeld J, Gollmann-Tepeköylü C, Tzankov A, Weiss G, Giera M, Tancevski I. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza. Front Physiol 2021;12:688946. [PMID: 34366882 DOI: 10.3389/fphys.2021.688946] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
496 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
497 Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol 2021. [PMID: 34290398 DOI: 10.1038/s41423-021-00728-2] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
498 Cotsapas C, Saarela J, Farmer JR, Scaria V, Abraham RS. Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? J Clin Invest 2021;131:149459. [PMID: 34061775 DOI: 10.1172/JCI149459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Nomura T, Yamamoto H, Nishizawa M, Hau TTT, Harada S, Ishii H, Seki S, Nakamura-Hoshi M, Okazaki M, Daigen S, Kawana-Tachikawa A, Nagata N, Iwata-Yoshikawa N, Shiwa N, Iida S, Katano H, Suzuki T, Park ES, Maeda K, Suzaki Y, Ami Y, Matano T. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques. PLoS Pathog 2021;17:e1009668. [PMID: 34280241 DOI: 10.1371/journal.ppat.1009668] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
500 Copley HC, Gragert L, Leach AR, Kosmoliaptsis V. Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level. Front Immunol 2021;12:669357. [PMID: 34349756 DOI: 10.3389/fimmu.2021.669357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
501 Prokop JW, Hartog NL, Chesla D, Faber W, Love CP, Karam R, Abualkheir N, Feldmann B, Teng L, McBride T, Leimanis ML, English BK, Holsworth A, Frisch A, Bauss J, Kalpage N, Derbedrossian A, Pinti RM, Hale N, Mills J, Eby A, VanSickle EA, Pageau SC, Shankar R, Chen B, Carcillo JA, Sanfilippo D, Olivero R, Bupp CP, Rajasekaran S. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. Front Immunol 2021;12:694243. [PMID: 34335605 DOI: 10.3389/fimmu.2021.694243] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
502 Rashid F, Suleman M, Shah A, Dzakah EE, Wang H, Chen S, Tang S. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System. Front Microbiol 2021;12:703145. [PMID: 34335535 DOI: 10.3389/fmicb.2021.703145] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
503 Mehta P, Fajgenbaum DC. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate. Curr Opin Rheumatol 2021;33:419-30. [PMID: 34264880 DOI: 10.1097/BOR.0000000000000822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
504 Singh D, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger L, Artyomov M, Khader S, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Res Sq 2021:rs. [PMID: 34282414 DOI: 10.21203/rs.3.rs-664507/v1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
505 Smieszek SP, Polymeropoulos VM, Xiao C, Polymeropoulos CM, Polymeropoulos MH. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility. J Glob Antimicrob Resist 2021;26:239-40. [PMID: 34273592 DOI: 10.1016/j.jgar.2021.06.005] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
506 Kritselis M, Yambayev I, Prilutskiy A, Shevtsov A, Vadlamudi C, Zheng H, Elsadwai M, Ma L, Aniskovich E, Kataria Y, Higgins S, Sarita-Reyes C, Zuo T, Zhao Q, Quillen K, Burks EJ. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19. Hum Pathol 2021;116:49-62. [PMID: 34273395 DOI: 10.1016/j.humpath.2021.06.008] [Reference Citation Analysis]
507 Chen DY, Khan N, Close BJ, Goel RK, Blum B, Tavares AH, Kenney D, Conway HL, Ewoldt JK, Chitalia VC, Crossland NA, Chen CS, Kotton DN, Baker SC, Fuchs SY, Connor JH, Douam F, Emili A, Saeed M. SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway. J Virol 2021;:JVI0086221. [PMID: 34260266 DOI: 10.1128/JVI.00862-21] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
508 Mazer MB, Turnbull IR, Miles S, Blood TM, Sadler B, Hess A, Botney MD, Martin RS, Bosanquet JP, Striker DA, Anand NS, Morre M, Caldwell CC, Brakenridge SC, Moldawer LL, Di Paola JA, Hotchkiss RS, Remy KE. Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report. Crit Care Explor 2021;3:e0500. [PMID: 34345826 DOI: 10.1097/CCE.0000000000000500] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
509 Tovo PA, Garazzino S, Daprà V, Pruccoli G, Calvi C, Mignone F, Alliaudi C, Denina M, Scolfaro C, Zoppo M, Licciardi F, Ramenghi U, Galliano I, Bergallo M. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases. Int J Mol Sci 2021;22:7481. [PMID: 34299101 DOI: 10.3390/ijms22147481] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
510 Callaway E. The quest to find genes that drive severe COVID. Nature 2021;595:346-8. [PMID: 34239118 DOI: 10.1038/d41586-021-01827-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
511 Bigley TM, Cooper MA. Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation. Curr Opin Immunol 2021;72:230-8. [PMID: 34265589 DOI: 10.1016/j.coi.2021.06.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
512 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, Dragon-Durey MA, Pagès F, Cremer I. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol 2021;12:701273. [PMID: 34322128 DOI: 10.3389/fimmu.2021.701273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
513 Karnell JL, Wu Y, Mittereder N, Smith MA, Gunsior M, Yan L, Casey KA, Henault J, Riggs JM, Nicholson SM, Sanjuan MA, Vousden KA, Werth VP, Drappa J, Illei GG, Rees WA, Ratchford JN; VIB7734 Trial Investigators. Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus. Sci Transl Med 2021;13:eabf8442. [PMID: 34039741 DOI: 10.1126/scitranslmed.abf8442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
514 de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin. EMBO Mol Med 2021;13:e14122. [PMID: 34170074 DOI: 10.15252/emmm.202114122] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
515 Asgari S, Pousaz LA. Human genetic variants identified that affect COVID susceptibility and severity. Nature 2021;600:390-1. [PMID: 34239107 DOI: 10.1038/d41586-021-01773-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
516 Malave Sanchez M, Saleeb P, Kottilil S, Mathur P. Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies? Open Forum Infect Dis 2021;8:ofab367. [PMID: 34381846 DOI: 10.1093/ofid/ofab367] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
517 Sattui SE, Crow MK, Navarro-Millán I. The role of immunomodulatory medications in the treatment of COVID-19. Curr Opin Rheumatol 2021;33:431-45. [PMID: 34397605 DOI: 10.1097/BOR.0000000000000817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
518 Cegan JC, Trump BD, Cibulsky SM, Collier ZA, Cummings CL, Greer SL, Jarman H, Klasa K, Kleinman G, Surette MA, Wells E, Linkov I. Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates? Risk Manag Healthc Policy 2021;14:2877-85. [PMID: 34267565 DOI: 10.2147/RMHP.S313312] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
519 Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L, Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C; Musc-19., Covisep study groups. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol 2021;8:1738-44. [PMID: 34240579 DOI: 10.1002/acn3.51408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
520 Park SH. An Impaired Inflammatory and Innate Immune Response in COVID-19. Mol Cells 2021;44:384-91. [PMID: 34098591 DOI: 10.14348/molcells.2021.0068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
521 Kim K, Cho KT. A Review of Global Collaboration on COVID-19 Research during the Pandemic in 2020. Sustainability 2021;13:7618. [DOI: 10.3390/su13147618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
522 Gupta RK, Rosenheim J, Bell LC, Chandran A, Guerra-Assuncao JA, Pollara G, Whelan M, Artico J, Joy G, Kurdi H, Altmann DM, Boyton RJ, Maini MK, McKnight A, Lambourne J, Cutino-Moguel T, Manisty C, Treibel TA, Moon JC, Chain BM, Noursadeghi M; COVIDsortium Investigators. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study. Lancet Microbe 2021. [PMID: 34250515 DOI: 10.1016/S2666-5247(21)00146-4] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
523 Kehrer T, García-Sastre A, Miorin L. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. J Interferon Cytokine Res 2021;41:205-19. [PMID: 34161170 DOI: 10.1089/jir.2021.0060] [Reference Citation Analysis]
524 Polat C, Ergunay K. Insights into the virologic and immunologic features of SARS-COV-2. World J Clin Cases 2021; 9(19): 5007-5018 [PMID: 34307551 DOI: 10.12998/wjcc.v9.i19.5007] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
525 Esenboga S, Ocak M, Akarsu A, Bildik HN, Cagdas D, Iskit AT, Tezcan I. COVID-19 in Patients with Primary Immunodeficiency. J Clin Immunol 2021. [PMID: 34231093 DOI: 10.1007/s10875-021-01065-9] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
526 Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021. [PMID: 34226718 DOI: 10.1038/s41581-021-00452-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 64] [Article Influence: 1.0] [Reference Citation Analysis]
527 Krsak M, Harry BL, Palmer BE, Franco-Paredes C. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2. Viral Immunol 2021. [PMID: 34227891 DOI: 10.1089/vim.2021.0054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
528 Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M, Jolly C, Towers GJ. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J 2021;40:e107826. [PMID: 34101213 DOI: 10.15252/embj.2021107826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
529 Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, Peters Z, Day-Lewis M, Novak T, Armant M, Williams L, Rockowitz S, Sliz P, Williams DA, Randolph AG, Geha RS; Taking on COVID-19 Together Study Investigators. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol 2021:S0091-6749(21)01052-6. [PMID: 34224783 DOI: 10.1016/j.jaci.2021.06.024] [Cited by in F6Publishing: 30] [Reference Citation Analysis]
530 Kosmicki JA, Horowitz JE, Banerjee N, Lanche R, Marcketta A, Maxwell E, Bai X, Sun D, Backman JD, Sharma D, Kury FSP, Kang HM, O'Dushlaine C, Yadav A, Mansfield AJ, Li AH, Watanabe K, Gurski L, McCarthy SE, Locke AE, Khalid S, O'Keeffe S, Mbatchou J, Chazara O, Huang Y, Kvikstad E, O'Neill A, Nioi P, Parker MM, Petrovski S, Runz H, Szustakowski JD, Wang Q, Wong E, Cordova-Palomera A, Smith EN, Szalma S, Zheng X, Esmaeeli S, Davis JW, Lai YP, Chen X, Justice AE, Leader JB, Mirshahi T, Carey DJ, Verma A, Sirugo G, Ritchie MD, Rader DJ, Povysil G, Goldstein DB, Kiryluk K, Pairo-Castineira E, Rawlik K, Pasko D, Walker S, Meynert A, Kousathanas A, Moutsianas L, Tenesa A, Caulfield M, Scott R, Wilson JF, Baillie JK, Butler-Laporte G, Nakanishi T, Lathrop M, Richards JB, Jones M, Balasubramanian S, Salerno W, Shuldiner AR, Marchini J, Overton JD, Habegger L, Cantor MN, Reid JG, Baras A, Abecasis GR, Ferreira MAR; Regeneron Genetics Center., UKB Exome Sequencing Consortium. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am J Hum Genet 2021;108:1350-5. [PMID: 34115965 DOI: 10.1016/j.ajhg.2021.05.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
531 Sampaio NG, Chauveau L, Hertzog J, Bridgeman A, Fowler G, Moonen JP, Dupont M, Russell RA, Noerenberg M, Rehwinkel J. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci Rep 2021;11:13638. [PMID: 34211037 DOI: 10.1038/s41598-021-92940-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
532 Schmidt A, Peters S, Knaus A, Sabir H, Hamsen F, Maj C, Fazaal J, Sivalingam S, Savchenko O, Mantri A, Holzinger D, Neudorf U, Müller A, Ludwig KU, Krawitz PM, Engels H, Nöthen MM, Bagci S. TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19. NPJ Genom Med 2021;6:55. [PMID: 34210994 DOI: 10.1038/s41525-021-00220-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
533 Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol 2021;21:475-84. [PMID: 34211186 DOI: 10.1038/s41577-021-00578-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 141] [Article Influence: 14.0] [Reference Citation Analysis]
534 Apostolidou S, Harbauer T, Lasch P, Biermann D, Hempel M, Lütgehetmann M, Pfefferle S, Herrmann J, Rüffer A, Reinshagen K, Kozlik-Feldmann R, Gieras A, Kniep I, Oh J, Singer D, Ebenebe CU, Kobbe R. Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report. Children (Basel) 2021;8:564. [PMID: 34208887 DOI: 10.3390/children8070564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
535 Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee SA, Ghosn E, Lynch KL, Roan NR. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep 2021;36:109414. [PMID: 34260965 DOI: 10.1016/j.celrep.2021.109414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
536 Ricci D, Etna MP, Rizzo F, Sandini S, Severa M, Coccia EM. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators. Int J Mol Sci 2021;22:7017. [PMID: 34209845 DOI: 10.3390/ijms22137017] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
537 Zanella I, Zacchi E, Piva S, Filosto M, Beligni G, Alaverdian D, Amitrano S, Fava F, Baldassarri M, Frullanti E, Meloni I, Renieri A, Castelli F, Quiros-Roldan E; GEN-COVID Multicenter Study., GEVACOBA Study Group. C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age. Int J Mol Sci 2021;22:6991. [PMID: 34209673 DOI: 10.3390/ijms22136991] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
538 Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol 2021;99:107916. [PMID: 34224994 DOI: 10.1016/j.intimp.2021.107916] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
539 Le Voyer T, Sakata S, Tsumura M, Khan T, Esteve-Sole A, Al-Saud BK, Gungor HE, Taur P, Jeanne-Julien V, Christiansen M, Köhler LM, ElGhazali GE, Rosain J, Nishimura S, Sakura F, Bouaziz M, Oleaga-Quintas C, Nieto-Patlán A, Deyà-Martinez À, Altuner Torun Y, Neehus AL, Roynard M, Bozdemir SE, Al Kaabi N, Al Hassani M, Mersiyanova I, Rozenberg F, Speckmann C, Hainmann I, Hauck F, Alzahrani MH, Alhajjar SH, Al-Muhsen S, Cole T, Fuleihan R, Arkwright PD, Badolato R, Alsina L, Abel L, Desai M, Al-Mousa H, Shcherbina A, Marr N, Boisson-Dupuis S, Casanova JL, Okada S, Bustamante J. Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency. J Immunol 2021:ji2001451. [PMID: 34183371 DOI: 10.4049/jimmunol.2001451] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
540 Bozonnat A, Assan F, LeGoff J, Bourrat E, Bachelez H. SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist. J Clin Immunol 2021. [PMID: 34176064 DOI: 10.1007/s10875-021-01076-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
541 Choi YM, Jeong H, Park U, Cho NH, Kim BJ. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner. Viruses 2021;13:1227. [PMID: 34202029 DOI: 10.3390/v13071227] [Reference Citation Analysis]
542 Al-Saud B, Hazzazi KM, Mohammed R, Al Najjar A, Al Hazmi T, Monies D, Alkuraya FS. SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease. J Clin Immunol 2021. [PMID: 34173127 DOI: 10.1007/s10875-021-01063-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
543 Gyngell C, Savulescu J. Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines? J Med Ethics 2021:medethics-2021-107297. [PMID: 34172526 DOI: 10.1136/medethics-2021-107297] [Reference Citation Analysis]
544 Alfi O, Yakirevitch A, Wald O, Wandel O, Izhar U, Oiknine-Djian E, Nevo Y, Elgavish S, Dagan E, Madgar O, Feinmesser G, Pikarsky E, Bronstein M, Vorontsov O, Jonas W, Ives J, Walter J, Zakay-Rones Z, Oberbaum M, Panet A, Wolf DG. Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract. J Virol 2021;95:e0013021. [PMID: 33893170 DOI: 10.1128/JVI.00130-21] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
545 McLaren PJ, Fellay J. HIV-1 and human genetic variation. Nat Rev Genet 2021. [PMID: 34168330 DOI: 10.1038/s41576-021-00378-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
546 Ma Y, Huang Y, Zhao S, Yao Y, Zhang Y, Qu J, Wu N, Su J. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19. Hum Mol Genet 2021;30:1247-58. [PMID: 33949668 DOI: 10.1093/hmg/ddab125] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
547 Meyerowitz EA, Sen P, Schoenfeld SR, Neilan TG, Frigault MJ, Stone JH, Kim AY, Mansour MK. Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions. Clin Infect Dis 2021;72:e1130-43. [PMID: 33216852 DOI: 10.1093/cid/ciaa1759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
548 Kino T, Burd I, Segars JH. Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? Int J Mol Sci 2021;22:6764. [PMID: 34201797 DOI: 10.3390/ijms22136764] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
549 Renn M, Bartok E, Zillinger T, Hartmann G, Behrendt R. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions. Pharmacol Ther 2021;228:107931. [PMID: 34171328 DOI: 10.1016/j.pharmthera.2021.107931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
550 Trombetta AC, Farias GB, Gomes AMC, Godinho-Santos A, Rosmaninho P, Conceição CM, Laia J, Santos DF, Almeida ARM, Mota C, Gomes A, Serrano M, Veldhoen M, Sousa AE, Fernandes SM. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front Immunol 2021;12:691725. [PMID: 34248984 DOI: 10.3389/fimmu.2021.691725] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
551 Goudouris ES, Pinto-Mariz F, Mendonça LO, Aranda CS, Guimarães RR, Kokron C, Barros MT, Anísio F, Alonso MLO, Marcelino F, Valle SOR, Junior SD, Barreto IDP, Ferreira JFS, Roxo-Junior P, do Rego Silva AM, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Di Gesu RSW, Schidlowski L, Fillipo P, Bichuetti-Silva DC, Soldateli G, Ferraroni NR, de Oliveira Dantas E, Pestana S, Mansour E, Ulaf RG, Prando C, Condino-Neto A, Grumach AS. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study. J Clin Immunol 2021. [PMID: 34164762 DOI: 10.1007/s10875-021-01066-8] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
552 Peng T, Du SY, Son M, Diamond B. HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. Proc Natl Acad Sci U S A 2021;118:e2106017118. [PMID: 34108245 DOI: 10.1073/pnas.2106017118] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
553 Long MJC, Aye Y. Science's Response to CoVID-19. ChemMedChem 2021;16:2288-314. [PMID: 33811458 DOI: 10.1002/cmdc.202100079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
554 Ochoa-Grullón J, Peña Cortijo A, Guevara-Hoyer K, Jiménez García C, de la Fuente E, de la Peña AR, Fernández-Arquero M, González Fernández A, Sánchez-Ramón S. B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome? EJHaem 2021. [PMID: 34518828 DOI: 10.1002/jha2.249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
555 Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Pfützner W, Novak N, Merk H, Rabe U, Schlenter W, Ring J, Wehrmann W, Mülleneisen N, Wrede H, Fuchs T, Jensen-Jarolim E. Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper. Allergo J Int 2021;:1-14. [PMID: 34178577 DOI: 10.1007/s40629-021-00178-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A, Alam SM, Wiehe K, Lu X, Parks R, Sutherland LL, Oguin TH 3rd, McDanal C, Perez LG, Mansouri K, Gobeil SMC, Janowska K, Stalls V, Kopp M, Cai F, Lee E, Foulger A, Hernandez GE, Sanzone A, Tilahun K, Jiang C, Tse LV, Bock KW, Minai M, Nagata BM, Cronin K, Gee-Lai V, Deyton M, Barr M, Von Holle T, Macintyre AN, Stover E, Feldman J, Hauser BM, Caradonna TM, Scobey TD, Rountree W, Wang Y, Moody MA, Cain DW, DeMarco CT, Denny TN, Woods CW, Petzold EW, Schmidt AG, Teng IT, Zhou T, Kwong PD, Mascola JR, Graham BS, Moore IN, Seder R, Andersen H, Lewis MG, Montefiori DC, Sempowski GD, Baric RS, Acharya P, Haynes BF, Saunders KO. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell 2021;184:4203-4219.e32. [PMID: 34242577 DOI: 10.1016/j.cell.2021.06.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 77] [Article Influence: 4.0] [Reference Citation Analysis]
557 Frankel AE, Yip WC, Naik E, Hasselbalch HC. Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clin Case Rep 2021;9:e04218. [PMID: 34136234 DOI: 10.1002/ccr3.4218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Sun AM, Hoffman T, Luu BQ, Ashammakhi N, Li S. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review. Biodes Manuf 2021;:1-19. [PMID: 34178414 DOI: 10.1007/s42242-021-00136-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
559 MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, Paglionico A, Petricca L, Bosello SL, Carfì A, Sali M, Stigliano E, Cingolani A, Murri R, Arena V, Fantoni M, Antonelli M, Landi F, Franceschi F, Sanguinetti M, McInnes IB, McSharry C, Gasbarrini A, Otto TD, Kurowska-Stolarska M, Gremese E. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight 2021;6:147413. [PMID: 34143756 DOI: 10.1172/jci.insight.147413] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
560 Mao T, Israelow B, Lucas C, Vogels CBF, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M, Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A; Yale SARS-CoV-2 Genome Surveillance Initiative. A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice. bioRxiv 2021:2021. [PMID: 34159330 DOI: 10.1101/2021.06.16.448754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
561 Post NF, Luiten RM, Wolkerstorfer A, Bekkenk MW, Böhm M. Does autoimmune vitiligo protect against COVID-19 disease? Exp Dermatol 2021;30:1254-7. [PMID: 34081788 DOI: 10.1111/exd.14407] [Reference Citation Analysis]
562 Kammertoens T, Jeuthe S, Baranzke H, Klippert A, Thöne-Reineke C. Breeding and Maintenance of Immunodeficient Mouse Lines under SPF Conditions-A Call for Individualized Severity Analyses and Approval Procedures. Animals (Basel) 2021;11:1789. [PMID: 34203900 DOI: 10.3390/ani11061789] [Reference Citation Analysis]
563 Baldassarri M, Fava F, Fallerini C, Daga S, Benetti E, Zguro K, Amitrano S, Valentino F, Doddato G, Giliberti A, Di Sarno L, Palmieri M, Carriero ML, Alaverdian D, Beligni G, Iuso N, Castelli F, Quiros-Roldan E, Mondelli MU, Miceli R, Frullanti E, Furini S, Mari F, Renieri A, Gabbi C, On Behalf Of The Gen-Covid Multicenter Study. Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants. J Pers Med 2021;11:558. [PMID: 34203982 DOI: 10.3390/jpm11060558] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
564 Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay MÈ. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Front Cell Neurosci 2021;15:670298. [PMID: 34211370 DOI: 10.3389/fncel.2021.670298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
565 Cheemarla NR, Watkins TA, Mihaylova VT, Wang B, Zhao D, Wang G, Landry ML, Foxman EF. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. J Exp Med 2021;218:e20210583. [PMID: 34128960 DOI: 10.1084/jem.20210583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
566 Menachery VD, Gralinski LE. Coagulation and wound repair during COVID-19. J Heart Lung Transplant 2021:S1053-2498(21)02359-7. [PMID: 34334300 DOI: 10.1016/j.healun.2021.06.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
567 Aghbash PS, Eslami N, Shirvaliloo M, Baghi HB. Viral coinfections in COVID-19. J Med Virol 2021;93:5310-22. [PMID: 34032294 DOI: 10.1002/jmv.27102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
568 Saleki K, Yaribash S, Banazadeh M, Hajihosseinlou E, Gouravani M, Saghazadeh A, Rezaei N. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies. Eur J Pharmacol 2021;906:174248. [PMID: 34126092 DOI: 10.1016/j.ejphar.2021.174248] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
569 Talla A, Vasaikar SV, Lemos MP, Moodie Z, Pebworth ML, Henderson KE, Cohen KW, Czartoski JL, Lai L, Suthar MS, Heubeck AT, Genge PC, Roll CR, Weiss M, Reading J, Kondza N, MacMillan H, Fong OC, Thomson ZJ, Graybuck LT, Newell EW, Coffey EM, Meijer P, Becker LA, De Rosa SC, Torgerson TR, Skene PJ, Li X, Szeto GL, McElrath MJ, Bumol TF. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv 2021:2021. [PMID: 34075380 DOI: 10.1101/2021.05.26.442666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
570 Del Bello A, Kamar N, Vergez F, Faguer S, Marion O, Beq A, Lathrache Y, Abravanel F, Izopet J, Treiner E. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int 2021:S0085-2538(21)00588-3. [PMID: 34126110 DOI: 10.1016/j.kint.2021.05.032] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
571 Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O'Farrill-Romanillos PM, Muzquiz Zermeño D, Scheffler Mendoza SC, Venegas Montoya E, García Campos JA, Sánchez-Sánchez LM, Gámez González LB, Ramírez López JM, Bustamante Ogando JC, Vásquez-Echeverri E, Medina Torres EA, Lopez-Herrera G, Blancas Galicia L, Berrón Ruiz L, Staines-Boone AT, Espinosa-Padilla SE, Segura Mendez NH, Lugo Reyes SO. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico. J Clin Immunol 2021. [PMID: 34114122 DOI: 10.1007/s10875-021-01077-5] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
572 Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, Kosti I, Leon KE, Bunis DG, Li C, Kumar GR, White KM, García-Sastre A, Ott M, Sirota M. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Sci Rep 2021;11:12310. [PMID: 34112877 DOI: 10.1038/s41598-021-91625-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
573 A Malhani A, A Enani M, Saheb Sharif-Askari F, R Alghareeb M, T Bin-Brikan R, A AlShahrani S, Halwani R, Tleyjeh IM. Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study. PLoS One 2021;16:e0252984. [PMID: 34111191 DOI: 10.1371/journal.pone.0252984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
574 Moreews M, Le Gouge K, Khaldi-Plassart S, Pescarmona R, Mathieu AL, Malcus C, Djebali S, Bellomo A, Dauwalder O, Perret M, Villard M, Chopin E, Rouvet I, Vandenesh F, Dupieux C, Pouyau R, Teyssedre S, Guerder M, Louazon T, Moulin-Zinsch A, Duperril M, Patural H, Giovannini-Chami L, Portefaix A, Kassai B, Venet F, Monneret G, Lombard C, Flodrops H, De Guillebon JM, Bajolle F, Launay V, Bastard P, Zhang SY, Dubois V, Thaunat O, Richard JC, Mezidi M, Allatif O, Saker K, Dreux M, Abel L, Casanova JL, Marvel J, Trouillet-Assant S, Klatzmann D, Walzer T, Mariotti-Ferrandiz E, Javouhey E, Belot A. Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children. Sci Immunol 2021;6:eabh1516. [PMID: 34035116 DOI: 10.1126/sciimmunol.abh1516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
575 Ahsan H, Sonn JK, Lee YS, Islam SU, Khalil SK. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay. Viral Immunol 2021. [PMID: 34101517 DOI: 10.1089/vim.2021.0017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
576 Russo R, Andolfo I, Lasorsa VA, Cantalupo S, Marra R, Frisso G, Abete P, Cassese GM, Servillo G, Esposito G, Gentile I, Piscopo C, Della Monica M, Fiorentino G, Russo G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. The TNFRSF13C H159Y Variant Is Associated with Severe COVID-19: A Retrospective Study of 500 Patients from Southern Italy. Genes (Basel) 2021;12:881. [PMID: 34201032 DOI: 10.3390/genes12060881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
577 Vinh DC, Abel L, Bastard P, Cheng MP, Condino-Neto A, Gregersen PK, Haerynck F, Cicalese MP, Hagin D, Soler-Palacín P, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova JL, Meyts I; COVID Human Genetic Effort. Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β. J Clin Immunol 2021. [PMID: 34101091 DOI: 10.1007/s10875-021-01068-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
578 Santoso CS, Li Z, Rottenberg JT, Liu X, Shen VX, Fuxman Bass JI. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19. Front Pharmacol 2021;12:673485. [PMID: 34163359 DOI: 10.3389/fphar.2021.673485] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
579 Thorne LG, Bouhaddou M, Reuschl AK, Zuliani-Alvarez L, Polacco B, Pelin A, Batra J, Whelan MVX, Ummadi M, Rojc A, Turner J, Obernier K, Braberg H, Soucheray M, Richards A, Chen KH, Harjai B, Memon D, Hosmillo M, Hiatt J, Jahun A, Goodfellow IG, Fabius JM, Shokat K, Jura N, Verba K, Noursadeghi M, Beltrao P, Swaney DL, Garcia-Sastre A, Jolly C, Towers GJ, Krogan NJ. Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant. bioRxiv 2021:2021. [PMID: 34127972 DOI: 10.1101/2021.06.06.446826] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
580 Sui Y, Li J, Venzon DJ, Berzofsky JA. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage. Front Immunol 2021;12:658428. [PMID: 34149696 DOI: 10.3389/fimmu.2021.658428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
581 Matucci-Cerinic C, Caorsi R, Consolaro A, Rosina S, Civino A, Ravelli A. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum? Front Pediatr 2021;9:680813. [PMID: 34178896 DOI: 10.3389/fped.2021.680813] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
582 Hanan N, Doud RL Jr, Park IW, Jones HP, Mathew SO. The Many Faces of Innate Immunity in SARS-CoV-2 Infection. Vaccines (Basel) 2021;9:596. [PMID: 34199761 DOI: 10.3390/vaccines9060596] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
583 Sharifinejad N, Zaki-Dizaji M, Tebyanian S, Zainaldain H, Jamee M, Rizvi FS, Hosseinzadeh S, Fayyaz F, Hamedifar H, Sabzevari A, Matloubi M, Heropolitańska-Pliszka E, Aghamahdi F, Abolhassani H, Azizi G. Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review. Expert Rev Clin Immunol 2021;:1-11. [PMID: 33957837 DOI: 10.1080/1744666X.2021.1925543] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
584 Zhang P, Cobat A, Lee YS, Wu Y, Bayrak CS, Boccon-Gibod C, Matuozzo D, Lorenzo L, Jain A, Boucherit S, Vallée L, Stüve B, Chabrier S, Casanova JL, Abel L, Zhang SY, Itan Y. A computational approach for detecting physiological homogeneity in the midst of genetic heterogeneity. Am J Hum Genet 2021;108:1012-25. [PMID: 34015270 DOI: 10.1016/j.ajhg.2021.04.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
585 Vishwanathan K, Kambhampati SBS, Vaishya R. Top 100 cited articles on diabetes mellitus and Covid-19: A bibliometric analysis. Diabetes Metab Syndr 2021;15:102160. [PMID: 34245962 DOI: 10.1016/j.dsx.2021.05.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
586 Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 2021;17:737-59. [PMID: 34015983 DOI: 10.1080/1744666X.2021.1932467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
587 Lee HK, Jung O, Hennighausen L. JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells. Commun Biol 2021;4:654. [PMID: 34079039 DOI: 10.1038/s42003-021-02167-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
588 Aluri J, Cooper MA, Schuettpelz LG. Toll-Like Receptor Signaling in the Establishment and Function of the Immune System. Cells 2021;10:1374. [PMID: 34199501 DOI: 10.3390/cells10061374] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
589 . A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol 2021;6:eabi9002. [PMID: 34010139 DOI: 10.1126/sciimmunol.abi9002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
590 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif L, Peeples ME, Liu SL. SARS-CoV-2 Spreads through Cell-to-Cell Transmission. bioRxiv 2021:2021. [PMID: 34100011 DOI: 10.1101/2021.06.01.446579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
591 Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY; RegCOVID Study Group. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol 2021;12:666163. [PMID: 34135895 DOI: 10.3389/fimmu.2021.666163] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
592 Sharma A, Ong JW, Loke MF, Chua EG, Lee JJ, Choi HW, Tan YJ, Lal SK, Chow VT. Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes. Microorganisms 2021;9:1193. [PMID: 34073047 DOI: 10.3390/microorganisms9061193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
593 Mazini L, Rochette L, Malka G. Exosomes contribution in COVID-19 patients' treatment. J Transl Med 2021;19:234. [PMID: 34059065 DOI: 10.1186/s12967-021-02884-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
594 Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights into SARS-CoV-2 Persistence and Its Relevance. Viruses 2021;13:1025. [PMID: 34072390 DOI: 10.3390/v13061025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
595 Patel S, Wadhwa M. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19. Biomed Pharmacother 2021;140:111785. [PMID: 34126316 DOI: 10.1016/j.biopha.2021.111785] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
596 Jamme M, Mazeraud A. Plasmapheresis Efficiency in Coronavirus Disease 2019: More Related to What You Add and Not What You Take Away? Crit Care Med 2021;49:e651-2. [PMID: 33769769 DOI: 10.1097/CCM.0000000000004926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Tu WJ, McCuaig RD, Melino M, Rawle DJ, Le TT, Yan K, Suhrbier A, Johnston RL, Koufariotis LT, Waddell N, Cross EM, Tsimbalyuk S, Bain A, Ahern E, Collinson N, Phipps S, Forwood JK, Seddiki N, Rao S. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication. Cell Discov 2021;7:37. [PMID: 34031383 DOI: 10.1038/s41421-021-00279-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
598 Knight V, Heimall JR, Chong H, Nandiwada SL, Chen K, Lawrence MG, Sadighi Akha AA, Kumánovics A, Jyonouchi S, Ngo SY, Vinh DC, Hagin D, Forbes Satter LR, Marsh RA, Chiang SCC, Willrich MAV, Frazer-Abel AA, Rider NL. A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00582-1. [PMID: 34033983 DOI: 10.1016/j.jaip.2021.05.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
599 Salgado-Albarrán M, Navarro-Delgado EI, Del Moral-Morales A, Alcaraz N, Baumbach J, González-Barrios R, Soto-Reyes E. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection. NPJ Syst Biol Appl 2021;7:21. [PMID: 34031419 DOI: 10.1038/s41540-021-00181-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
600 Liu W, Reyes HM, Yang JF, Li Y, Stewart KM, Basil MC, Lin SM, Katzen J, Morrisey EE, Weiss SR, You J. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection. J Virol 2021;95:e00490-21. [PMID: 33789998 DOI: 10.1128/JVI.00490-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
601 Maecker HT. Immune profiling of COVID-19: preliminary findings and implications for the pandemic. J Immunother Cancer 2021;9:e002550. [PMID: 33963016 DOI: 10.1136/jitc-2021-002550] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
602 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
603 Islam MA, Albarracin L, Melnikov V, Andrade BGN, Cuadrat RRC, Kitazawa H, Villena J. Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells. Pathogens 2021;10:634. [PMID: 34064210 DOI: 10.3390/pathogens10060634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
604 Cantalupo S, Lasorsa VA, Russo R, Andolfo I, D'Alterio G, Rosato BE, Frisso G, Abete P, Cassese GM, Servillo G, Gentile I, Piscopo C, Della Monica M, Fiorentino G, Russo G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19. Int J Mol Sci 2021;22:5372. [PMID: 34065289 DOI: 10.3390/ijms22105372] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
605 Ku CL, Chen IT, Lai MZ. Infection-induced inflammation from specific inborn errors of immunity to COVID-19. FEBS J 2021;288:5021-41. [PMID: 33971084 DOI: 10.1111/febs.15961] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
606 Franceschi VB, Caldana GD, de Menezes Mayer A, Cybis GB, Neves CAM, Ferrareze PAG, Demoliner M, de Almeida PR, Gularte JS, Hansen AW, Weber MN, Fleck JD, Zimerman RA, Kmetzsch L, Spilki FR, Thompson CE. Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil. BMC Genomics 2021;22:371. [PMID: 34016042 DOI: 10.1186/s12864-021-07708-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
607 Wack A. Monocyte and dendritic cell defects in COVID-19. Nat Cell Biol 2021;23:445-7. [PMID: 33972732 DOI: 10.1038/s41556-021-00685-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
608 Lowery SA, Sariol A, Perlman S. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Cell Host Microbe 2021;29:1052-62. [PMID: 34022154 DOI: 10.1016/j.chom.2021.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
609 Barh D, Aljabali AA, Tambuwala MM, Tiwari S, Serrano-Aroca Á, Alzahrani KJ, Silva Andrade B, Azevedo V, Ganguly NK, Lundstrom K. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management. Biomedicines 2021;9:556. [PMID: 34067609 DOI: 10.3390/biomedicines9050556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
610 Wulandari L, Hamidah B, Pakpahan C, Damayanti NS, Kurniati ND, Adiatmaja CO, Wigianita MR, Soedarsono, Husada D, Tinduh D, Prakoeswa CRS, Endaryanto A, Puspaningsih NNT, Mori Y, Lusida MI, Shimizu K, Oceandy D. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients. Hum Genomics 2021;15:29. [PMID: 34001248 DOI: 10.1186/s40246-021-00330-7] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
611 Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, Ruffieux H, De Sa A, Huhn O, Morgan MD, Gerber PP, Wills MR, Baker S, Calero-Nieto FJ, Doffinger R, Dougan G, Elmer A, Goodfellow IG, Gupta RK, Hosmillo M, Hunter K, Kingston N, Lehner PJ, Matheson NJ, Nicholson JK, Petrunkina AM, Richardson S, Saunders C, Thaventhiran JED, Toonen EJM, Weekes MP, Göttgens B, Toshner M, Hess C, Bradley JR, Lyons PA, Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 2021;54:1257-1275.e8. [PMID: 34051148 DOI: 10.1016/j.immuni.2021.05.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]
612 Nasonov EL. 2019 Coronavirus disease (COVID-19): contribution of rheumatology. Terapevticheskii arkhiv 2021;93. [DOI: 10.26442/00403660.2021.05.200799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, Bogaard HJ, Tuinman PR, van Agtmael MA, Hamann J, Teunissen CE, Wiersinga WJ, Koos Zwinderman AH, Brouwer MC, van de Beek D, Vlaar APJ; Amsterdam UMC COVID-19 Biobank Investigators. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 2021;67:103378. [PMID: 34000622 DOI: 10.1016/j.ebiom.2021.103378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
614 Mawson AR, Croft AM, Gonzalez-Fernandez F. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis. Viral Immunol 2021;34:376-9. [PMID: 33983857 DOI: 10.1089/vim.2020.0330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
615 Cervantes-Barragan L, Vanderheiden A, Royer CJ, Davis-Gardner ME, Ralfs P, Chirkova T, Anderson LJ, Grakoui A, Suthar MS. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 34013278 DOI: 10.1101/2021.05.12.443948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
616 da Silva RP, Gonçalves JIB, Zanin RF, Schuch FB, de Souza APD. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:657363. [PMID: 34054820 DOI: 10.3389/fimmu.2021.657363] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
617 Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Lukin VV, Holbrook MR. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses 2021;13:893. [PMID: 34065987 DOI: 10.3390/v13050893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
618 Declerck K, Novo CP, Grielens L, Van Camp G, Suter A, Vanden Berghe W. Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences. BMC Complement Med Ther 2021;21:141. [PMID: 33980308 DOI: 10.1186/s12906-021-03310-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
619 McBride JD, Narang J, Simonds R, Agrawal S, Rodriguez ER, Tan CD, Baldwin WM, Dvorina N, Krywanczyk AR, Fernandez AP. Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. J Cutan Pathol 2021;48:1166-72. [PMID: 33931901 DOI: 10.1111/cup.14038] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
620 Traish AM. Sex steroids and COVID-19 mortality in women. Trends Endocrinol Metab 2021;32:533-6. [PMID: 33966962 DOI: 10.1016/j.tem.2021.04.006] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
621 Gyngell C, Christodoulou J, Savulescu J. Ethically utilising COVID-19 host-genomic data. NPJ Genom Med 2021;6:31. [PMID: 33972547 DOI: 10.1038/s41525-021-00194-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
622 Carnicelli A, Fiori B, Ricci R, Piano A, Bonadia N, Taddei E, Fantoni M, Murri R, Cingolani A, Barillaro C, Cutuli SL, Marchesini D, Della Polla DA, Forte E, Fuorlo M, Di Maurizio L, Amorini P, Cattani P, Franceschi F, Sanguinetti M. Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital. Intern Emerg Med 2021. [PMID: 33970428 DOI: 10.1007/s11739-021-02750-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
623 Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, Amblard E, Noel F, Marie Y, Bouteiller D, Medvedovic J, Pène F, Soumelis V. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol 2021;23:538-51. [PMID: 33972731 DOI: 10.1038/s41556-021-00681-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
624 Novelli G, Biancolella M, Mehrian-Shai R, Colona VL, Brito AF, Grubaugh ND, Vasiliou V, Luzzatto L, Reichardt JKV. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genomics 2021;15:27. [PMID: 33966626 DOI: 10.1186/s40246-021-00326-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
625 Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity 2021;54:1578-1593.e5. [PMID: 34051147 DOI: 10.1016/j.immuni.2021.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
626 Vologzhanin DA, Golota AS, Kamilova TA, Shneider OV, Sherbak SG. Genetics of COVID-19. Journal of Clinical Practice 2021;12:41-52. [DOI: 10.17816/clinpract64972] [Reference Citation Analysis]
627 Kiener M, Roldan N, Machahua C, Sengupta A, Geiser T, Guenat OT, Funke-Chambour M, Hobi N, Kruithof-de Julio M. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19. Front Med (Lausanne) 2021;8:644678. [PMID: 34026781 DOI: 10.3389/fmed.2021.644678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
628 Roussel M, Ferrant J, Reizine F, Le Gallou S, Dulong J, Carl S, Lesouhaitier M, Gregoire M, Bescher N, Verdy C, Latour M, Bézier I, Cornic M, Vinit A, Monvoisin C, Sawitzki B, Leonard S, Paul S, Feuillard J, Jeannet R, Daix T, Tiwari VK, Tadié JM, Cogné M, Tarte K. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Cell Rep Med 2021;2:100291. [PMID: 33977279 DOI: 10.1016/j.xcrm.2021.100291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
629 Alarcon PC, Damen MSMA, Madan R, Deepe GS Jr, Spearman P, Way SS, Divanovic S. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution. Mucosal Immunol 2021. [PMID: 33958704 DOI: 10.1038/s41385-021-00404-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
630 Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 129] [Article Influence: 17.0] [Reference Citation Analysis]
631 Sancho-Shimizu V, Brodin P, Cobat A, Biggs CM, Toubiana J, Lucas CL, Henrickson SE, Belot A, Tangye SG, Milner JD, Levin M, Abel L, Bogunovic D, Casanova JL, Zhang SY; MIS-C@CHGE. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? J Exp Med 2021;218:e20210446. [PMID: 33904890 DOI: 10.1084/jem.20210446] [Cited by in Crossref: 10] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
632 Dzankic PJ, Partridge L. Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults. Lancet Healthy Longev 2021;2:e232-3. [PMID: 33977282 DOI: 10.1016/S2666-7568(21)00090-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Mannick JB, Teo G, Bernardo P, Quinn D, Russell K, Klickstein L, Marshall W, Shergill S. Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials. Lancet Healthy Longev 2021;2:e250-62. [PMID: 33977284 DOI: 10.1016/S2666-7568(21)00062-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
634 Haslbauer JD, Matter MS, Stalder AK, Tzankov A. Histomorphological patterns of regional lymph nodes in COVID-19 lungs. Pathologe 2021. [PMID: 33950285 DOI: 10.1007/s00292-021-00945-6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
635 Scohy A, Gruson D, Simon A, Kabamba-Mukadi B, De Greef J, Belkhir L, Rodriguez-Villalobos H, Robert A, Yombi JC. Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity. Diagn Microbiol Infect Dis 2021;100:115414. [PMID: 34082266 DOI: 10.1016/j.diagmicrobio.2021.115414] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
636 Yang L, Wang J, Hui P, Yarovinsky TO, Badeti S, Pham K, Liu C. Potential role of IFN-α in COVID-19 patients and its underlying treatment options. Appl Microbiol Biotechnol 2021;105:4005-15. [PMID: 33950278 DOI: 10.1007/s00253-021-11319-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
637 Frankel AE, Reddy R, DeSuza KR, Deeb K, Carlin AF, Smith D, Xie Y, Naik E, Silver RT, Hasselbalch HC. Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clin Case Rep 2021;9:2228-35. [PMID: 33936671 DOI: 10.1002/ccr3.3997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
638 Wu B, Ramaiah A, Garcia G, Gwack Y, Arumugaswami V, Srikanth S. ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling. bioRxiv 2021:2021. [PMID: 33972946 DOI: 10.1101/2021.05.04.442548] [Reference Citation Analysis]
639 Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Gerszten RE, Heimberg GS, Hoover PJ, Lieb DJ, Lin B, Ngo D, Pelka K, Reyes M, Smillie CS, Waghray A, Wood TE, Zajac AS, Jennings LL, Grundberg I, Bhattacharyya RP, Parry BA, Villani AC, Sade-Feldman M, Hacohen N, Goldberg MB. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med 2021;2:100287. [PMID: 33969320 DOI: 10.1016/j.xcrm.2021.100287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
640 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
641 Hashemi SMA, Thijssen M, Hosseini SY, Tabarraei A, Pourkarim MR, Sarvari J. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Arch Virol 2021;166:2089-108. [PMID: 33934196 DOI: 10.1007/s00705-021-05070-6] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
642 Badolato R, Cattalini M, Scaduto R, Roversi S, Galli J, Ferraro RM, Cortesi M, Orcesi S, Giliani S, Fazzi E. IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report. Clin Immunol 2021;227:108743. [PMID: 33930555 DOI: 10.1016/j.clim.2021.108743] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
643 Bastard P, Orlova E, Sozaeva L, Lévy R, James A, Schmitt MM, Ochoa S, Kareva M, Rodina Y, Gervais A, Le Voyer T, Rosain J, Philippot Q, Neehus AL, Shaw E, Migaud M, Bizien L, Ekwall O, Berg S, Beccuti G, Ghizzoni L, Thiriez G, Pavot A, Goujard C, Frémond ML, Carter E, Rothenbuhler A, Linglart A, Mignot B, Comte A, Cheikh N, Hermine O, Breivik L, Husebye ES, Humbert S, Rohrlich P, Coaquette A, Vuoto F, Faure K, Mahlaoui N, Kotnik P, Battelino T, Trebušak Podkrajšek K, Kisand K, Ferré EMN, DiMaggio T, Rosen LB, Burbelo PD, McIntyre M, Kann NY, Shcherbina A, Pavlova M, Kolodkina A, Holland SM, Zhang SY, Crow YJ, Notarangelo LD, Su HC, Abel L, Anderson MS, Jouanguy E, Neven B, Puel A, Casanova JL, Lionakis MS. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med 2021;218:e20210554. [PMID: 33890986 DOI: 10.1084/jem.20210554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
644 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
645 Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel) 2021;9:436. [PMID: 33946736 DOI: 10.3390/vaccines9050436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
646 Sui Y, Li J, Zhang R, Prabhu SK, Andersen H, Venzon D, Cook A, Brown R, Teow E, Velasco J, Greenhouse J, Putman-Taylor T, Campbell TA, Pessaint L, Moore IN, Lagenaur L, Talton J, Breed MW, Kramer J, Bock KW, Minai M, Nagata BM, Lewis MG, Wang LX, Berzofsky JA. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques. JCI Insight 2021;6:148494. [PMID: 33908897 DOI: 10.1172/jci.insight.148494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
647 Luo W, Huang L, Wang X, Ma Y, Xiao J, Song X, Liu P, Wang Y, Wang Y, Ren Z. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo. Int J Med Sci 2021;18:2561-9. [PMID: 34104087 DOI: 10.7150/ijms.56630] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
648 Hayn M, Hirschenberger M, Koepke L, Nchioua R, Straub JH, Klute S, Hunszinger V, Zech F, Prelli Bozzo C, Aftab W, Christensen MH, Conzelmann C, Müller JA, Srinivasachar Badarinarayan S, Stürzel CM, Forne I, Stenger S, Conzelmann KK, Münch J, Schmidt FI, Sauter D, Imhof A, Kirchhoff F, Sparrer KMJ. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep 2021;35:109126. [PMID: 33974846 DOI: 10.1016/j.celrep.2021.109126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
649 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
650 Banerjee A, El-Sayes N, Budylowski P, Jacob RA, Richard D, Maan H, Aguiar JA, Demian WL, Baid K, D'Agostino MR, Ang JC, Murdza T, Tremblay BJ, Afkhami S, Karimzadeh M, Irving AT, Yip L, Ostrowski M, Hirota JA, Kozak R, Capellini TD, Miller MS, Wang B, Mubareka S, McGeer AJ, McArthur AG, Doxey AC, Mossman K. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses. iScience 2021;24:102477. [PMID: 33937724 DOI: 10.1016/j.isci.2021.102477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
651 Rusmini M, Uva P, Amoroso A, Tolomeo M, Cavalli A. How Genetics Might Explain the Unusual Link Between Malaria and COVID-19. Front Med (Lausanne) 2021;8:650231. [PMID: 33981715 DOI: 10.3389/fmed.2021.650231] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
652 Mithal A, Hume AJ, Lindstrom-Vautrin J, Villacorta-Martin C, Olejnik J, Bullitt E, Hinds A, Mühlberger E, Mostoslavsky G. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response. Stem Cell Reports 2021;16:940-53. [PMID: 33852884 DOI: 10.1016/j.stemcr.2021.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
653 Ghavasieh A, Bontorin S, Artime O, Verstraete N, De Domenico M. Multiscale statistical physics of the pan-viral interactome unravels the systemic nature of SARS-CoV-2 infections. Commun Phys 2021;4. [DOI: 10.1038/s42005-021-00582-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
654 Dorgham K, Quentric P, Gökkaya M, Marot S, Parizot C, Sauce D, Guihot A, Luyt CE, Schmidt M, Mayaux J, Beurton A, Le Guennec L, Demeret S, Ben Salah E, Mathian A, Yssel H, Combadiere B, Combadiere C, Traidl-Hoffmann C, Burrel S, Marcelin AG, Amoura Z, Voiriot G, Neumann AU, Gorochov G. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol 2021;147:2098-107. [PMID: 33894209 DOI: 10.1016/j.jaci.2021.03.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
655 Farshadpour F, Taherkhani R. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations. Med Princ Pract 2021. [PMID: 33882487 DOI: 10.1159/000516693] [Reference Citation Analysis]
656 Chilosi M, Poletti V, Ravaglia C, Rossi G, Dubini A, Piciucchi S, Pedica F, Bronte V, Pizzolo G, Martignoni G, Doglioni C. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime. Mod Pathol 2021;34:1444-55. [PMID: 33883694 DOI: 10.1038/s41379-021-00808-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
657 Schönfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F, Risse J, Schmidt K, Sutharsan S, Taube C, Jöckel KH, Siffert W, Kribben A, Möhlendick B. Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study. Front Genet 2021;12:667231. [PMID: 33968142 DOI: 10.3389/fgene.2021.667231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
658 Satterfield BA, Dikilitas O, Kullo IJ. Leveraging the Electronic Health Record to Address the COVID-19 Pandemic. Mayo Clin Proc 2021;96:1592-608. [PMID: 34088418 DOI: 10.1016/j.mayocp.2021.04.008] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
659 Goel S, Saheb Sharif-Askari F, Saheb Sharif Askari N, Madkhana B, Alwaa AM, Mahboub B, Zakeri AM, Ratemi E, Hamoudi R, Hamid Q, Halwani R. SARS-CoV-2 Switches 'on' MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression. Front Pharmacol 2021;12:631879. [PMID: 33995033 DOI: 10.3389/fphar.2021.631879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
660 Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep Med 2021;2:100275. [PMID: 33899033 DOI: 10.1016/j.xcrm.2021.100275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
661 Li Y, Renner DM, Comar CE, Whelan JN, Reyes HM, Cardenas-Diaz FL, Truitt R, Tan LH, Dong B, Alysandratos KD, Huang J, Palmer JN, Adappa ND, Kohanski MA, Kotton DN, Silverman RH, Yang W, Morrisey EE, Cohen NA, Weiss SR. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc Natl Acad Sci U S A 2021;118:e2022643118. [PMID: 33811184 DOI: 10.1073/pnas.2022643118] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 40.0] [Reference Citation Analysis]
662 Mittal S, Federman HG, Sievert D, Gleeson JG. The Neurobiology of Modern Viral Scourges: ZIKV and COVID-19. Neuroscientist 2021;:10738584211009149. [PMID: 33874789 DOI: 10.1177/10738584211009149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
663 Bencze D, Fekete T, Pázmándi K. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control. Int J Mol Sci 2021;22:4190. [PMID: 33919546 DOI: 10.3390/ijms22084190] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
664 Vavassori S, Chou J, Faletti LE, Haunerdinger V, Opitz L, Joset P, Fraser CJ, Prader S, Gao X, Schuch LA, Wagner M, Hoefele J, Maccari ME, Zhu Y, Elakis G, Gabbett MT, Forstner M, Omran H, Kaiser T, Kessler C, Olbrich H, Frosk P, Almutairi A, Platt CD, Elkins M, Weeks S, Rubin T, Planas R, Marchetti T, Koovely D, Klämbt V, Soliman NA, von Hardenberg S, Klemann C, Baumann U, Lenz D, Klein-Franke A, Schwemmle M, Huber M, Sturm E, Hartleif S, Häffner K, Gimpel C, Brotschi B, Laube G, Güngör T, Buckley MF, Kottke R, Staufner C, Hildebrandt F, Reu-Hofer S, Moll S, Weber A, Kaur H, Ehl S, Hiller S, Geha R, Roscioli T, Griese M, Pachlopnik Schmid J. Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency. J Allergy Clin Immunol 2021;148:381-93. [PMID: 33872655 DOI: 10.1016/j.jaci.2021.03.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
665 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
666 Lemarquis A, Campbell T, Aranda-Guillén M, Hennings V, Brodin P, Kämpe O, Blennow K, Zetterberg H, Wennerås C, Eriksson K, Landegren N, Bryceson Y, Berg S, Ekwall O. Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis. J Allergy Clin Immunol 2021;148:96-8. [PMID: 33892926 DOI: 10.1016/j.jaci.2021.03.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
667 Monticelli M, Mele BH, Andreotti G, Cubellis MV, Riccio G. Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19. Eur J Med Genet 2021;64:104227. [PMID: 33872774 DOI: 10.1016/j.ejmg.2021.104227] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
668 Joma M, Fovet CM, Seddiki N, Gressens P, Laforge M. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns. Vaccines (Basel) 2021;9:391. [PMID: 33921113 DOI: 10.3390/vaccines9040391] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
669 Castro de Moura M, Davalos V, Planas-Serra L, Alvarez-Errico D, Arribas C, Ruiz M, Aguilera-Albesa S, Troya J, Valencia-Ramos J, Vélez-Santamaria V, Rodríguez-Palmero A, Villar-Garcia J, Horcajada JP, Albu S, Casasnovas C, Rull A, Reverte L, Dietl B, Dalmau D, Arranz MJ, Llucià-Carol L, Planas AM, Pérez-Tur J, Fernandez-Cadenas I, Villares P, Tenorio J, Colobran R, Martin-Nalda A, Soler-Palacin P, Vidal F, Pujol A, Esteller M. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine 2021;66:103339. [PMID: 33867313 DOI: 10.1016/j.ebiom.2021.103339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
670 Topless RK, Phipps-Green A, Leask M, Dalbeth N, Stamp LK, Robinson PC, Merriman TR. Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank. ACR Open Rheumatol 2021;3:333-40. [PMID: 33856739 DOI: 10.1002/acr2.11252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
671 Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol 2021;22:404-11. [PMID: 33723418 DOI: 10.1038/s41590-021-00901-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
672 Carsetti R, Quinti I, Locatelli F. COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum. Curr Opin Pulm Med 2021;27:193-8. [PMID: 33629970 DOI: 10.1097/MCP.0000000000000775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
673 Alberca RW. Animal models and COVID-19: Mechanism and comorbidities. Respirology 2021;26:616-7. [PMID: 33851474 DOI: 10.1111/resp.14043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
674 Gavriilaki E, Asteris PG, Touloumenidou T, Koravou EE, Koutra M, Papayanni PG, Karali V, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Grigoriadis S, Rapti E, Chloros D, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Sakellari I, Kalantzis IG, Parastatidis ST, Koopialipoor M, Cavaleri L, Armaghani DJ, Papadopoulou A, Brodsky RA, Kokoris S, Anagnostopoulos A. Genetic justification of severe COVID-19 using a rigorous algorithm. Clin Immunol 2021;226:108726. [PMID: 33845193 DOI: 10.1016/j.clim.2021.108726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
675 Zhang J, Zhao C, Zhao W. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. Front Immunol 2021;12:633769. [PMID: 33912161 DOI: 10.3389/fimmu.2021.633769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
676 Tougeron D, Seitz-Polski B, Hentzien M, Bani-Sadr F, Bourhis J, Ducreux M, Gaujoux S, Gorphe P, Guiu B, Hardy-Bessard AC, Hoang Xuan K, Huguet F, Lecomte T, Lièvre A, Louvet C, Maggiori L, Mariani P, Michel P, Servettaz A, Thariat J, Westeel V, Aparicio T, Blay JY, Bouché O; Thésaurus national de cancérologie digestive (TNCD)., réseau de groupes coopérateurs en oncologie (GCO)., Fédération nationale des centres de lutte contre le cancer (UNICANCER)., association de chirurgie hépato-bilio-pancréatique et transplantation (ACHBT)., association de recherche sur les cancers gynecologiques-groupes d’investigateurs nationaux pour l’étude des cancers ovariens et du sein (ARCAGY-GINECO)., Fédération francophone de cancérologie digestive (FFCD), groupe coopérateur multidisciplinaire en oncologie (GERCOR), groupe d’oncologie radiothérapie tête et cou-intergroupe ORL (GORTEC-Intergroupe ORL)., intergroupe francophone de cancérologie thoracique (IFCT)., intergroupe coopérateur de neuro-oncologie association des neuro-oncologues d’expression française (IGCNO-ANOCEF)., Société française de chirurgie digestive (SFCD)., Société française d’endoscopie digestive (SFED)., Société française de radiothérapie oncologique (SFRO)., Société française de radiologie (SFR)., Société nationale française de colo-proctologie (SNFCP)., Société nationale française de gastroentérologie (SNFGE). [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]. Bull Cancer 2021;108:614-26. [PMID: 33902918 DOI: 10.1016/j.bulcan.2021.03.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
677 Chouaki Benmansour N, Carvelli J, Vivier E. Complement cascade in severe forms of COVID-19: Recent advances in therapy. Eur J Immunol 2021;51:1652-9. [PMID: 33738806 DOI: 10.1002/eji.202048959] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
678 Chouaki Benmansour N, Carvelli J, Vivier É. [Involvement of the complement cascade in severe forms of COVID-19]. Med Sci (Paris) 2021;37:333-41. [PMID: 33835019 DOI: 10.1051/medsci/2021021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
679 Esposito S, Marchetti F, Lanari M, Caramelli F, De Fanti A, Vergine G, Iughetti L, Fornaro M, Suppiej A, Zona S, Pession A, Biasucci G; Working Group on COVID-19 in Pediatrics of the Emilia-Romagna Region (RE-CO-Ped). COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy. Int J Environ Res Public Health 2021;18:3919. [PMID: 33917940 DOI: 10.3390/ijerph18083919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
680 Schein CH. Repurposing approved drugs for cancer therapy. Br Med Bull 2021;137:13-27. [PMID: 33517358 DOI: 10.1093/bmb/ldaa045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
681 Ong SYQ, Flyamer IM, Bickmore WA, Biddie SC. From bedside to bench: regulation of host factors in SARS-CoV-2 infection. Exp Mol Med 2021;53:483-94. [PMID: 33828231 DOI: 10.1038/s12276-021-00595-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
682 Alghamdi J, Alaamery M, Barhoumi T, Rashid M, Alajmi H, Aljasser N, Alhendi Y, Alkhalaf H, Alqahtani H, Algablan O, Alshaya AI, Tashkandi N, Massadeh S, Almuzzaini B, Ehaideb SN, Bosaeed M, Ayoub K, Yezli S, Khan A, Alaskar A, Bouchama A. Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality. Genomics 2021;113:1733-41. [PMID: 33838280 DOI: 10.1016/j.ygeno.2021.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
683 Chirmule N, Nair P, Desai B, Khare R, Nerurkar V, Gaur A. Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model. medRxiv 2021:2021. [PMID: 33851191 DOI: 10.1101/2021.04.01.21254804] [Reference Citation Analysis]
684 De Sanctis JB, García AH, Moreno D, Hajduch M. Coronavirus infection: An immunologists' perspective. Scand J Immunol 2021;93:e13043. [PMID: 33783027 DOI: 10.1111/sji.13043] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
685 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
686 Pluskota-Karwatka D, Hoffmann M, Barciszewski J. Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules. J Pharm Anal 2021. [PMID: 33842018 DOI: 10.1016/j.jpha.2021.03.012] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
687 Stovbun SV, Kalinina TS, Zlenko DV, Kiselev AV, Litvin AA, Bukhvostov AA, Usachev SV, Kuznetsov DA. Antiviral potential of plant polysaccharide nanoparticles actuating non-specific immunity. Int J Biol Macromol 2021;182:743-9. [PMID: 33831450 DOI: 10.1016/j.ijbiomac.2021.03.135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
688 Hartog N, Faber W, Frisch A, Bauss J, Bupp CP, Rajasekaran S, Prokop JW. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Rev Proteomics 2021;18:105-18. [PMID: 33779460 DOI: 10.1080/14789450.2021.1908894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
689 Meyts I, Casanova JL. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur J Immunol 2021;51:1039-61. [PMID: 33729549 DOI: 10.1002/eji.202048793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
690 Bahouth MN, Venkatesan A. Acute Viral Illnesses and Ischemic Stroke: Pathophysiological Considerations in the Era of the COVID-19 Pandemic. Stroke 2021;52:1885-94. [PMID: 33794653 DOI: 10.1161/STROKEAHA.120.030630] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
691 Secolin R, de Araujo TK, Gonsales MC, Rocha CS, Naslavsky M, Marco L, Bicalho MAC, Vazquez VL, Zatz M, Silva WA, Lopes-Cendes I. Genetic variability in COVID-19-related genes in the Brazilian population. Hum Genome Var 2021;8:15. [PMID: 33824725 DOI: 10.1038/s41439-021-00146-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
692 Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell 2021;184:1990-2019. [PMID: 33811810 DOI: 10.1016/j.cell.2021.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
693 Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells 2021;10:796. [PMID: 33918318 DOI: 10.3390/cells10040796] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
694 Fricke-Galindo I, Falfán-Valencia R. Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Front Immunol 2021;12:622176. [PMID: 33868239 DOI: 10.3389/fimmu.2021.622176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
695 Jirjees F, Saad AK, Al Hano Z, Hatahet T, Al Obaidi H, Dallal Bashi YH. COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic? Infect Dis Rep 2021;13:259-84. [PMID: 33915690 DOI: 10.3390/idr13020029] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
696 Das A, Ahmed R, Akhtar S, Begum K, Banu S. An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies. Gene Rep 2021;23:101122. [PMID: 33821222 DOI: 10.1016/j.genrep.2021.101122] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
697 Harker JA, Lloyd CM. Overlapping and distinct features of viral and allergen immunity in the human lung. Immunity 2021;54:617-31. [PMID: 33852829 DOI: 10.1016/j.immuni.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
698 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 63] [Article Influence: 17.0] [Reference Citation Analysis]
699 Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, Clementi M, Mancini N. Viral Respiratory Pathogens and Lung Injury. Clin Microbiol Rev 2021;34:e00103-20. [PMID: 33789928 DOI: 10.1128/CMR.00103-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
700 O'Rourke RW, Lumeng CN. Pathways to Severe COVID-19 for People with Obesity. Obesity (Silver Spring) 2021;29:645-53. [PMID: 33270351 DOI: 10.1002/oby.23099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
701 Sposito B, Broggi A, Pandolfi L, Crotta S, Ferrarese R, Sisti S, Clementi N, Ambrosi A, Liu E, Frangipane V, Saracino L, Marongiu L, Facchini FA, Bottazzi A, Fossali T, Colombo R, Clementi M, Tagliabue E, Pontiroli AE, Meloni F, Wack A, Mancini N, Zanoni I. Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients. bioRxiv 2021:2021. [PMID: 33821280 DOI: 10.1101/2021.03.30.437173] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
702 Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, Kosti I, Leon KE, Bunis DG, Li C, Kumar GR, White KM, García-Sastre A, Ott M, Sirota M. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Res Sq 2021:rs. [PMID: 33821262 DOI: 10.21203/rs.3.rs-333578/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
703 Jagannathan P, Andrews JR, Bonilla H, Hedlin H, Jacobson KB, Balasubramanian V, Purington N, Kamble S, de Vries CR, Quintero O, Feng K, Ley C, Winslow D, Newberry J, Edwards K, Hislop C, Choong I, Maldonado Y, Glenn J, Bhatt A, Blish C, Wang T, Khosla C, Pinsky BA, Desai M, Parsonnet J, Singh U. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Nat Commun 2021;12:1967. [PMID: 33785743 DOI: 10.1038/s41467-021-22177-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
704 Nachega JB, Maeurer M, Sam-Agudu NA, Chakaya J, Katoto PDM, Zumla A. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Int J Infect Dis 2021:S1201-9712(21)00279-4. [PMID: 33794380 DOI: 10.1016/j.ijid.2021.03.060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [